name	nt_name	aa_name	multi_aa_name	multiaa_comb_mutation	start	vcf_gene	chrom_region	mutation_type	sequence_depth	sample_size	ps_filter	ps_exc	mat_pep_id	mat_pep_desc	mat_pep_acc	ro	ao	reference_seq	variant_seq	viral_lineages	function_category	citation	comb_mutation	function_description	heterozygosity	clade_defining	who_variant	status	voi_designation_date	voc_designation_date	vum_designation_date
c.-3delA	c.-3delA				28270	N	intergenic		47631	1,924						64	47549.0,0.0,0.0	TA	T	B.1.617.2, B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.28, AY.111, AY.111, AY.104, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.26, AY.29, AY.29, AY.3.1, AY.3.1, AY.107, AY.107, AY.110, AY.110, AY.1, AY.1, AY.34, AY.34, AY.2, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.38, AY.46.4, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.10, AY.75.1, AY.75.1, AY.33, AY.33, AY.46.2, AY.46.2, AY.41, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.64, AY.4.2, AY.4.2, AY.48, AY.65, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.88, AY.5, AY.5, AY.57, AY.57, AY.20, AY.20, AY.32, AY.32, AY.39, AY.39, AY.35, AY.35, AY.46, AY.46, AY.72, AY.72, AY.59, AY.59, AY.9.2, AY.9.2, AY.43, AY.43, AY.9.1, AY.9.1, AY.75, AY.75, AY.47, AY.47, AY.46.1, AY.46.1, AY.55, AY.55, AY.92, AY.92, AY.42, AY.42, AY.73, AY.73, AY.98.1, AY.98.1, AY.87, AY.87, AY.108, AY.108, AY.81, AY.81, AY.54, AY.54, AY.61, AY.61, AY.85, AY.85, AY.9.2.1, AY.9.2.1, AY.67, AY.67, AY.37, AY.37, AY.39.1, AY.39.1, AY.46.6, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.82, AY.77, AY.77, AY.9, AY.9, AY.24, AY.24, AY.84, AY.84, AY.68, AY.68, AY.99, AY.99, AY.70, AY.70, AY.51, AY.51, AY.62, AY.62, AY.7.1, AY.7.1, AY.74, AY.74, AY.27, AY.27, AY.25, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
c.A-3G	c.A-3G				263	orf1ab	5' UTR		5	5						4	1.0,0.0,0.0	A	G	AY.55					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.A-3G	c.A-3G				27891	ORF8	intergenic		8	8						7	1.0,0.0,0.0	A	G	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.A-41T	c.A-41T				27853	ORF8	intergenic		12	12						10	2.0,0.0,0.0	A	T	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.A29700G	c.A*4316G				29700	intergenic	3' UTR		449	410						25	424.0,0.0,0.0	A	G	AY.44, AY.54					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
c.A29723G	c.A*4339G				29723	intergenic	3' UTR		34	34						29	5.0,0.0,0.0	A	G	AY.47					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-119T	c.C-119T				147	orf1ab	5' UTR		27	27						5	22.0,0.0,0.0	C	T	AY.109					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-11T	c.C-11T				255	orf1ab	5' UTR		10	10						9	1.0,0.0,0.0	C	T	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-125T	c.C-125T				27769	ORF8	intergenic		40	35						3	37.0,0.0,0.0	C	T	AY.48, AY.53, AY.51					False	True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-17T	c.C-17T				29541	ORF10	intergenic		2	2						0	2.0,0.0,0.0	C	T	AY.37					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-1T	c.C-1T				27393	ORF7a	intergenic		1	1						0	1.0,0.0,0.0	C	T	AY.7.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-20T	c.C-20T				27874	ORF8	intergenic		12975	1,924						721	12254.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.111, AY.104, AY.103, AY.100, AY.106, AY.12, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.46.4, AY.4.5, AY.44, AY.33, AY.46.2, AY.41, AY.102, AY.4.2, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.5, AY.20, AY.32, AY.39, AY.46, AY.43, AY.46.1, AY.92, AY.42, AY.98.1, AY.87, AY.108, AY.85, AY.39.1, AY.46.6, AY.4.3, AY.99.2, AY.93, AY.82, AY.84, AY.99, AY.7.1, AY.25					False	False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, True, True, True, True, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-25T	c.C-25T				241	orf1ab	5' UTR		26002	1,924						3	25999.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-41T	c.C-41T				225	orf1ab	5' UTR		3	3						1	2.0,0.0,0.0	C	T	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-73T	c.C-73T				193	orf1ab	5' UTR		43	43						2	41.0,0.0,0.0	C	T	AY.54					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-87T	c.C-87T				27807	ORF8	intergenic		43	30						15	28.0,0.0,0.0	C	T	AY.16, AY.18					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-90T	c.C-90T				176	orf1ab	5' UTR		5	5						4	1.0,0.0,0.0	C	T	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.C-94A	c.C-94A				27800	ORF8	intergenic		6	6						3	3.0,0.0,0.0	C	A	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.C29696G	c.C*4312G				29696	intergenic	3' UTR		9	9						7	2.0,0.0,0.0	C	G	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.C29708T	c.C*4324T				29708	intergenic	3' UTR		20	20						14	6.0,0.0,0.0	C	T	AY.107					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.C29733T	c.C*4349T				29733	intergenic	Stem-loop,3' UTR		14	7						12	2.0,0.0,0.0	C	T	AY.100, AY.29					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
c.C29750T	c.C*4366T				29750	intergenic	Stem-loop,3' UTR		8	8						7	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.CCACG29738TCACT	c.CCACG*4354_*4358TCACT				29738	intergenic	Stem-loop,3' UTR		126	160						0	125.0,0.0,0.0	CCACG	TCACT	AY.36					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
c.G-114A	c.G-114A				152	orf1ab	5' UTR		20	20						18	2.0,0.0,0.0	G	A	AY.107					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G-161T	c.G-161T				105	orf1ab	5' UTR		4	4						3	1.0,0.0,0.0	G	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G-1T	c.G-1T				29557	ORF10	intergenic		114	114						98	16.0,0.0,0.0	G	T	AY.43					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G-47T	c.G-47T				219	orf1ab	5' UTR		130	130						1	129.0,0.0,0.0	G	T	AY.10					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
c.G-53T	c.G-53T				27841	ORF8	intergenic		78	78						66	12.0,0.0,0.0	G	T	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G-56C	c.G-56C				210	orf1ab	5' UTR		130	130						0	10.0,120.0,0.0	G	C,T	AY.10					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
c.G-56T	c.G-56T				210	orf1ab	5' UTR		25875	1,924						2	25873.0,0.0,0.0	G	T	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
c.G-5T	c.G-5T				29553	ORF10	intergenic		5	5	mask	highly_homoplasic,single_src				4	1.0,0.0,0.0	G	T	AY.55					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G-62T	c.G-62T				204	orf1ab	5' UTR		41	41						35	6.0,0.0,0.0	G	T	AY.13					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G-92T	c.G-92T				174	orf1ab	5' UTR		22	22						18	4.0,0.0,0.0	G	T	AY.108					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G-96T	c.G-96T				27798	ORF8	intergenic		16	16						14	2.0,0.0,0.0	G	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29688T	c.G*4304T				29688	intergenic	3' UTR		31	20						9	22.0,0.0,0.0	G	T	AY.64, AY.55, AY.24					False	True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29690T	c.G*4306T				29690	intergenic	3' UTR		5	5						4	1.0,0.0,0.0	G	T	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29692T	c.G*4308T				29692	intergenic	3' UTR		5	5						4	1.0,0.0,0.0	G	T	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29705T	c.G*4321T				29705	intergenic	3' UTR		6	6						1	5.0,0.0,0.0	G	T	AY.70					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29706T	c.G*4322T				29706	intergenic	3' UTR		52	52						43	9.0,0.0,0.0	G	T	AY.26					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29737T	c.G*4353T				29737	intergenic	Stem-loop,3' UTR		20	20	caution	ambiguous,single_src				17	3.0,0.0,0.0	G	T	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29742T	c.G*4358T				29742	intergenic	Stem-loop,3' UTR		25436	1,924						1	25433.0,0.0,0.0	G	T	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29759T	c.G*4375T				29759	intergenic	Stem-loop,3' UTR		3	3						1	2.0,0.0,0.0	G	T	AY.12					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29777A	c.G*4393A				29777	intergenic	3' UTR		7	12						6	1.0,0.0,0.0	G	A	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29777T	c.G*4393T				29777	intergenic	3' UTR		54	20						47	7.0,0.0,0.0	G	T	AY.64, AY.75, AY.24					False	False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29783T	c.G*4399T				29783	intergenic	3' UTR		3	11	mask	highly_homoplasic				2	1.0,0.0,0.0	G	T	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.G29810T	c.G*4426T				29810	intergenic	3' UTR		7	12	mask	seq_end				6	1.0,0.0,0.0	G	T	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
c.T-16C	c.T-16C				27878	ORF8	intergenic		4	4						3	1.0,0.0,0.0	T	C	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.157del	c.467_472delAGTTCA	p.E156_R158delinsG	E156_R158delinsG	'E156del', 'R158G'	22028	S	S		50560	1,924						16	50544.0,0.0,0.0	GAGTTCA	G	B.1.617.2, B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.28, AY.111, AY.111, AY.104, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.26, AY.29, AY.29, AY.3.1, AY.3.1, AY.107, AY.107, AY.110, AY.110, AY.1, AY.1, AY.34, AY.34, AY.2, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.38, AY.46.4, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.10, AY.75.1, AY.75.1, AY.33, AY.33, AY.46.2, AY.46.2, AY.41, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.64, AY.4.2, AY.4.2, AY.48, AY.48, AY.65, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.88, AY.5, AY.5, AY.57, AY.57, AY.20, AY.20, AY.32, AY.32, AY.39, AY.39, AY.35, AY.35, AY.46, AY.46, AY.72, AY.72, AY.59, AY.59, AY.9.2, AY.9.2, AY.43, AY.43, AY.9.1, AY.9.1, AY.75, AY.75, AY.47, AY.47, AY.46.1, AY.46.1, AY.55, AY.55, AY.92, AY.92, AY.42, AY.42, AY.98.1, AY.98.1, AY.87, AY.87, AY.108, AY.108, AY.81, AY.81, AY.54, AY.54, AY.61, AY.61, AY.85, AY.85, AY.9.2.1, AY.9.2.1, AY.67, AY.67, AY.39.1, AY.39.1, AY.46.6, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.82, AY.77, AY.77, AY.9, AY.9, AY.24, AY.24, AY.84, AY.84, AY.68, AY.68, AY.99, AY.99, AY.70, AY.70, AY.51, AY.51, AY.7.1, AY.7.1, AY.74, AY.74, AY.27, AY.27, AY.25, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.221	c.GGAC657_660TGAT	p.221			922	orf1ab	ORF1ab		9	9			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	7	2.0,0.0,0.0	GGAC	TGAT	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1016S	c.G3046T	p.A1016S			24608	S	S	MISSENSE	5	5						4	1.0,0.0,0.0	G	T	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A103_P104insP	c.307_308insCCC	p.A103_P104insP			25699	ORF3a	ORF3a		7	7						0	7.0,0.0,0.0	G	GCCC	AY.34					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1078S	c.G3232T	p.A1078S			24794	S	S	MISSENSE	3	3						0	3.0,0.0,0.0	G	T	AY.28					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1087S	c.G3259T	p.A1087S			24821	S	S	MISSENSE	9	9						8	1.0,0.0,0.0	G	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A110S	c.G328T	p.A110S			25720	ORF3a	ORF3a	MISSENSE	8	8						7	1.0,0.0,0.0	G	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1146T	c.G3436A	p.A1146T			3701	orf1ab	ORF1ab	MISSENSE	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	G	A	AY.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A119S	c.G355T	p.A119S			28628	N	N	MISSENSE	160	160						144	16.0,0.0,0.0	G	T	AY.36					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A125V	c.C374T	p.A125V			28647	N	N	MISSENSE	4561	4,563						4099	462.0,0.0,0.0	C	T	AY.74					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1283V	c.C3848T	p.A1283V			4113	orf1ab	ORF1ab	MISSENSE	9	9			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	7	2.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1298V	c.C3893T	p.A1298V			4158	orf1ab	ORF1ab	MISSENSE	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	1.0,0.0,0.0	C	T	AY.39.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1306S	c.G3916T	p.A1306S			4181	orf1ab	ORF1ab	MISSENSE	12983	1,924			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	726	12184.0,73.0,0.0	G	T	B.1.617.2, AY.109, AY.19, AY.111, AY.104, AY.103, AY.100, AY.106, AY.12, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.46.4, AY.4.5, AY.44, AY.33, AY.46.2, AY.41, AY.102, AY.4.2, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.5, AY.20, AY.32, AY.39, AY.46, AY.43, AY.9.1, AY.46.1, AY.92, AY.42, AY.98.1, AY.87, AY.108, AY.85, AY.39.1, AY.46.6, AY.4.3, AY.99.2, AY.93, AY.82, AY.84, AY.99, AY.7.1, AY.25					False	False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1306V	c.C3917T	p.A1306V			4182	orf1ab	ORF1ab	MISSENSE	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	1.0,0.0,0.0	C	T	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1314A	c.G3942T	p.A1314A			4207	orf1ab	ORF1ab	SILENT	159	160			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	141	18.0,0.0,0.0	G	T	AY.36					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1352A	c.C4056T	p.A1352A			4321	orf1ab	ORF1ab	SILENT	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	3	2.0,0.0,0.0	C	T	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1352T	c.G4054A	p.A1352T			4319	orf1ab	ORF1ab	MISSENSE	8	8			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	3.0,0.0,0.0	G	A	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A138A	c.C414T	p.A138A			679	orf1ab	ORF1ab	SILENT	17	17			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	15	2.0,0.0,0.0	C	T	AY.18					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1397A	c.C4191T	p.A1397A			4456	orf1ab	ORF1ab	SILENT	18	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	12	6.0,0.0,0.0	C	T	AY.111, AY.106, AY.55, AY.67, AY.51					False	True, False, False, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1432E	c.C4295A	p.A1432E			4560	orf1ab	ORF1ab	MISSENSE	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	1.0,0.0,0.0	C	A	AY.17					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A1432V	c.C4295T	p.A1432V			4560	orf1ab	ORF1ab	MISSENSE	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	3.0,0.0,0.0	C	T	AY.100					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A163A	c.G489T	p.A163A			22051	S	S	SILENT	30	15						4	26.0,0.0,0.0	G	T	AY.98.1, AY.98.1					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A2040V	c.C6119T	p.A2040V			6384	orf1ab	ORF1ab	MISSENSE	3	3			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	1.0,0.0,0.0	C	T	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A206A	c.A618G	p.A206A			883	orf1ab	ORF1ab	SILENT	25	25			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	20	5.0,0.0,0.0	A	G	AY.9.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A208S	c.G622T	p.A208S			28895	N	N	MISSENSE	160	152						129	31.0,0.0,0.0	G	T	AY.103, AY.46.6					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A2129V	c.C6386T	p.A2129V			6651	orf1ab	ORF1ab	MISSENSE	9	9			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A222V	c.C665T	p.A222V			22227	S	S	MISSENSE	29196	1,924						3461	25735.0,0.0,0.0	C	T	B.1.617.2, B.1.617.2, AY.28, AY.28, AY.106, AY.26, AY.26, AY.2, AY.2, AY.38, AY.38, AY.10, AY.10, AY.75.1, AY.75.1, AY.64, AY.4.2, AY.4.2, AY.65, AY.65, AY.45, AY.45, AY.60, AY.60, AY.88, AY.57, AY.57, AY.35, AY.35, AY.72, AY.72, AY.59, AY.59, AY.9.2, AY.9.1, AY.9.1, AY.75, AY.75, AY.47, AY.47, AY.46.1, AY.46.1, AY.55, AY.55, AY.73, AY.61, AY.61, AY.9.2.1, AY.9.2.1, AY.67, AY.67, AY.37, AY.63, AY.63, AY.9, AY.9, AY.24, AY.24, AY.68, AY.68, AY.70, AY.70, AY.62, AY.74, AY.74, AY.27, AY.27	antibody epitope effects	McCallum et al. (2021)		"Not associated with significant reduction of EC50 (recognition) in any antigenic supersite ""i"" monoclonal antibodies."	False	False, False, True, True, False, True, True, True, True, True, True, True, True, False, False, True, True, True, True, True, False, False, True, True, False, True, True, False, False, True, True, True, True, True, False, False, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, False, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A222V	c.C665T	p.A222V			22227	S	S	MISSENSE	29194	1,924						3461	25733.0,0.0,0.0	C	T	B.1.617.2, B.1.617.2, AY.28, AY.28, AY.106, AY.26, AY.26, AY.2, AY.2, AY.38, AY.38, AY.10, AY.10, AY.75.1, AY.75.1, AY.64, AY.4.2, AY.4.2, AY.65, AY.65, AY.45, AY.45, AY.60, AY.60, AY.88, AY.57, AY.57, AY.35, AY.35, AY.72, AY.72, AY.59, AY.59, AY.9.2, AY.9.1, AY.9.1, AY.75, AY.75, AY.47, AY.47, AY.46.1, AY.46.1, AY.55, AY.55, AY.73, AY.61, AY.61, AY.9.2.1, AY.9.2.1, AY.37, AY.63, AY.63, AY.9, AY.9, AY.24, AY.24, AY.68, AY.68, AY.70, AY.70, AY.62, AY.74, AY.74, AY.27, AY.27	humoral response durability	Brehm et al. (2021)	'D614G'	27yo female nurse reinfected in December 2020 (B.1.177) after initial infection in March 2020 (B.3), i.e. with a  9 month interval. Both cases were mild. No significant differences in the neutralizing capacity of the two linages were observed in 4 sera taken (1 pre-reinfection,  three post-reinfection). Neutralizing antibody titres (IC50) before and immediately after re-infection were <300 against  both strains, and jumped >7x upon re-infection. Viral titres were also higher in the second case. Second case also includes N:p.A220V	False	False, False, True, True, False, True, True, True, True, True, True, True, True, False, False, True, True, True, True, True, False, False, True, True, False, True, True, False, False, True, True, True, True, True, False, False, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, False, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A222V	c.C665T	p.A222V			22227	S	S	MISSENSE	29194	1,924						3461	25733.0,0.0,0.0	C	T	B.1.617.2, B.1.617.2, AY.28, AY.28, AY.106, AY.26, AY.26, AY.2, AY.2, AY.38, AY.38, AY.10, AY.10, AY.75.1, AY.75.1, AY.64, AY.4.2, AY.4.2, AY.65, AY.65, AY.45, AY.45, AY.60, AY.60, AY.88, AY.57, AY.57, AY.35, AY.35, AY.72, AY.72, AY.59, AY.59, AY.9.2, AY.9.1, AY.9.1, AY.75, AY.75, AY.47, AY.47, AY.46.1, AY.46.1, AY.55, AY.55, AY.73, AY.61, AY.61, AY.9.2.1, AY.9.2.1, AY.37, AY.63, AY.63, AY.9, AY.9, AY.24, AY.24, AY.68, AY.68, AY.70, AY.70, AY.62, AY.74, AY.74, AY.27, AY.27	reinfection	Brehm et al. (2021)	'D614G'	27yo female nurse reinfected in December 2020 (B.1.177) after initial infection in March 2020 (B.3). Both cases were mild. Second case also includes N:p.A220V	False	False, False, True, True, False, True, True, True, True, True, True, True, True, False, False, True, True, True, True, True, False, False, True, True, False, True, True, False, False, True, True, True, True, True, False, False, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, False, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A2249V	c.C6746T	p.A2249V			7011	orf1ab	ORF1ab	MISSENSE	4	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	3	1.0,0.0,0.0	C	T	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A2470A	c.G7410T	p.A2470A			7675	orf1ab	ORF1ab	SILENT	3	3			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	1.0,0.0,0.0	G	T	AY.46.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A2529V	c.C7586T	p.A2529V			7851	orf1ab	ORF1ab	MISSENSE	87	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	87.0,0.0,0.0	C	T	AY.4.5, AY.4.2, AY.4, AY.4.3					False	True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A252S	c.G754T	p.A252S			29027	N	N	MISSENSE	394	394						351	43.0,0.0,0.0	G	T	AY.9.2.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A2554V	c.C7661T	p.A2554V			7926	orf1ab	ORF1ab	MISSENSE	408	410			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	9	399.0,0.0,0.0	C	T	AY.44					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A2557A	c.G7671T	p.A2557A			7936	orf1ab	ORF1ab	SILENT	3	3			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	3.0,0.0,0.0	G	T	AY.41					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A260A	c.A780T	p.A260A			1045	orf1ab	ORF1ab	SILENT	1	1			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	1.0,0.0,0.0	A	T	AY.62					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A2616V	c.C7847T	p.A2616V			8112	orf1ab	ORF1ab	MISSENSE	70	70			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	63	7.0,0.0,0.0	C	T	AY.3					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A262S	c.G784T	p.A262S			22346	S	S	MISSENSE	30	24						21	9.0,0.0,0.0	G	T	AY.33, AY.41, AY.41					False	False, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A27S	c.G79T	p.A27S			21641	S	S	MISSENSE	27	24						19	8.0,0.0,0.0	G	T	AY.39, AY.53					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A2994V	c.C8981T	p.A2994V			9246	orf1ab	ORF1ab	MISSENSE	3	3			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	0	3.0,0.0,0.0	C	T	AY.28					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A2S	c.G4T	p.A2S			26526	M	M	MISSENSE	30	30						27	3.0,0.0,0.0	G	T	AY.16	immunosuppression variant emergence	Avanzato et al. (2020)		Emergent as 16% variant by day 70 post-infection of female immunocompromised  individual with chronic lymphocytic leukemia and acquired hypogammaglobulinemia.  Variant became 100% in day 70 culture. Variant disappeared after convalescent plasma treatment (day 71) in subsequent patient sample sequencing.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A313A	c.G939T	p.A313A			29212	N	N	SILENT	25	25						22	3.0,0.0,0.0	G	T	AY.38					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3209V	c.C9626T	p.A3209V			9891	orf1ab	ORF1ab	MISSENSE	14963	1,924			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	1475	13488.0,0.0,0.0	C	T	B.1.617.2, AY.19, AY.28, AY.16, AY.106, AY.40, AY.15, AY.14, AY.26, AY.2, AY.13, AY.17, AY.38, AY.10, AY.75.1, AY.18, AY.64, AY.65, AY.45, AY.60, AY.88, AY.57, AY.35, AY.72, AY.59, AY.9.2, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.73, AY.81, AY.54, AY.61, AY.9.2.1, AY.67, AY.37, AY.53, AY.63, AY.77, AY.9, AY.24, AY.68, AY.70, AY.51, AY.62, AY.74, AY.27					False	False, False, True, True, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, False, True, True, True, False, True, True, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3270A	c.A9810G	p.A3270A			10075	orf1ab	ORF1ab	SILENT	70	70			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	59	11.0,0.0,0.0	A	G	AY.3					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3333V	c.C9998T	p.A3333V			10263	orf1ab	ORF1ab	MISSENSE	10	10			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	9	1.0,0.0,0.0	C	T	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3357T	c.G10069A	p.A3357T			10334	orf1ab	ORF1ab	MISSENSE	9	9			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	8	1.0,0.0,0.0	G	A	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3392V	c.C10175T	p.A3392V			10440	orf1ab	ORF1ab	MISSENSE	6	6			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	5	1.0,0.0,0.0	C	T	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3523A	c.C10569A	p.A3523A			10834	orf1ab	ORF1ab	SILENT	2	2			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	1	1.0,0.0,0.0	C	A	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3523A	c.C10569T	p.A3523A			10834	orf1ab	ORF1ab	SILENT	7	7			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	6	1.0,0.0,0.0	C	T	AY.100					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A354V	c.C1061T	p.A354V			1326	orf1ab	ORF1ab	MISSENSE	2	2			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	1.0,0.0,0.0	C	T	AY.104					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3571A	c.A10713G	p.A3571A			10978	orf1ab	ORF1ab	SILENT	5	5			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	2	3.0,0.0,0.0	A	G	AY.55					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3571V	c.C10712T	p.A3571V			10977	orf1ab	ORF1ab	MISSENSE	55	5			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	18	37.0,0.0,0.0	C	T	AY.46.4, AY.46.2, AY.65, AY.46, AY.46.1, AY.46.6					False	True, True, False, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3610A	c.C10830T	p.A3610A			11095	orf1ab	ORF1ab	SILENT	5	5			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	4	1.0,0.0,0.0	C	T	AY.55					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A381S	c.G1141T	p.A381S			29414	N	N	MISSENSE	160	160						118	42.0,0.0,0.0	G	T	AY.36					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3837A	c.C11511T	p.A3837A			11776	orf1ab	ORF1ab	SILENT	9	9			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	7	2.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A385V	c.C1154T	p.A385V			1419	orf1ab	ORF1ab	MISSENSE	30	30			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	26	4.0,0.0,0.0	C	T	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A38A	c.C114T	p.A38A			26636	M	M	SILENT	11	11						9	2.0,0.0,0.0	C	T	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A3995A	c.A11985T	p.A3995A			12250	orf1ab	ORF1ab	SILENT	48	48			nsp8	produced by both pp1a and pp1ab	YP_009725304.1	13	35.0,0.0,0.0	A	T	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A4123A	c.A12369G	p.A4123A			12634	orf1ab	ORF1ab	SILENT	2	2			nsp8	produced by both pp1a and pp1ab	YP_009725304.1	1	1.0,0.0,0.0	A	G	AY.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A421A	c.C1263A	p.A421A			1528	orf1ab	ORF1ab	SILENT	17	17			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	15	2.0,0.0,0.0	C	A	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A4247T	c.G12739A	p.A4247T			13004	orf1ab	ORF1ab	MISSENSE	3	3			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab	YP_009725305.1	2	1.0,0.0,0.0	G	A	AY.53					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A4357V	c.C13070T	p.A4357V			13335	orf1ab	ORF1ab	MISSENSE	5	5			nsp10	nsp10_CysHis, formerly known as growth-factor-like protein (GFL), produced by both pp1a and pp1ab	YP_009725306.1	4	1.0,0.0,0.0	C	T	AY.55					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A4577V	c.C13730T	p.A4577V			13994	orf1ab	ORF1ab	MISSENSE	15	15			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	15.0,0.0,0.0	C	T	AY.82					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A4771V	c.C14312T	p.A4771V			14576	orf1ab	ORF1ab	MISSENSE	7	7			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	6	1.0,0.0,0.0	C	T	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A4815V	c.C14444T	p.A4815V			14708	orf1ab	ORF1ab	MISSENSE	6	6			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	6.0,0.0,0.0	C	T	AY.17					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A4840A	c.T14520C	p.A4840A			14784	orf1ab	ORF1ab	SILENT	17	17			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	8	9.0,0.0,0.0	T	C	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A4921V	c.C14762T	p.A4921V			15026	orf1ab	ORF1ab	MISSENSE	28	20			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	25	3.0,0.0,0.0	C	T	AY.64, AY.46.6					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5026A	c.C15078A	p.A5026A			15342	orf1ab	ORF1ab	SILENT	6	6			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	5	1.0,0.0,0.0	C	A	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5048S	c.G15142T	p.A5048S			15406	orf1ab	ORF1ab	MISSENSE	33	9			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	29	4.0,0.0,0.0	G	T	AY.106, AY.33					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5094A	c.C15282T	p.A5094A			15546	orf1ab	ORF1ab	SILENT	1917	1,924			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	1703	214.0,0.0,0.0	C	T	B.1.617.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A516V	c.C1547T	p.A516V			1812	orf1ab	ORF1ab	MISSENSE	3	3			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	2.0,0.0,0.0	C	T	AY.41					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A520A	c.C1560T	p.A520A			1825	orf1ab	ORF1ab	SILENT	1	1			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	1.0,0.0,0.0	C	T	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5232A	c.C15696T	p.A5232A			15960	orf1ab	ORF1ab	SILENT	8	8			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	7	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5270V	c.C15809T	p.A5270V			16073	orf1ab	ORF1ab	MISSENSE	8	8			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	5	3.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A540V	c.C1619T	p.A540V			1884	orf1ab	ORF1ab	MISSENSE	20	20			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	17	3.0,0.0,0.0	C	T	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5476A	c.T16428C	p.A5476A			16692	orf1ab	ORF1ab	SILENT	30	30			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	24	6.0,0.0,0.0	T	C	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A54S	c.G160T	p.A54S			25552	ORF3a	ORF3a	MISSENSE	10	10						9	1.0,0.0,0.0	G	T	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A54V	c.C161T	p.A54V			25553	ORF3a	ORF3a	MISSENSE	41	41						14	27.0,0.0,0.0	C	T	AY.13					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5532T	c.G16594A	p.A5532T			16858	orf1ab	ORF1ab	MISSENSE	30	30			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	24	6.0,0.0,0.0	G	A	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5532V	c.C16595T	p.A5532V			16859	orf1ab	ORF1ab	MISSENSE	17	17			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	0	17.0,0.0,0.0	C	T	AY.18					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5620S	c.G16858T	p.A5620S			17122	orf1ab	ORF1ab	MISSENSE	9	7			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	0	9.0,0.0,0.0	G	T	AY.100, AY.60					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A566T	c.G1696A	p.A566T			1961	orf1ab	ORF1ab	MISSENSE	5	5			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	4	1.0,0.0,0.0	G	A	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5686A	c.A17058T	p.A5686A			17322	orf1ab	ORF1ab	SILENT	6	6			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	3	3.0,0.0,0.0	A	T	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5727S	c.G17179T	p.A5727S			17443	orf1ab	ORF1ab	MISSENSE	6	6			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	4	2.0,0.0,0.0	G	T	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5770A	c.T17310C	p.A5770A			17574	orf1ab	ORF1ab	SILENT	24	25			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	16	8.0,0.0,0.0	T	C	AY.9.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A591V	c.C1772T	p.A591V			2037	orf1ab	ORF1ab	MISSENSE	409	410			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	246	163.0,0.0,0.0	C	T	AY.44					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A5922S	c.G17764T	p.A5922S			18028	orf1ab	ORF1ab	MISSENSE	95	95			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	80	15.0,0.0,0.0	G	T	AY.86					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A599A	c.C1797T	p.A599A			2062	orf1ab	ORF1ab	SILENT	6	6			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	3	3.0,0.0,0.0	C	T	AY.63					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A599V	c.C1796T	p.A599V			2061	orf1ab	ORF1ab	MISSENSE	103	25			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	17	86.0,0.0,0.0	C	T	AY.38, AY.20					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6025S	c.G18073T	p.A6025S			18337	orf1ab	ORF1ab	MISSENSE	20	20			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	18	2.0,0.0,0.0	G	T	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6044V	c.C18131T	p.A6044V			18395	orf1ab	ORF1ab	MISSENSE	3	3			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	3.0,0.0,0.0	C	T	AY.41					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6139V	c.C18416T	p.A6139V			18680	orf1ab	ORF1ab	MISSENSE	1	1			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	1.0,0.0,0.0	C	T	AY.3.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6285V	c.C18854T	p.A6285V			19118	orf1ab	ORF1ab	MISSENSE	409	410			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	277	132.0,0.0,0.0	C	T	AY.44					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6319V	c.C18956T	p.A6319V			19220	orf1ab	ORF1ab	MISSENSE	12980	1,924			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	725	12255.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.111, AY.104, AY.103, AY.100, AY.106, AY.12, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.46.4, AY.4.5, AY.44, AY.33, AY.46.2, AY.41, AY.102, AY.4.2, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.5, AY.20, AY.32, AY.39, AY.46, AY.43, AY.9.1, AY.46.1, AY.92, AY.42, AY.98.1, AY.87, AY.108, AY.85, AY.39.1, AY.46.6, AY.4.3, AY.99.2, AY.93, AY.82, AY.84, AY.99, AY.7.1, AY.25					False	False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6533V	c.C19598T	p.A6533V			19862	orf1ab	ORF1ab	MISSENSE	30	30			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	26	4.0,0.0,0.0	C	T	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6544V	c.C19631T	p.A6544V			19895	orf1ab	ORF1ab	MISSENSE	43	43			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	20	23.0,0.0,0.0	C	T	AY.54					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6546S	c.G19636T	p.A6546S			19900	orf1ab	ORF1ab	MISSENSE	9	9			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	8	1.0,0.0,0.0	G	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A656V	c.C1967T	p.A656V			2232	orf1ab	ORF1ab	MISSENSE	27	27			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	23	4.0,0.0,0.0	C	T	AY.19					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6589A	c.C19767T	p.A6589A			20031	orf1ab	ORF1ab	SILENT	3	3			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	0	3.0,0.0,0.0	C	T	AY.53					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A65S	c.G193T	p.A65S			28086	ORF8	ORF8	MISSENSE	58	41						34	23.0,0.0,0.0	G	T	AY.13, AY.98.1, AY.84					False	False, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A65V	c.C194T	p.A65V			28087	ORF8	ORF8	MISSENSE	254	17						225	29.0,0.0,0.0	C	T	AY.92, AY.61					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6843A	c.A20529T	p.A6843A			20793	orf1ab	ORF1ab	SILENT	1	1			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	0	1.0,0.0,0.0	A	T	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A684A	c.A2052T	p.A684A			23614	S	S	SILENT	1	1						0	1.0,0.0,0.0	A	T	AY.111					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A687V	c.C2060T	p.A687V			2325	orf1ab	ORF1ab	MISSENSE	7098	7,103			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	6313	785.0,0.0,0.0	C	T	AY.27					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6914V	c.C20741T	p.A6914V			21005	orf1ab	ORF1ab	MISSENSE	24	24			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	18	6.0,0.0,0.0	C	T	AY.33					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A6997A	c.G20991T	p.A6997A			21255	orf1ab	ORF1ab	SILENT	34	25			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	19	15.0,0.0,0.0	G	T	AY.38, AY.81, AY.70					False	False, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A701S	c.G2101T	p.A701S			23663	S	S	MISSENSE	3	3						0	3.0,0.0,0.0	G	T	AY.28					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A706V	c.C2117T	p.A706V			23679	S	S	MISSENSE	1	1						0	1.0,0.0,0.0	C	T	AY.46.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A776A	c.T2328G	p.A776A			2593	orf1ab	ORF1ab	SILENT	6	6			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	4	2.0,0.0,0.0	T	G	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A79D	c.C236A	p.A79D			27629	ORF7a	ORF7a	MISSENSE	1	1						0	1.0,0.0,0.0	C	A	AY.7.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A845S	c.G2533T	p.A845S			24095	S	S	MISSENSE	122	27						7	115.0,0.0,0.0	G	T	AY.19, AY.86					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.A846V	c.C2537T	p.A846V			24099	S	S	MISSENSE	8	8						7	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A872A	c.C2616A	p.A872A			2881	orf1ab	ORF1ab	SILENT	28	28			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	23	5.0,0.0,0.0	C	A	AY.46					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A876V	c.C2627T	p.A876V			2892	orf1ab	ORF1ab	MISSENSE	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	1.0,0.0,0.0	C	T	AY.99.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A879V	c.C2636T	p.A879V			24198	S	S	MISSENSE	28	28						25	3.0,0.0,0.0	C	T	AY.46					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A8T	c.G22A	p.A8T			27415	ORF7a	ORF7a	MISSENSE	48	48						12	36.0,0.0,0.0	G	A	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A903A	c.T2709C	p.A903A			2974	orf1ab	ORF1ab	SILENT	78	78			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	33	45.0,0.0,0.0	T	C	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A942S	c.G2824T	p.A942S			24386	S	S	MISSENSE	30	30						26	4.0,0.0,0.0	G	T	AY.75					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A964V	c.C2891T	p.A964V			3156	orf1ab	ORF1ab	MISSENSE	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	1.0,0.0,0.0	C	T	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.A989A	c.T2967C	p.A989A			24529	S	S	SILENT	9	9						8	1.0,0.0,0.0	T	C	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.AI81ST	c.GCTAT241_245TCTAC	p.AI81ST			26763	M	M		7104	1						0	6785.0,0.0,0.0	GCTAT	TCTAC	AY.67, AY.27					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.C102F	c.G305T	p.C102F			28198	ORF8	ORF8	MISSENSE	24	24						21	3.0,0.0,0.0	G	T	AY.39					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C1247S	c.G3740C	p.C1247S			25302	S	S	MISSENSE	25	25						17	8.0,0.0,0.0	G	C	AY.9.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C130C	c.C390T	p.C130C			25782	ORF3a	ORF3a	SILENT	4	4						3	1.0,0.0,0.0	C	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C1744C	c.C5232T	p.C1744C			5497	orf1ab	ORF1ab	SILENT	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	6.0,0.0,0.0	C	T	AY.57					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.C1889Y	c.G5666A	p.C1889Y			5931	orf1ab	ORF1ab	MISSENSE	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	5.0,0.0,0.0	G	A	AY.70					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.C19C	c.C57T	p.C19C			29614	ORF10	ORF10	SILENT	3	3						2	1.0,0.0,0.0	C	T	AY.99					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C2041C	c.C6123T	p.C2041C			6388	orf1ab	ORF1ab	SILENT	31	20			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	9	22.0,0.0,0.0	C	T	AY.64, AY.55, AY.24					False	True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C2288Y	c.G6863A	p.C2288Y			7128	orf1ab	ORF1ab	MISSENSE	3	3			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	1.0,0.0,0.0	G	A	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C2459C	c.T7377C	p.C2459C			7642	orf1ab	ORF1ab	SILENT	41	41			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	34	7.0,0.0,0.0	T	C	AY.13					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C3059F	c.G9176T	p.C3059F			9441	orf1ab	ORF1ab	MISSENSE	7	7			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	0	7.0,0.0,0.0	G	T	AY.34					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.C3766C	c.C11298T	p.C3766C			11563	orf1ab	ORF1ab	SILENT	24	24			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	19	5.0,0.0,0.0	C	T	AY.39					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C3766F	c.G11297T	p.C3766F			11562	orf1ab	ORF1ab	MISSENSE	8906	11			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	561	8345.0,0.0,0.0	G	T	AY.23, AY.46.6, AY.99.2, AY.25					False	False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.C3778S	c.T11332A	p.C3778S			11597	orf1ab	ORF1ab	MISSENSE	8	8			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	7	1.0,0.0,0.0	T	A	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C3790F	c.G11369T	p.C3790F			11634	orf1ab	ORF1ab	MISSENSE	4	4			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	3	1.0,0.0,0.0	G	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C3891C	c.T11673C	p.C3891C			11938	orf1ab	ORF1ab	SILENT	7129	25			nsp7	produced by both pp1a and pp1ab	YP_009725303.1	19	7110.0,0.0,0.0	T	C	AY.38, AY.67, AY.27					False	False, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.C3931S	c.T11791A	p.C3931S			12056	orf1ab	ORF1ab	MISSENSE	2	2			nsp7	produced by both pp1a and pp1ab	YP_009725303.1	0	2.0,0.0,0.0	T	A	AY.60					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.C432C	c.C1296T	p.C432C			22858	S	S	SILENT	2	2						1	1.0,0.0,0.0	C	T	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C4373C	c.C13119T	p.C4373C			13384	orf1ab	ORF1ab	SILENT	28	28			nsp10	nsp10_CysHis, formerly known as growth-factor-like protein (GFL), produced by both pp1a and pp1ab	YP_009725306.1	25	3.0,0.0,0.0	C	T	AY.46					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C4404S	c.T13210A	p.C4404S			13474	orf1ab	ORF1ab	MISSENSE	1	1			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	1.0,0.0,0.0	T	A	AY.62					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.C5122R	c.T15364C	p.C5122R			15628	orf1ab	ORF1ab	MISSENSE	160	160			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	1	159.0,0.0,0.0	T	C	AY.36					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.C5332C	c.C15996T	p.C5332C			16260	orf1ab	ORF1ab	SILENT	101	95			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	82	19.0,0.0,0.0	C	T	AY.86, AY.70					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C5343C	c.C16029T	p.C5343C			16293	orf1ab	ORF1ab	SILENT	3	3			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	0	3.0,0.0,0.0	C	T	AY.99					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.C58F	c.G173T	p.C58F			27566	ORF7a	ORF7a	MISSENSE	1	1						0	1.0,0.0,0.0	G	T	AY.7.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.C6307C	c.C18921T	p.C6307C			19185	orf1ab	ORF1ab	SILENT	3	3			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	1	2.0,0.0,0.0	C	T	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C86F	c.G257T	p.C86F			26779	M	M	MISSENSE	79	79						53	26.0,0.0,0.0	G	T	AY.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.C90C	c.C270T	p.C90C			28163	ORF8	ORF8	SILENT	238	238						176	62.0,0.0,0.0	C	T	AY.61					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1089Y	c.G3265T	p.D1089Y			3530	orf1ab	ORF1ab	MISSENSE	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	G	T	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1127Y	c.G3379T	p.D1127Y			3644	orf1ab	ORF1ab	MISSENSE	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	G	T	AY.3.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1139N	c.G3415A	p.D1139N			24977	S	S	MISSENSE	5	5						4	1.0,0.0,0.0	G	A	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1153Y	c.G3457T	p.D1153Y			25019	S	S	MISSENSE	27	27						5	22.0,0.0,0.0	G	T	AY.19					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D119del	c.355_360delGATTTC	p.D119_F120del	D119_F120del	'F120del'	28247	ORF8	ORF8		25936	1,924						2	25734.0,188.0,0.0	AGATTTC	A,AGATTTT	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1228G	c.A3683G	p.D1228G			3948	orf1ab	ORF1ab	MISSENSE	8904	11			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	587	8317.0,0.0,0.0	A	G	AY.23, AY.46.6, AY.99.2, AY.25					False	False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1259D	c.C3777T	p.D1259D			25339	S	S	SILENT	88	1						51	37.0,0.0,0.0	C	T	AY.3.1, AY.3, AY.92					False	True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1259Y	c.G3775T	p.D1259Y			25337	S	S	MISSENSE	1	1						0	1.0,0.0,0.0	G	T	AY.4.5					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D128D	c.C384T	p.D128D			28657	N	N	SILENT	23	17						6	17.0,0.0,0.0	C	T	AY.92, AY.70					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D138Y	c.G412T	p.D138Y			21974	S	S	MISSENSE	2	6						1	1.0,0.0,0.0	G	T	AY.70	ACE2 receptor binding affinity	Gong et al. (2021)	'D614G'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.32x increase in binding (KD) relative to D614G.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D138Y	c.G412T	p.D138Y			21974	S	S	MISSENSE	2	6						1	1.0,0.0,0.0	G	T	AY.70	convalescent plasma binding	Gong et al. (2021)	'D614G'	1.56x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D138Y	c.G412T	p.D138Y			21974	S	S	MISSENSE	2	6						1	1.0,0.0,0.0	G	T	AY.70	vaccinee plasma binding	Gong et al. (2021)	'D614G'	1.37x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.56x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D138Y	c.G412T	p.D138Y			21974	S	S	MISSENSE	2	6						1	1.0,0.0,0.0	G	T	AY.70	virion structure	Spratt et al. (2021)		Estimated free energy change (ddG) for this variant is 0.43 kcal/mol (i.e. stabilizing relative to wild type) 	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1554D	c.C4662T	p.D1554D			4927	orf1ab	ORF1ab	SILENT	34	28			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	23	10.0,0.0,0.0	C	T	AY.46, AY.99.2					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D155G	c.A464G	p.D155G			25856	ORF3a	ORF3a	MISSENSE	2	2						1	1.0,0.0,0.0	A	G	AY.72					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D155Y	c.G463T	p.D155Y			25855	ORF3a	ORF3a	MISSENSE	3	3						0	3.0,0.0,0.0	G	T	AY.28	caveolin binding	Gupta et al. (2021)		In silico, this mutation is the only one weakening ORF3a's binding affinity for caveolin-1 (essential for entry and endomembrane trafficking of SARS-CoV-2). This mutation is a widespread homoplasy in 20A and 20B lineages.	False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1697D	c.T5091C	p.D1697D			5356	orf1ab	ORF1ab	SILENT	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	1.0,0.0,0.0	T	C	AY.46.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1849D	c.C5547T	p.D1849D			5812	orf1ab	ORF1ab	SILENT	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	6	1.0,0.0,0.0	C	T	AY.100					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1903Y	c.G5707T	p.D1903Y			5972	orf1ab	ORF1ab	MISSENSE	24	24			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	21	3.0,0.0,0.0	G	T	AY.33					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1939Y	c.G5815T	p.D1939Y			6080	orf1ab	ORF1ab	MISSENSE	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	1.0,0.0,0.0	G	T	AY.72					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D1962D	c.C5886T	p.D1962D			6151	orf1ab	ORF1ab	SILENT	122	120			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	79	43.0,0.0,0.0	C	T	AY.15, AY.75.1					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D198Y	c.G592T	p.D198Y			22154	S	S	MISSENSE	24	12						20	4.0,0.0,0.0	G	T	AY.42, AY.42					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D210A	c.A629C	p.D210A			26021	ORF3a	ORF3a	MISSENSE	4	4						3	1.0,0.0,0.0	A	C	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D222Y	c.G664T	p.D222Y			26056	ORF3a	ORF3a	MISSENSE	7	2						5	2.0,0.0,0.0	G	T	AY.1, AY.32					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D22H	c.G64C	p.D22H			28337	N	N	MISSENSE	16	16						14	2.0,0.0,0.0	G	C	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D238Y	c.G712T	p.D238Y			26104	ORF3a	ORF3a	MISSENSE	114	114						91	23.0,0.0,0.0	G	T	AY.43					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D253A	c.A758C	p.D253A			22320	S	S	MISSENSE	4	4						3	1.0,0.0,0.0	A	C	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D253Y	c.G757T	p.D253Y			22319	S	S	MISSENSE	2	2						1	1.0,0.0,0.0	G	T	AY.104	antibody epitope effects	McCallum et al. (2021)		"Massive reduction in S2L28 monoclonal antibody EC50 (i.e. ablated recognition), within antigenic supersite ""i"", but no effect on other mAbs within that supersite"	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D265D	c.T795C	p.D265D			26187	ORF3a	ORF3a	SILENT	9	9						8	1.0,0.0,0.0	T	C	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D2662D	c.C7986T	p.D2662D			8251	orf1ab	ORF1ab	SILENT	43	43			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	38	5.0,0.0,0.0	C	T	AY.54					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D2687D	c.C8061T	p.D2687D			8326	orf1ab	ORF1ab	SILENT	8	8			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	6.0,0.0,0.0	C	T	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D288D	c.C864T	p.D288D			29137	N	N	SILENT	3	3						0	3.0,0.0,0.0	C	T	AY.81					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D2907D	c.C8721T	p.D2907D			8986	orf1ab	ORF1ab	SILENT	12983	1,924			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	730	12253.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.111, AY.104, AY.103, AY.100, AY.106, AY.12, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.46.4, AY.4.5, AY.44, AY.33, AY.46.2, AY.41, AY.102, AY.4.2, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.5, AY.20, AY.32, AY.39, AY.46, AY.43, AY.9.1, AY.46.1, AY.92, AY.42, AY.98.1, AY.87, AY.108, AY.85, AY.39.1, AY.46.6, AY.4.3, AY.99.2, AY.93, AY.82, AY.84, AY.99, AY.7.1, AY.25					False	False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D290D	c.C870T	p.D290D			22432	S	S	SILENT	154	78						130	24.0,0.0,0.0	C	T	AY.20, AY.20					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D2951D	c.C8853T	p.D2951D			9118	orf1ab	ORF1ab	SILENT	15	15			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	2	13.0,0.0,0.0	C	T	AY.98.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D2980N	c.G8938A	p.D2980N			9203	orf1ab	ORF1ab	MISSENSE	1966	1,924			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	1731	235.0,0.0,0.0	G	A	B.1.617.2, AY.48, AY.35, AY.51					False	False, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D30D	c.T90C	p.D30D			27291	ORF6	ORF6	SILENT	152	152						97	55.0,0.0,0.0	T	C	AY.103					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D31H	c.G91C	p.D31H			29648	ORF10	ORF10	MISSENSE	30	30						26	4.0,0.0,0.0	G	C	AY.75					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D324D	c.T972C	p.D324D			1237	orf1ab	ORF1ab	SILENT	9	9			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	8	1.0,0.0,0.0	T	C	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D3297D	c.C9891T	p.D3297D			10156	orf1ab	ORF1ab	SILENT	1	1			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	0	1.0,0.0,0.0	C	T	AY.87					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D341D	c.C1023T	p.D341D			29296	N	N	SILENT	11	11						9	2.0,0.0,0.0	C	T	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D3450D	c.C10350T	p.D3450D			10615	orf1ab	ORF1ab	SILENT	34	34			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	27	7.0,0.0,0.0	C	T	AY.47					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D377Y	c.G1129T	p.D377Y			29402	N	N	MISSENSE	25960	1,924						1	25959.0,0.0,0.0	G	T	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D3936D	c.C11808T	p.D3936D			12073	orf1ab	ORF1ab	SILENT	12	12			nsp7	produced by both pp1a and pp1ab	YP_009725303.1	0	12.0,0.0,0.0	C	T	AY.42					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D3G	c.A8G	p.D3G			26530	M	M	MISSENSE	2	2						1	1.0,0.0,0.0	A	G	AY.51					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D3Y	c.G7T	p.D3Y			26529	M	M	MISSENSE	27	27						24	3.0,0.0,0.0	G	T	AY.19					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D402A	c.A1205C	p.D402A			29478	N	N	MISSENSE	3	3						2	1.0,0.0,0.0	A	C	AY.46.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D402Y	c.G1204T	p.D402Y			29477	N	N	MISSENSE	2	2						1	1.0,0.0,0.0	G	T	AY.51					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D4317D	c.T12951C	p.D4317D			13216	orf1ab	ORF1ab	SILENT	9	6			nsp10	nsp10_CysHis, formerly known as growth-factor-like protein (GFL), produced by both pp1a and pp1ab	YP_009725306.1	1	8.0,0.0,0.0	T	C	AY.99.2, AY.99					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D4454G	c.A13361G	p.D4454G			13625	orf1ab	ORF1ab	MISSENSE	12	12			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	9	3.0,0.0,0.0	A	G	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D4650G	c.A13949G	p.D4650G			14213	orf1ab	ORF1ab	MISSENSE	3	3			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	2	1.0,0.0,0.0	A	G	AY.53					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D4652D	c.C13956T	p.D4652D			14220	orf1ab	ORF1ab	SILENT	1	1			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	1.0,0.0,0.0	C	T	AY.4.3					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D4661G	c.A13982G	p.D4661G			14246	orf1ab	ORF1ab	MISSENSE	6	6			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	6.0,0.0,0.0	A	G	AY.63					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D4666D	c.C13998T	p.D4666D			14262	orf1ab	ORF1ab	SILENT	3	3			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	3.0,0.0,0.0	C	T	AY.81					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D4873A	c.A14618C	p.D4873A			14882	orf1ab	ORF1ab	MISSENSE	1	1			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	1.0,0.0,0.0	A	C	AY.4.5					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D51D	c.T153C	p.D51D			27546	ORF7a	ORF7a	SILENT	7	7						6	1.0,0.0,0.0	T	C	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D5271Y	c.G15811T	p.D5271Y			16075	orf1ab	ORF1ab	MISSENSE	27	27			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	5	22.0,0.0,0.0	G	T	AY.19					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D5293N	c.G15877A	p.D5293N			16141	orf1ab	ORF1ab	MISSENSE	8	8			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	7	1.0,0.0,0.0	G	A	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D5356D	c.C16068T	p.D5356D			16332	orf1ab	ORF1ab	SILENT	4	4			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	3	1.0,0.0,0.0	C	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D53D	c.C159T	p.D53D			21721	S	S	SILENT	3	8						2	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D5437D	c.C16311T	p.D5437D			16575	orf1ab	ORF1ab	SILENT	17	17			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	15	2.0,0.0,0.0	C	T	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D5652N	c.G16954A	p.D5652N			17218	orf1ab	ORF1ab	MISSENSE	6	6			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	4	2.0,0.0,0.0	G	A	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D571D	c.C1713T	p.D571D			23275	S	S	SILENT	7	7						6	1.0,0.0,0.0	C	T	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D574D	c.T1722C	p.D574D			23284	S	S	SILENT	88	1						53	35.0,0.0,0.0	T	C	AY.3.1, AY.3, AY.92					False	True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6069N	c.G18205A	p.D6069N			18469	orf1ab	ORF1ab	MISSENSE	1	1			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	1.0,0.0,0.0	G	A	AY.91					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6104D	c.C18312T	p.D6104D			18576	orf1ab	ORF1ab	SILENT	34	34			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	27	7.0,0.0,0.0	C	T	AY.47					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	ACE2 receptor binding affinity	Gong et al. (2021)	'L452R'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 2.66x increase in binding (KD) relative to D614G.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	24	24						0	13.0,11.0,0.0	GGA	TGG,GGG	AY.33	ACE2 receptor binding affinity	Gong et al. (2021)	'T95I'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.33x decrease in binding (KD) relative to D614G.	False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	ACE2 receptor binding affinity	Li et al. (2020)		In four cell lines (including 293T-hACE2 cells), this mutation combination increases infectivity vs D614G alone	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	convalescent plasma binding	Gong et al. (2021)	'L452R'	2.15x increase in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	24	24						0	13.0,11.0,0.0	GGA	TGG,GGG	AY.33	convalescent plasma binding	Gong et al. (2021)	'T95I'	No change in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	convalescent plasma escape	Wilhelm et al. (2021)	'L452R'	Relative to B.1, Epsilon (B.1.417/429) shows 1.74x-2.35x decrease in neutralization efficiency by convalescent plasma [no cohort details provided]	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7119	25						0	5336.0,1767.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.27	humoral response durability	Brehm et al. (2021)	'A222V'	27yo female nurse reinfected in December 2020 (B.1.177) after initial infection in March 2020 (B.3), i.e. with a  9 month interval. Both cases were mild. No significant differences in the neutralizing capacity of the two linages were observed in 4 sera taken (1 pre-reinfection,  three post-reinfection). Neutralizing antibody titres (IC50) before and immediately after re-infection were <300 against  both strains, and jumped >7x upon re-infection. Viral titres were also higher in the second case. Second case also includes N:p.A220V	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	immunosuppression variant emergence	Landis et al. (2021)		Studying 94 COVID-19 extended infection cases with genomics April 1 to October 17, 2020, one case developed 23 mutations in a 19 day period, including this combination in Spike.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7119	25						0	5336.0,1767.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.27	reinfection	Brehm et al. (2021)	'A222V'	27yo female nurse reinfected in December 2020 (B.1.177) after initial infection in March 2020 (B.3). Both cases were mild. Second case also includes N:p.A220V	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	syncytium formation	Kim et al. (2021)		Slight increase in Vero cell-cell membrane fusion assay under infection with VSV pseudotyped virus.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	tissue specific neutralization	Planas et al. (2021)		The nasal mucosa of Pfizer vaccinees with time course collection was evaluated against VSV pseudotypes: results (only one nasal  swab from different previously infected vacinee neutralizing at weeks 3 and 6 against B.1.1.7 and D614G) suggest that vaccinees probably  do not elicit an early humoral response detectable at mucosal surfaces even though sera neutralization was observed. They strengthen the hypothesis that some vaccines may not protect against  viral acquisition and infection of the oralnasal region, but may prevent severe disease associated with viral dissemination in the lower respiratory tract. 	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	trafficking	Barrett et al. (2021)		Circulating variant shown in vitro to not have major defects or enhancement of cell surface protein trafficking (i.e. Spike cleavage or fusion required for cell entry)	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	trafficking	Daniloski et al. (2021)		The increased transduction with Spike D614G ranged from 1.3- to 2.4-fold in Caco-2 and Calu-3 cells expressing  endogenous ACE2 and from 1.5- to 7.7-fold in A549ACE2 and Huh7.5ACE2 overexpressing ACE2.  Although there is minimal difference in ACE2 receptor binding between the D614 and G614 Spike variants,  the G614 variant is more resistant to proteolytic cleavage, suggesting a possible mechanism for the increased transduction.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	trafficking	Kim et al. (2021)		No change in infectivity (24h) relative to D614G alone in Caco-2 cells, Vero or Calu-3.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	trafficking	Kim et al. (2021)		~4x more efficient S2 domain cleavage compared to wild type in Caco-2 cells, mid-range of three cell line tested (Vero and Calu-3).	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	trafficking	Ozono et al. (2020)		Among S variants tested, the D614G mutant shows the highest cell entry (~3.5x wild type), as supported by  structural and binding analyses. 	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	trafficking	Tada et al. (2021)	'P681R'	Quantification of the band intensities showed that the P681R mutation, which lies near the proteolytic processing site,  caused a small increase in proteolytic processing as measured by a 2-fold decrease in the ratio of S/S2.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	trafficking	Zhang et l. (2020)		We report here pseudoviruses carrying SG614 enter ACE2-expressing cells more efficiently than wild type (~9-fold).  This increased entry correlates with less S1-domain shedding and higher S-protein incorporation into the virion.  D614G does not alter S-protein binding to ACE2 or neutralization sensitivity of pseudoviruses. Thus, D614G may  increase infectivity by assembling more functional S protein into the virion.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	transmissibility	Tada et al. (2021)	'L452R'	Increased infectivity of the B.1.617 spike was attributed to L452R, which itself caused a 3.5-fold increase in infectivity relative to D614G wild type.  [In combination with E484Q caused a lower 3-fold increase]	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	vaccine neutralization efficacy	Garcia-Beltran et al. (2021)		Pseudotyped D614G virus has reduced neutralization activity vs wild type: 1.2x (37 sera Pfizer median 9  days post 2nd dose, 37 sera Moderna median 18 days post 2nd dose). This was NOT significant by ANOVA.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	vaccine neutralization efficacy	Kuzmina et al. (2021)		Using a lentivirus virus pseudotyped with D614G Spike, sera from vaccinated individuals who received the second dose (911 days post-second dose of Pfizer) exhibited a robust  neutralizing potential, with a mean NT50 value of 99,000. This was an average of a 2-fold increase, relative to sera drawn from the  individuals who received one dose of vaccinationmean NT50 dilution of 51,300. Importantly, a 6-fold increase in mean NT50 dilution was  obtained when sera from the first vaccination dose was compared to convalescent sera from cohort with severe disease (NT50 51,000 vs 8,700)  21 to 63 days post-onset. 	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	vaccine neutralization efficacy	Wilhelm et al. (2021)	'L452R'	Relative to B.1, Epsilon (B.1.417/429) shows 1.74x-2.35x decrease in neutralization efficiency by 18 vaccinee sera (BNT162b2 and mRNA1273).	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	vaccinee plasma binding	Gong et al. (2021)	'L452R'	1.05x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects. 1.16x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	24	24						0	13.0,11.0,0.0	GGA	TGG,GGG	AY.33	vaccinee plasma binding	Gong et al. (2021)	'T95I'	1.16x increase in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.02x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	viral load	Plante et al. (2020)		Hamsters infected with SARS-CoV-2 expressing spike(D614G) (G614 virus) produced higher infectious titres in nasal washes and the trachea, but not in the lungs,  supporting clinical evidence showing that the mutation enhances viral loads in the upper respiratory tract of COVID-19 patients and may increase transmission.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	virion structure	Spratt et al. (2021)		Estimated free energy change (ddG) for this variant is 2.5 kcal/mol (i.e. stabilizing relative to wild type) 	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	virion structure	Weissman et al. (2020)		"Negative stain EM shows increased proportion of ""one-up"" trimer conformation of Spike proteins on the surface of virions, where the up  conformation is presumed to be more likely to bind ACE2."	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	virion structure	Yurkovetskiy et al. (2020)		"CryoEM shows increased proportion of ""one-up"" trimer conformation of Spike proteins on the surface of virions, where the up  conformation is presumed to be more likely to bind ACE2."	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23401	S	S	MISSENSE	7143	25						0	5349.0,1778.0,15.0	GGA	CGG,TGG,GGG	AY.38, AY.33, AY.27	virion structure	Zhang et al. (2020)		Based on pseudotyped virus experiments, D614G may increase infectivity by assembling more functional S protein into the virion.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	6	6						0	6.0,0.0,0.0	A	G	AY.70	ACE2 receptor binding affinity	Gong et al. (2021)	'D138Y'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.32x increase in binding (KD) relative to D614G.	False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	A	G	AY.1, AY.2	ACE2 receptor binding affinity	Gong et al. (2021)	'K417N'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.5x decrease in binding (KD) relative to D614G.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18858	1,924						1	18857.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	ACE2 receptor binding affinity	Gong et al. (2021)	'L452R'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 2.66x increase in binding (KD) relative to D614G.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	A	G	AY.35, AY.70	ACE2 receptor binding affinity	Gong et al. (2021)	'L452R', 'E484Q'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant combination (representing lineage B.1.617) showed a 1.85x increase  in binding (KD) relative to D614G. [exact variant list not provided in manuscript, is inferred fro common knowledge]	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	15	10						0	15.0,0.0,0.0	A	G	AY.65, AY.35	ACE2 receptor binding affinity	Gong et al. (2021)	'L5F'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.1x decrease in binding (KD) relative to D614G.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	6	5						0	6.0,0.0,0.0	A	G	AY.9.1, AY.4.3	ACE2 receptor binding affinity	Gong et al. (2021)	'P26S'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.58x increase in binding (KD) relative to D614G.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	2550	1,924						0	2550.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.111, AY.104, AY.100, AY.106, AY.29, AY.107, AY.110, AY.1, AY.34, AY.4.5, AY.102, AY.4.2, AY.4, AY.36, AY.20, AY.39, AY.46, AY.92, AY.42, AY.108, AY.85, AY.39.1, AY.4.3	ACE2 receptor binding affinity	Gong et al. (2021)	'T95I'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.33x decrease in binding (KD) relative to D614G.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	ACE2 receptor binding affinity	Li et al. (2020)		In four cell lines (including 293T-hACE2 cells), this mutation combination increases infectivity vs D614G alone	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	6	6						0	6.0,0.0,0.0	A	G	AY.70	convalescent plasma binding	Gong et al. (2021)	'D138Y'	1.56x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	A	G	AY.1, AY.2	convalescent plasma binding	Gong et al. (2021)	'K417N'	2.16x increase in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18858	1,924						1	18857.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	convalescent plasma binding	Gong et al. (2021)	'L452R'	2.15x increase in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	A	G	AY.35, AY.70	convalescent plasma binding	Gong et al. (2021)	'L452R', 'E484Q'	This variant combination (representing lineage B.1.617) showed a 1.22x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 8 months post-symptom-onset. [exact variant list not provided in manuscript, is inferred fro common knowledge]	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	15	10						0	15.0,0.0,0.0	A	G	AY.65, AY.35	convalescent plasma binding	Gong et al. (2021)	'L5F'	No change in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	6	5						0	6.0,0.0,0.0	A	G	AY.9.1, AY.4.3	convalescent plasma binding	Gong et al. (2021)	'P26S'	1.08x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	2550	1,924						0	2550.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.111, AY.104, AY.100, AY.106, AY.29, AY.107, AY.110, AY.1, AY.34, AY.4.5, AY.102, AY.4.2, AY.4, AY.36, AY.20, AY.39, AY.46, AY.92, AY.42, AY.108, AY.85, AY.39.1, AY.4.3	convalescent plasma binding	Gong et al. (2021)	'T95I'	No change in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	A	G	AY.35, AY.70	convalescent plasma escape	Tada et al. (2021)	'L452R', 'E484Q'	Pseudotyped viruses for B.1.617 was 2.3-fold resistant to neutralization by convalescent sera compared to wild type - a finding that was similar to that of the 3-fold resistance of the South Africa B.1.351 variant using the same assay. The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617. [details on the convalescent patient sera collection are not abundantly clear in the preprint]	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18858	1,924						1	18857.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	convalescent plasma escape	Wilhelm et al. (2021)	'L452R'	Relative to B.1, Epsilon (B.1.417/429) shows 1.74x-2.35x decrease in neutralization efficiency by convalescent plasma [no cohort details provided]	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	7527	1,924						1	7526.0,0.0,0.0	A	G	B.1.617.2, AY.28, AY.106, AY.26, AY.2, AY.10, AY.75.1, AY.64, AY.4.2, AY.65, AY.45, AY.60, AY.88, AY.57, AY.35, AY.72, AY.59, AY.9.2, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.73, AY.61, AY.9.2.1, AY.37, AY.63, AY.9, AY.24, AY.68, AY.70, AY.62, AY.74	humoral response durability	Brehm et al. (2021)	'A222V'	27yo female nurse reinfected in December 2020 (B.1.177) after initial infection in March 2020 (B.3), i.e. with a  9 month interval. Both cases were mild. No significant differences in the neutralizing capacity of the two linages were observed in 4 sera taken (1 pre-reinfection,  three post-reinfection). Neutralizing antibody titres (IC50) before and immediately after re-infection were <300 against  both strains, and jumped >7x upon re-infection. Viral titres were also higher in the second case. Second case also includes N:p.A220V	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	immunosuppression variant emergence	Landis et al. (2021)		Studying 94 COVID-19 extended infection cases with genomics April 1 to October 17, 2020, one case developed 23 mutations in a 19 day period, including this combination in Spike.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	7527	1,924						1	7526.0,0.0,0.0	A	G	B.1.617.2, AY.28, AY.106, AY.26, AY.2, AY.10, AY.75.1, AY.64, AY.4.2, AY.65, AY.45, AY.60, AY.88, AY.57, AY.35, AY.72, AY.59, AY.9.2, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.73, AY.61, AY.9.2.1, AY.37, AY.63, AY.9, AY.24, AY.68, AY.70, AY.62, AY.74	reinfection	Brehm et al. (2021)	'A222V'	27yo female nurse reinfected in December 2020 (B.1.177) after initial infection in March 2020 (B.3). Both cases were mild. Second case also includes N:p.A220V	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	syncytium formation	Kim et al. (2021)		Slight increase in Vero cell-cell membrane fusion assay under infection with VSV pseudotyped virus.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	tissue specific neutralization	Planas et al. (2021)		The nasal mucosa of Pfizer vaccinees with time course collection was evaluated against VSV pseudotypes: results (only one nasal  swab from different previously infected vacinee neutralizing at weeks 3 and 6 against B.1.1.7 and D614G) suggest that vaccinees probably  do not elicit an early humoral response detectable at mucosal surfaces even though sera neutralization was observed. They strengthen the hypothesis that some vaccines may not protect against  viral acquisition and infection of the oralnasal region, but may prevent severe disease associated with viral dissemination in the lower respiratory tract. 	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	trafficking	Barrett et al. (2021)		Circulating variant shown in vitro to not have major defects or enhancement of cell surface protein trafficking (i.e. Spike cleavage or fusion required for cell entry)	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	trafficking	Daniloski et al. (2021)		The increased transduction with Spike D614G ranged from 1.3- to 2.4-fold in Caco-2 and Calu-3 cells expressing  endogenous ACE2 and from 1.5- to 7.7-fold in A549ACE2 and Huh7.5ACE2 overexpressing ACE2.  Although there is minimal difference in ACE2 receptor binding between the D614 and G614 Spike variants,  the G614 variant is more resistant to proteolytic cleavage, suggesting a possible mechanism for the increased transduction.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	trafficking	Kim et al. (2021)		No change in infectivity (24h) relative to D614G alone in Caco-2 cells, Vero or Calu-3.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	trafficking	Kim et al. (2021)		~4x more efficient S2 domain cleavage compared to wild type in Caco-2 cells, mid-range of three cell line tested (Vero and Calu-3).	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	A	G	AY.1, AY.2	trafficking	Kuzmina et al. (2021)	'K417N'	~2x more infectivity than D614G alone in HEK293T-ACE2 cells 48h post-transduction.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	trafficking	Ozono et al. (2020)		Among S variants tested, the D614G mutant shows the highest cell entry (~3.5x wild type), as supported by  structural and binding analyses. 	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	trafficking	Tada et al. (2021)	'P681R'	Quantification of the band intensities showed that the P681R mutation, which lies near the proteolytic processing site,  caused a small increase in proteolytic processing as measured by a 2-fold decrease in the ratio of S/S2.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	trafficking	Zhang et l. (2020)		We report here pseudoviruses carrying SG614 enter ACE2-expressing cells more efficiently than wild type (~9-fold).  This increased entry correlates with less S1-domain shedding and higher S-protein incorporation into the virion.  D614G does not alter S-protein binding to ACE2 or neutralization sensitivity of pseudoviruses. Thus, D614G may  increase infectivity by assembling more functional S protein into the virion.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18858	1,924						1	18857.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	transmissibility	Tada et al. (2021)	'L452R'	Increased infectivity of the B.1.617 spike was attributed to L452R, which itself caused a 3.5-fold increase in infectivity relative to D614G wild type.  [In combination with E484Q caused a lower 3-fold increase]	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	A	G	AY.35, AY.70	transmissibility	Tada et al. (2021)	'L452R', 'E484Q'	The combination caused a 3-fold increase in infectivity relative to D614G wild type. [compare to 3.5x for L452R alone]	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	A	G	AY.35, AY.70	transmissibility	Tada et al. (2021)	'L452R', 'E484Q', 'P681R'	Normalized for particle number, on ACE2.293T cells showed that the B.1.617 spike protein was >2-fold increase in infectivity relative to D614G wild type.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	vaccine neutralization efficacy	Garcia-Beltran et al. (2021)		Pseudotyped D614G virus has reduced neutralization activity vs wild type: 1.2x (37 sera Pfizer median 9  days post 2nd dose, 37 sera Moderna median 18 days post 2nd dose). This was NOT significant by ANOVA.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	A	G	AY.35, AY.70	vaccine neutralization efficacy	Gong et al. (2021)	'L452R', 'E484Q'	1.4x reduction in neutralization (ID50) in sera 3 weeks after one dose of Pfizer/BioNTech BNT162b2 (up to 5 naive and post infection vaccinees)	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	vaccine neutralization efficacy	Kuzmina et al. (2021)		Using a lentivirus virus pseudotyped with D614G Spike, sera from vaccinated individuals who received the second dose (911 days post-second dose of Pfizer) exhibited a robust  neutralizing potential, with a mean NT50 value of 99,000. This was an average of a 2-fold increase, relative to sera drawn from the  individuals who received one dose of vaccinationmean NT50 dilution of 51,300. Importantly, a 6-fold increase in mean NT50 dilution was  obtained when sera from the first vaccination dose was compared to convalescent sera from cohort with severe disease (NT50 51,000 vs 8,700)  21 to 63 days post-onset. 	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	A	G	AY.1, AY.2	vaccine neutralization efficacy	Kuzmina et al. (2021)	'K417N'	This variant showed only minor in Pfizer sera (one or two dose) neutralization efficiency vs D614G (using lentivirus pseudotype).	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	A	G	AY.35, AY.70	vaccine neutralization efficacy	Tada et al. (2021)	'L452R', 'E484Q'	Pseudotyped viruses for B.1.617 was 4-fold resistant to neutralization by 6 BNT162b2 vaccine sera 28 days post-booster compared to wild type - a finding that was similar to that of the 3.4-fold resistance of the South Africa B.1.351 variant using the same assay. Neutralization by 3 Moderna vaccine sera 28 days post-booster was 5-fold resistant (vs. 2.2-fold for B.1.351). The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18858	1,924						1	18857.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	vaccine neutralization efficacy	Wilhelm et al. (2021)	'L452R'	Relative to B.1, Epsilon (B.1.417/429) shows 1.74x-2.35x decrease in neutralization efficiency by 18 vaccinee sera (BNT162b2 and mRNA1273).	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	6	6						0	6.0,0.0,0.0	A	G	AY.70	vaccinee plasma binding	Gong et al. (2021)	'D138Y'	1.37x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.56x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	A	G	AY.1, AY.2	vaccinee plasma binding	Gong et al. (2021)	'K417N'	1.76x increase in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.75x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18858	1,924						1	18857.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	vaccinee plasma binding	Gong et al. (2021)	'L452R'	1.05x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects. 1.16x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	A	G	AY.35, AY.70	vaccinee plasma binding	Gong et al. (2021)	'L452R', 'E484Q'	This variant combination (representing lineage B.1.617) showed a 1.30x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.   1.18x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees. [exact variant list not provided in manuscript, is inferred fro common knowledge]	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	15	10						0	15.0,0.0,0.0	A	G	AY.65, AY.35	vaccinee plasma binding	Gong et al. (2021)	'L5F'	1.23x increase in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.1x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	6	5						0	6.0,0.0,0.0	A	G	AY.9.1, AY.4.3	vaccinee plasma binding	Gong et al. (2021)	'P26S'	1.23x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.37x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	2550	1,924						0	2550.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.111, AY.104, AY.100, AY.106, AY.29, AY.107, AY.110, AY.1, AY.34, AY.4.5, AY.102, AY.4.2, AY.4, AY.36, AY.20, AY.39, AY.46, AY.92, AY.42, AY.108, AY.85, AY.39.1, AY.4.3	vaccinee plasma binding	Gong et al. (2021)	'T95I'	1.16x increase in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.02x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	viral load	Plante et al. (2020)		Hamsters infected with SARS-CoV-2 expressing spike(D614G) (G614 virus) produced higher infectious titres in nasal washes and the trachea, but not in the lungs,  supporting clinical evidence showing that the mutation enhances viral loads in the upper respiratory tract of COVID-19 patients and may increase transmission.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	virion structure	Spratt et al. (2021)		Estimated free energy change (ddG) for this variant is 2.5 kcal/mol (i.e. stabilizing relative to wild type) 	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	virion structure	Weissman et al. (2020)		"Negative stain EM shows increased proportion of ""one-up"" trimer conformation of Spike proteins on the surface of virions, where the up  conformation is presumed to be more likely to bind ACE2."	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	virion structure	Yurkovetskiy et al. (2020)		"CryoEM shows increased proportion of ""one-up"" trimer conformation of Spike proteins on the surface of virions, where the up  conformation is presumed to be more likely to bind ACE2."	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D614G	c.A1841G	p.D614G			23403	S	S	MISSENSE	18861	1,924						1	18860.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	virion structure	Zhang et al. (2020)		Based on pseudotyped virus experiments, D614G may increase infectivity by assembling more functional S protein into the virion.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6168D	c.T18504C	p.D6168D			18768	orf1ab	ORF1ab	SILENT	7	7			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	6	1.0,0.0,0.0	T	C	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D61D	c.T183C	p.D61D			27384	ORF6	ORF6	SILENT	1	1						0	1.0,0.0,0.0	T	C	AY.91					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D61H	c.G181C	p.D61H			27382	ORF6	ORF6	MISSENSE	164	120						15	149.0,0.0,0.0	G	C	AY.15, AY.13, AY.75.1, AY.77					False	True, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D61L	c.GAT181_183CTC	p.D61L			27382	ORF6	ORF6		9	9						7	2.0,0.0,0.0	GAT	CTC	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6249Y	c.G18745T	p.D6249Y			19009	orf1ab	ORF1ab	MISSENSE	26	10			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	19	7.0,0.0,0.0	G	T	AY.65, AY.9					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6270Y	c.G18808T	p.D6270Y			19072	orf1ab	ORF1ab	MISSENSE	1	1			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	1.0,0.0,0.0	G	T	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6283D	c.C18849T	p.D6283D			19113	orf1ab	ORF1ab	SILENT	2	2			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	2.0,0.0,0.0	C	T	AY.84					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D629G	c.A1886G	p.D629G			2151	orf1ab	ORF1ab	MISSENSE	5	5			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	4	1.0,0.0,0.0	A	G	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6300D	c.C18900T	p.D6300D			19164	orf1ab	ORF1ab	SILENT	3	3			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	1	2.0,0.0,0.0	C	T	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D63G	c.A188G	p.D63G			28461	N	N	MISSENSE	26008	1,924						3	26005.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6421Y	c.G19261T	p.D6421Y			19525	orf1ab	ORF1ab	MISSENSE	7	7			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	6	1.0,0.0,0.0	G	T	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6539D	c.C19617T	p.D6539D			19881	orf1ab	ORF1ab	SILENT	30	30			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	24	6.0,0.0,0.0	C	T	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6580Y	c.G19738T	p.D6580Y			20002	orf1ab	ORF1ab	MISSENSE	16	16			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	14	2.0,0.0,0.0	G	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6584Y	c.G19750T	p.D6584Y			20014	orf1ab	ORF1ab	MISSENSE	12	12			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	10	2.0,0.0,0.0	G	T	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6724D	c.C20172T	p.D6724D			20436	orf1ab	ORF1ab	SILENT	2	2			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	1	1.0,0.0,0.0	C	T	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D6752G	c.A20255G	p.D6752G			20519	orf1ab	ORF1ab	MISSENSE	238	238			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	176	62.0,0.0,0.0	A	G	AY.61					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D691N	c.G2071A	p.D691N			2336	orf1ab	ORF1ab	MISSENSE	2	2			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	2.0,0.0,0.0	G	A	AY.6					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D80G	c.A239G	p.D80G			21801	S	S	MISSENSE	94	95						80	14.0,0.0,0.0	A	G	AY.86					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D820D	c.T2460C	p.D820D			24022	S	S	SILENT	20	20						18	2.0,0.0,0.0	T	C	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D828D	c.C2484T	p.D828D			2749	orf1ab	ORF1ab	SILENT	16	16			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	6	10.0,0.0,0.0	C	T	AY.40					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D848D	c.C2544T	p.D848D			24106	S	S	SILENT	30	30						27	3.0,0.0,0.0	C	T	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.D930D	c.T2790C	p.D930D			3055	orf1ab	ORF1ab	SILENT	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	T	C	AY.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.D979E	c.T2937A	p.D979E			24499	S	S	MISSENSE	4	4						3	1.0,0.0,0.0	T	A	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E1013D	c.G3039T	p.E1013D			3304	orf1ab	ORF1ab	MISSENSE	24	24			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	21	3.0,0.0,0.0	G	T	AY.39					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E1024E	c.A3072G	p.E1024E			3337	orf1ab	ORF1ab	SILENT	9	9			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	8	1.0,0.0,0.0	A	G	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E102Q	c.G304C	p.E102Q			25696	ORF3a	ORF3a	MISSENSE	164	120						85	79.0,0.0,0.0	G	C	AY.15, AY.13, AY.75.1, AY.77					False	False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E1047K	c.G3139A	p.E1047K			3404	orf1ab	ORF1ab	MISSENSE	8	8			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	7	1.0,0.0,0.0	G	A	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E106X	c.G316T	p.E106X			28209	ORF8	ORF8	NONSENSE	43	43						38	5.0,0.0,0.0	G	T	AY.54					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E1144V	c.A3431T	p.E1144V			24993	S	S	MISSENSE	4	4						3	1.0,0.0,0.0	A	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E1195E	c.A3585G	p.E1195E			25147	S	S	SILENT	30	30						25	5.0,0.0,0.0	A	G	AY.75					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E1340D	c.G4020T	p.E1340D			4285	orf1ab	ORF1ab	MISSENSE	8	8			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	7	1.0,0.0,0.0	G	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E1341D	c.G4023T	p.E1341D			4288	orf1ab	ORF1ab	MISSENSE	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	1.0,0.0,0.0	G	T	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E1363D	c.G4089T	p.E1363D			4354	orf1ab	ORF1ab	MISSENSE	20	20			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	18	2.0,0.0,0.0	G	T	AY.107					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E148G	c.A443G	p.E148G			708	orf1ab	ORF1ab	MISSENSE	1	1			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	0	1.0,0.0,0.0	A	G	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E1633D	c.G4899T	p.E1633D			5164	orf1ab	ORF1ab	MISSENSE	34	34			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	32.0,0.0,0.0	G	T	AY.47					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E1724D	c.G5172T	p.E1724D			5437	orf1ab	ORF1ab	MISSENSE	15	15			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	15.0,0.0,0.0	G	T	AY.98.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E2049A	c.A6146C	p.E2049A			6411	orf1ab	ORF1ab	MISSENSE	20	20			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	18	2.0,0.0,0.0	A	C	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E231E	c.G693A	p.E231E			28966	N	N	SILENT	2	2						1	1.0,0.0,0.0	G	A	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E239E	c.G717A	p.E239E			26109	ORF3a	ORF3a	SILENT	7	7						0	7.0,0.0,0.0	G	A	AY.34					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E239Q	c.G715C	p.E239Q			26107	ORF3a	ORF3a	MISSENSE	8905	11						22	8882.0,0.0,0.0	G	C	AY.23, AY.46.6, AY.99.2, AY.25					False	False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E253D	c.G759T	p.E253D			29032	N	N	MISSENSE	5	5						4	1.0,0.0,0.0	G	T	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E281Q	c.G841C	p.E281Q			22403	S	S	MISSENSE	10	5						8	2.0,0.0,0.0	G	C	AY.46.4, AY.46.4					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E2970E	c.A8910G	p.E2970E			9175	orf1ab	ORF1ab	SILENT	7	7			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	6	1.0,0.0,0.0	A	G	AY.100					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E41D	c.G123T	p.E41D			27516	ORF7a	ORF7a	MISSENSE	2	2						1	1.0,0.0,0.0	G	T	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E41E	c.G123A	p.E41E			27516	ORF7a	ORF7a	SILENT	30	30						4	25.0,0.0,0.0	G	A	AY.75					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E4828E	c.A14484G	p.E4828E			14748	orf1ab	ORF1ab	SILENT	7	7			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	6	1.0,0.0,0.0	A	G	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E4828G	c.A14483G	p.E4828G			14747	orf1ab	ORF1ab	MISSENSE	48	48			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	16	32.0,0.0,0.0	A	G	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	ACE2 receptor binding affinity	Gong et al. (2021)	'L452R', 'D614G'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant combination (representing lineage B.1.617) showed a 1.85x increase  in binding (KD) relative to D614G. [exact variant list not provided in manuscript, is inferred fro common knowledge]	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	antibody epitope effects	Sun et al. (2021)		>20% (ELISA significance threshold) drop in antibody binding by this variant against monoclonal antibody VH-Fc ab8.	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	convalescent plasma binding	Gong et al. (2021)	'L452R', 'D614G'	This variant combination (representing lineage B.1.617) showed a 1.22x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 8 months post-symptom-onset. [exact variant list not provided in manuscript, is inferred fro common knowledge]	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	convalescent plasma escape	Greaney et al. (2021)		In 3 of 11 subjects' convalescent sera in an early+late mutational landscape analysis of the RBD,  E484Q shows a notably resistant profile, comparable to or even more resistant than E484K at  later time points (i.e. more resistant to immune cell somatic mutation evolution), see Figure 5a,b. Subject C 32 days post-infection showed >>10 fold reduction in neutralization, reducing to ~10-fold by day 104. Subject B 26 days post-infection showed ~10 fold reduction in neutralization, reducing to ~4x at day 113. Notably, Subject B also showed smaller than typical (~10 vs 30+ fold) reduction in one-month neutralization by E484K at day 32,  and no E484K immune escape at day 104. Subject I 26 days post-infection showed ~10 fold reduction in neutralization, with no reduction in escape at day 102. Notably, Subject I also showed smaller than typical (~10 vs 30+ fold) reduction in one-month neutralization by E484K at day 26,  and no E484K immune escape at day 102.	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	convalescent plasma escape	Tada et al. (2021)	'L452R', 'D614G'	Pseudotyped viruses for B.1.617 was 2.3-fold resistant to neutralization by convalescent sera compared to wild type - a finding that was similar to that of the 3-fold resistance of the South Africa B.1.351 variant using the same assay. The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617. [details on the convalescent patient sera collection are not abundantly clear in the preprint]	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	monoclonal antibody serial passage escape	Starr et al. (2021)		Escape mutation against monoclonal antibody LY-CoV555 (antibody that forms the basis for Eli Lilly's bamlanivimab)	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	pharmaceutical effectiveness	Engelhart et al. (2021)		Bamlanivimab (LY-CoV555) lost ~20x binding against this isolated mutation. Casirivimab lost ~4x binding against this isolated mutation.	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	symptom prevalence	Yadav et al. (2021)	'L452R', 'P681R'	Gross examination of 3+3 hamster lung specimens showed pronounced congestion and hemorrhages on days 5 and 7 post-infection in the case of the B.1.617.1 as compared with the B.1. The lung lesions with  the B.1 variant were minimal to mild whereas with B.1.617.1 they were moderate. For B.1 pneumonic changes were minimal to mild (inflammatory cell infiltration, focal consolidation and mild congestion). The pronounced changes (moderate to severe) with mononuclear infiltration in the alveolar interstitial space, interstitial septal thickening, consolidation and pneumocyte hyperplasia were observed with B.1.617.1 variant consistently.	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	trafficking	Ferriera et al (2021)		This variant alone shows a 10x decrease in cell entry efficiency (RLU measurement in 293T cells) compared to D614G. 	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	transmissibility	Tada et al. (2021)	'L452R', 'D614G'	The combination caused a 3-fold increase in infectivity relative to D614G wild type. [compare to 3.5x for L452R alone]	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	transmissibility	Tada et al. (2021)	'L452R', 'P681R', 'D614G'	Normalized for particle number, on ACE2.293T cells showed that the B.1.617 spike protein was >2-fold increase in infectivity relative to D614G wild type.	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	vaccine neutralization efficacy	Ferreira et al. (2021)	'L452R'	Nine stored sera from Pfizer BNT162b2 vaccinees were tested against a range of spike mutation bearing PV. E484Q had a ~5x drop in neutralization (vs ~10x for E484K). When E484Q and L452R were combined, the fold change was significant, but similar to that of L452R alone (~2x), suggesting no evidence for an additive effect [perhaps even E484Q effect dilution]. 	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	vaccine neutralization efficacy	Gong et al. (2021)	'L452R', 'D614G'	1.4x reduction in neutralization (ID50) in sera 3 weeks after one dose of Pfizer/BioNTech BNT162b2 (up to 5 naive and post infection vaccinees)	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	vaccine neutralization efficacy	Tada et al. (2021)	'L452R', 'D614G'	Pseudotyped viruses for B.1.617 was 4-fold resistant to neutralization by 6 BNT162b2 vaccine sera 28 days post-booster compared to wild type - a finding that was similar to that of the 3.4-fold resistance of the South Africa B.1.351 variant using the same assay. Neutralization by 3 Moderna vaccine sera 28 days post-booster was 5-fold resistant (vs. 2.2-fold for B.1.351). The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617.	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	vaccinee plasma binding	Gong et al. (2021)	'L452R', 'D614G'	This variant combination (representing lineage B.1.617) showed a 1.30x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.   1.18x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees. [exact variant list not provided in manuscript, is inferred fro common knowledge]	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E484Q	c.G1450C	p.E484Q			23012	S	S	MISSENSE	11	5						9	2.0,0.0,0.0	G	C	AY.35, AY.70	viral load	Yadav et al. (2021)	'L452R', 'P681R'	In 9 infected hamsters each for B.1 and B.1.617.1, no significant change in viral load or subgenomic RNA levels were detected. 	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E504E	c.A1512G	p.E504E			1777	orf1ab	ORF1ab	SILENT	28	28			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	25	3.0,0.0,0.0	A	G	AY.46					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E5486E	c.A16458G	p.E5486E			16722	orf1ab	ORF1ab	SILENT	550	550			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	490	60.0,0.0,0.0	A	G	AY.93					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E5585D	c.G16755T	p.E5585D			17019	orf1ab	ORF1ab	MISSENSE	108	30			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	87	21.0,0.0,0.0	G	T	AY.16, AY.20					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E5665D	c.G16995T	p.E5665D			17259	orf1ab	ORF1ab	MISSENSE	39	9			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	34	5.0,0.0,0.0	G	T	AY.106, AY.75					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E5689D	c.G17067T	p.E5689D			17331	orf1ab	ORF1ab	MISSENSE	2	2			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	0	2.0,0.0,0.0	G	T	AY.6					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E5744E	c.A17232G	p.E5744E			17496	orf1ab	ORF1ab	SILENT	1966	1,924			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	1731	235.0,0.0,0.0	A	G	B.1.617.2, AY.48, AY.35, AY.51					False	False, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E6129D	c.G18387C	p.E6129D			18651	orf1ab	ORF1ab	MISSENSE	4603	9			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	889	3714.0,0.0,0.0	G	C	AY.106, AY.45, AY.88, AY.35, AY.72, AY.55, AY.24, AY.74					False	False, False, False, False, False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E640D	c.G1920T	p.E640D			2185	orf1ab	ORF1ab	MISSENSE	2	2			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	2.0,0.0,0.0	G	T	AY.37					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E661D	c.G1983T	p.E661D			23545	S	S	MISSENSE	5	5						0	5.0,0.0,0.0	G	T	AY.46.4					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E673E	c.G2019A	p.E673E			2284	orf1ab	ORF1ab	SILENT	7	2			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	5	2.0,0.0,0.0	G	A	AY.72, AY.55					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E6756E	c.A20268G	p.E6756E			20532	orf1ab	ORF1ab	SILENT	160	160			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	1	158.0,0.0,0.0	A	G	AY.36					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E750A	c.A2249C	p.E750A			2514	orf1ab	ORF1ab	MISSENSE	78	78			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	66	12.0,0.0,0.0	A	C	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E7E	c.A21G	p.E7E			26265	E	E	SILENT	24	24						21	3.0,0.0,0.0	A	G	AY.39					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.E87D	c.G261T	p.E87D			526	orf1ab	ORF1ab	MISSENSE	24	9			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	8	16.0,0.0,0.0	G	T	AY.106, AY.98.1					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.E995D	c.G2985T	p.E995D			3250	orf1ab	ORF1ab	MISSENSE	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	G	T	AY.3.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.F110F	c.C330T	p.F110F			28603	N	N	SILENT	8	8						7	1.0,0.0,0.0	C	T	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F114L	c.C342A	p.F114L			27735	ORF7a	ORF7a	MISSENSE	2	2						1	1.0,0.0,0.0	C	A	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F120F	c.C360T	p.F120F			28253	ORF8	ORF8	SILENT	35	35	mask	highly_homoplasic				0	35.0,0.0,0.0	C	T	AY.48					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.F120del	c.355_360delGATTTC	p.D119_F120del	D119_F120del	'D119del'	28247	ORF8	ORF8		25936	1,924						2	25734.0,188.0,0.0	AGATTTC	A,AGATTTT	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.F16F	c.T48C	p.F16F			27941	ORF8	ORF8	SILENT	7	7						6	1.0,0.0,0.0	T	C	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F190F	c.C570T	p.F190F			835	orf1ab	ORF1ab	SILENT	8	8			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	7	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F1925F	c.C5775T	p.F1925F			6040	orf1ab	ORF1ab	SILENT	408	410			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	403.0,0.0,0.0	C	T	AY.44					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.F207F	c.C621T	p.F207F			26013	ORF3a	ORF3a	SILENT	2	2						1	1.0,0.0,0.0	C	T	AY.72					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F2172F	c.C6516T	p.F2172F			6781	orf1ab	ORF1ab	SILENT	10	10			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	9	1.0,0.0,0.0	C	T	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F2338F	c.C7014T	p.F2338F			7279	orf1ab	ORF1ab	SILENT	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	1.0,0.0,0.0	C	T	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F2718F	c.C8154T	p.F2718F			8419	orf1ab	ORF1ab	SILENT	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	C	T	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.F274F	c.C822T	p.F274F			29095	N	N	SILENT	49	41						36	13.0,0.0,0.0	C	T	AY.13, AY.46.6					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F2787F	c.C8361T	p.F2787F			8626	orf1ab	ORF1ab	SILENT	65	65			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	54	11.0,0.0,0.0	C	T	AY.102					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F3100F	c.C9300T	p.F3100F			9565	orf1ab	ORF1ab	SILENT	2	2			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	1	1.0,0.0,0.0	C	T	AY.104					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F3138S	c.T9413C	p.F3138S			9678	orf1ab	ORF1ab	MISSENSE	1966	1,924			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	1731	235.0,0.0,0.0	T	C	B.1.617.2, AY.48, AY.35, AY.51					False	False, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F32V	c.T94G	p.F32V			21656	S	S	MISSENSE	3	3						1	2.0,0.0,0.0	T	G	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F3329F	c.C9987T	p.F3329F			10252	orf1ab	ORF1ab	SILENT	24	24			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	19	5.0,0.0,0.0	C	T	AY.33					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F3397F	c.C10191T	p.F3397F			10456	orf1ab	ORF1ab	SILENT	36	11			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	26	10.0,0.0,0.0	C	T	AY.23, AY.9.2					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F346F	c.C1038T	p.F346F			29311	N	N	SILENT	151	120						122	29.0,0.0,0.0	C	T	AY.15, AY.9.2, AY.63					False	False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F363L	c.T1087C	p.F363L			29360	N	N	MISSENSE	2	2						1	1.0,0.0,0.0	T	C	AY.75.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F3785F	c.C11355T	p.F3785F			11620	orf1ab	ORF1ab	SILENT	6	6			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	5	1.0,0.0,0.0	C	T	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F43F	c.C129T	p.F43F			25521	ORF3a	ORF3a	SILENT	13	7						11	2.0,0.0,0.0	C	T	AY.100, AY.17					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F4584V	c.T13750G	p.F4584V			14014	orf1ab	ORF1ab	MISSENSE	410	410			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	4	406.0,0.0,0.0	T	G	AY.44					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.F4614F	c.C13842T	p.F4614F			14106	orf1ab	ORF1ab	SILENT	3	3			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	1	2.0,0.0,0.0	C	T	AY.53					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F4820F	c.C14460T	p.F4820F			14724	orf1ab	ORF1ab	SILENT	15	15			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	2	13.0,0.0,0.0	C	T	AY.98.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.F4986F	c.C14958T	p.F4986F			15222	orf1ab	ORF1ab	SILENT	48	48			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	14	34.0,0.0,0.0	C	T	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F53F	c.C159T	p.F53F			26681	M	M	SILENT	4588	2						4083	505.0,0.0,0.0	C	T	AY.104, AY.106, AY.34, AY.60, AY.24, AY.74					False	False, False, True, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F53F	c.C159T	p.F53F			28432	N	N	SILENT	7	7						5	2.0,0.0,0.0	C	T	AY.100					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F5823F	c.C17469T	p.F5823F			17733	orf1ab	ORF1ab	SILENT	4	4			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	3	1.0,0.0,0.0	C	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F58F	c.C174T	p.F58F			21736	S	S	SILENT	3	3						1	2.0,0.0,0.0	C	T	AY.99					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F6302F	c.C18906T	p.F6302F			19170	orf1ab	ORF1ab	SILENT	8	8			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	7	1.0,0.0,0.0	C	T	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F6309F	c.T18927C	p.F6309F			19191	orf1ab	ORF1ab	SILENT	17	17			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	4	13.0,0.0,0.0	T	C	AY.18					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.F63fs	c.189_253delTGCTTTTGCTTGTCCTGACGGCGTAAAACACGTCTATCAGTTACGTGCCAGATCAGTTTCACCTA	p.F63fs			27581	ORF7a	ORF7a		157	160			(ORF7a|Gene_27393_27758|1|1.00)			0	16.0,141.0,0.0	TTGCTTTTGCTTGTCCTGACGGCGTAAAACACGTCTATCAGTTACGTGCCAGATCAGTTTCACCTA	T,TTGCTTTTGCTTGTCCTGACGGCGTAAAACACGTCTATCAGTTACGTGCCAGATCAGCTTCACCTA	AY.36					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.F6507F	c.T19521C	p.F6507F			19785	orf1ab	ORF1ab	SILENT	20	20			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	17	3.0,0.0,0.0	T	C	AY.107					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F6684F	c.C20052T	p.F6684F			20316	orf1ab	ORF1ab	SILENT	9	9			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F6985F	c.C20955T	p.F6985F			21219	orf1ab	ORF1ab	SILENT	9	9			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.F741F	c.C2223T	p.F741F			2488	orf1ab	ORF1ab	SILENT	1	1			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	1.0,0.0,0.0	C	T	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.F924F	c.C2772T	p.F924F			3037	orf1ab	ORF1ab	SILENT	26013	1,924			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	26013.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G100C	c.G298T	p.G100C			25690	ORF3a	ORF3a	MISSENSE	4	4						3	1.0,0.0,0.0	G	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G100V	c.G299T	p.G100V			25691	ORF3a	ORF3a	MISSENSE	26	20						23	3.0,0.0,0.0	G	T	AY.64, AY.24					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G1119G	c.C3357T	p.G1119G			3622	orf1ab	ORF1ab	SILENT	17	17			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	15	2.0,0.0,0.0	C	T	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G1119S	c.G3355A	p.G1119S			3620	orf1ab	ORF1ab	MISSENSE	3	3			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	1.0,0.0,0.0	G	A	AY.99					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G1125C	c.G3373T	p.G1125C			3638	orf1ab	ORF1ab	MISSENSE	3	3			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	1.0,0.0,0.0	G	T	AY.12					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G112C	c.G334T	p.G112C			599	orf1ab	ORF1ab	MISSENSE	27	27			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	5	22.0,0.0,0.0	G	T	AY.19					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G1155C	c.G3463T	p.G1155C			3728	orf1ab	ORF1ab	MISSENSE	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	1.0,0.0,0.0	G	T	AY.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G1167V	c.G3500T	p.G1167V			25062	S	S	MISSENSE	8	3						2	6.0,0.0,0.0	G	T	AY.41, AY.32					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G116G	c.G348T	p.G116G			28621	N	N	SILENT	16	16						14	2.0,0.0,0.0	G	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G11R	c.G31C	p.G11R			25423	ORF3a	ORF3a	MISSENSE	1	1						0	1.0,0.0,0.0	G	C	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G1219C	c.G3655T	p.G1219C			25217	S	S	MISSENSE	8	8						7	1.0,0.0,0.0	G	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G133G	c.C399T	p.G133G			664	orf1ab	ORF1ab	SILENT	79	79			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	53	26.0,0.0,0.0	C	T	AY.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G1369R	c.G4105A	p.G1369R			4370	orf1ab	ORF1ab	MISSENSE	27	27			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	10	17.0,0.0,0.0	G	A	AY.19					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G142D	c.G425A	p.G142D			21987	S	S	MISSENSE	22108	1,924	mask	amplicon_drop_or_primer_artefact,back_to_ref				21	22079.0,8.0,0.0	G	A	B.1.617.2, AY.109, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.13, AY.38, AY.46.4, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.54, AY.85, AY.9.2.1, AY.67, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.7.1, AY.74, AY.27, AY.25	monoclonal antibody serial passage escape	McCallum et al. (2021)		Escape mutation against Spike N terminal domain antigenic supersite i mAbs S2M28, S2X28, S2X333	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G142D	c.G425A	p.G142D			21987	S	S	MISSENSE	22108	1,924	mask	amplicon_drop_or_primer_artefact,back_to_ref				21	22079.0,8.0,0.0	G	A	B.1.617.2, AY.109, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.13, AY.38, AY.46.4, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.54, AY.85, AY.9.2.1, AY.67, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.7.1, AY.74, AY.27, AY.25	monoclonal antibody serial passage escape	Suryadevara et al. (2021)		Selected twice in passage with mAb COV2-2489.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G172C	c.G514T	p.G172C			25906	ORF3a	ORF3a	MISSENSE	5	6						4	1.0,0.0,0.0	G	T	AY.4.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G174C	c.G520T	p.G174C			25912	ORF3a	ORF3a	MISSENSE	16	16						14	2.0,0.0,0.0	G	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G181V	c.G542T	p.G181V			22104	S	S	MISSENSE	16	8						14	2.0,0.0,0.0	G	T	AY.88, AY.88					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G18V	c.G53T	p.G18V			28326	N	N	MISSENSE	34	34						3	31.0,0.0,0.0	G	T	AY.47					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G1982G	c.A5946C	p.G1982G			6211	orf1ab	ORF1ab	SILENT	12	12			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	10	2.0,0.0,0.0	A	C	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G202G	c.C606T	p.G202G			27128	M	M	SILENT	68	52						47	21.0,0.0,0.0	C	T	AY.26, AY.35, AY.82					False	False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G2091S	c.G6271A	p.G2091S			6536	orf1ab	ORF1ab	MISSENSE	9	9			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	8	1.0,0.0,0.0	G	A	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G215C	c.G643T	p.G215C			28916	N	N	MISSENSE	12979	1,924						720	12258.0,0.0,0.0	G	T	B.1.617.2, AY.109, AY.19, AY.111, AY.104, AY.103, AY.100, AY.106, AY.12, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.46.4, AY.4.5, AY.44, AY.33, AY.46.2, AY.41, AY.102, AY.4.2, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.5, AY.20, AY.32, AY.39, AY.46, AY.43, AY.46.1, AY.92, AY.42, AY.98.1, AY.87, AY.108, AY.85, AY.39.1, AY.46.6, AY.4.3, AY.99.2, AY.93, AY.82, AY.84, AY.99, AY.7.1, AY.25					False	False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, True, True, True, True, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G224C	c.G670T	p.G224C			26062	ORF3a	ORF3a	MISSENSE	30	30						5	25.0,0.0,0.0	G	T	AY.75					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G2258D	c.G6773A	p.G2258D			7038	orf1ab	ORF1ab	MISSENSE	6	6	caution	single_src,highly_ambiguous	nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	1.0,0.0,0.0	G	A	AY.17					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G238C	c.G712T	p.G238C			28985	N	N	MISSENSE	24	24	mask	highly_ambiguous,homoplasic,single_src				21	3.0,0.0,0.0	G	T	AY.33					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G254X	c.G760T	p.G254X			26152	ORF3a	ORF3a	NONSENSE	2	2						1	1.0,0.0,0.0	G	T	AY.104					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G334G	c.C1002T	p.G334G			1267	orf1ab	ORF1ab	SILENT	2296	1,924			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1476	820.0,0.0,0.0	C	T	B.1.617.2, AY.19, AY.16, AY.40, AY.15, AY.14, AY.13, AY.17, AY.75.1, AY.18, AY.48, AY.45, AY.35, AY.81, AY.54, AY.53, AY.77, AY.68, AY.51					False	False, False, True, True, True, True, True, True, False, True, True, False, False, True, True, True, True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G34W	c.G100T	p.G34W			28373	N	N	MISSENSE	9	9						8	1.0,0.0,0.0	G	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G3546C	c.G10636T	p.G3546C			10901	orf1ab	ORF1ab	MISSENSE	2	2			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	1	1.0,0.0,0.0	G	T	AY.75.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G38G	c.A114C	p.G38G			27507	ORF7a	ORF7a	SILENT	8899	11						21	8878.0,0.0,0.0	A	C	AY.23, AY.46.6, AY.99.2, AY.25					False	False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G38R	c.G112A	p.G38R			27505	ORF7a	ORF7a	MISSENSE	27	27						22	5.0,0.0,0.0	G	A	AY.109					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G38V	c.G113T	p.G38V			27506	ORF7a	ORF7a	MISSENSE	10	10						9	1.0,0.0,0.0	G	T	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G4177G	c.A12531G	p.G4177G			12796	orf1ab	ORF1ab	SILENT	2	2			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab	YP_009725305.1	1	1.0,0.0,0.0	A	G	AY.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G42S	c.G124A	p.G42S			27517	ORF7a	ORF7a	MISSENSE	27	27						5	22.0,0.0,0.0	G	A	AY.109					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G4417G	c.C13251T	p.G4417G			13515	orf1ab	ORF1ab	SILENT	2	2			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	2.0,0.0,0.0	C	T	AY.60					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G4529C	c.G13585T	p.G4529C			13849	orf1ab	ORF1ab	MISSENSE	6	6			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	5	1.0,0.0,0.0	G	T	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G4737G	c.A14211G	p.G4737G			14475	orf1ab	ORF1ab	SILENT	7141	25			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	31	7110.0,0.0,0.0	A	G	AY.38, AY.67, AY.9, AY.27					False	False, True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G485S	c.G1453A	p.G485S			23015	S	S	MISSENSE	6	6						4	2.0,0.0,0.0	G	A	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G5063S	c.G15187A	p.G5063S			15451	orf1ab	ORF1ab	MISSENSE	25978	1,924			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	204	25774.0,0.0,0.0	G	A	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G5166C	c.G15496T	p.G5166C			15760	orf1ab	ORF1ab	MISSENSE	25	25			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	22	3.0,0.0,0.0	G	T	AY.38					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G519S	c.G1555A	p.G519S			1820	orf1ab	ORF1ab	MISSENSE	61	3			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	45	16.0,0.0,0.0	G	A	AY.41, AY.65, AY.46, AY.42, AY.67, AY.24, AY.62					False	True, False, False, False, True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G5215D	c.G15644A	p.G5215D			15908	orf1ab	ORF1ab	MISSENSE	2	2			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	2.0,0.0,0.0	G	A	AY.37					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G5327G	c.G15981A	p.G5327G			16245	orf1ab	ORF1ab	SILENT	20	20			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	18	2.0,0.0,0.0	G	A	AY.107					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G5527G	c.T16581C	p.G5527G			16845	orf1ab	ORF1ab	SILENT	1	1			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	0	1.0,0.0,0.0	T	C	AY.4.3					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G572E	c.G1715A	p.G572E			1980	orf1ab	ORF1ab	MISSENSE	12	12			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	10	2.0,0.0,0.0	G	A	AY.42					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G6068G	c.A18204G	p.G6068G			18468	orf1ab	ORF1ab	SILENT	88	30			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	30	58.0,0.0,0.0	A	G	AY.16, AY.13, AY.18					False	True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G60G	c.C180T	p.G60G			28453	N	N	SILENT	3	3						2	1.0,0.0,0.0	C	T	AY.99					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G618G	c.C1854T	p.G618G			2119	orf1ab	ORF1ab	SILENT	2	2			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	1.0,0.0,0.0	C	T	AY.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G6598D	c.G19793A	p.G6598D			20057	orf1ab	ORF1ab	MISSENSE	15	15			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	0	15.0,0.0,0.0	G	A	AY.82					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.G857G	c.C2571T	p.G857G			24133	S	S	SILENT	70	70						57	13.0,0.0,0.0	C	T	AY.3					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G932G	c.C2796A	p.G932G			24358	S	S	SILENT	152	152						134	18.0,0.0,0.0	C	A	AY.103					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G957D	c.G2870A	p.G957D			3135	orf1ab	ORF1ab	MISSENSE	16	16			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	13	3.0,0.0,0.0	G	A	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.G989V	c.G2966T	p.G989V			3231	orf1ab	ORF1ab	MISSENSE	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	6	1.0,0.0,0.0	G	T	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H1101Q	c.C3303G	p.H1101Q			24865	S	S	MISSENSE	3	3						1	2.0,0.0,0.0	C	G	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H1101Y	c.C3301T	p.H1101Y			24863	S	S	MISSENSE	20	20						0	20.0,0.0,0.0	C	T	AY.107					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.H110Y	c.C328T	p.H110Y			593	orf1ab	ORF1ab	MISSENSE	5	5			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	4	1.0,0.0,0.0	C	T	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H1113Y	c.C3337T	p.H1113Y			3602	orf1ab	ORF1ab	MISSENSE	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	6	1.0,0.0,0.0	C	T	AY.100					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H146Y	c.C436T	p.H146Y			21998	S	S	MISSENSE	15	16						13	2.0,0.0,0.0	C	T	AY.9	antibody epitope effects	McCallum et al. (2021)		"Massive reduction in 4A8 monoclonal antibody EC50 (i.e. ablated recognition), but much milder effect on mAbs within antigenic supersite ""i"""	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H155Y	c.C463T	p.H155Y			26985	M	M	MISSENSE	10	11						9	1.0,0.0,0.0	C	T	AY.5					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H207H	c.C621T	p.H207H			22183	S	S	SILENT	4	2						2	2.0,0.0,0.0	C	T	AY.104, AY.104					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H2092Y	c.C6274T	p.H2092Y			6539	orf1ab	ORF1ab	MISSENSE	32	16			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	9	23.0,0.0,0.0	C	T	AY.40, AY.45, AY.81, AY.70, AY.51					False	True, False, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H2125Y	c.C6373T	p.H2125Y			6638	orf1ab	ORF1ab	MISSENSE	410	410			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	246	164.0,0.0,0.0	C	T	AY.44					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H2659H	c.T7977C	p.H2659H			8242	orf1ab	ORF1ab	SILENT	17	17			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	15.0,0.0,0.0	T	C	AY.18					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.H2799Y	c.C8395T	p.H2799Y			8660	orf1ab	ORF1ab	MISSENSE	109	95			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	89	20.0,0.0,0.0	C	T	AY.86, AY.57, AY.46.6					False	False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H2831Y	c.C8491T	p.H2831Y			8756	orf1ab	ORF1ab	MISSENSE	2	2			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	1	1.0,0.0,0.0	C	T	AY.104					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H3580Q	c.C10740A	p.H3580Q			11005	orf1ab	ORF1ab	MISSENSE	1966	1,924			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	1731	235.0,0.0,0.0	C	A	B.1.617.2, AY.48, AY.35, AY.51					False	False, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H417Y	c.C1249T	p.H417Y			1514	orf1ab	ORF1ab	MISSENSE	9	9			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H4301H	c.C12903T	p.H4301H			13168	orf1ab	ORF1ab	SILENT	31	7			nsp10	nsp10_CysHis, formerly known as growth-factor-like protein (GFL), produced by both pp1a and pp1ab	YP_009725306.1	27	4.0,0.0,0.0	C	T	AY.29, AY.33					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H4467H	c.C13401T	p.H4467H			13665	orf1ab	ORF1ab	SILENT	130	130			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	1	129.0,0.0,0.0	C	T	AY.10					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.H4991H	c.C14973T	p.H4991H			15237	orf1ab	ORF1ab	SILENT	12	12			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	12.0,0.0,0.0	C	T	AY.42					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.H5488Y	c.C16462T	p.H5488Y			16726	orf1ab	ORF1ab	MISSENSE	475	410			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	304	171.0,0.0,0.0	C	T	AY.44, AY.102					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H5806H	c.T17418C	p.H5806H			17682	orf1ab	ORF1ab	SILENT	48	48			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	39	9.0,0.0,0.0	T	C	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H5951Y	c.C17851T	p.H5951Y			18115	orf1ab	ORF1ab	MISSENSE	1	1			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	1.0,0.0,0.0	C	T	AY.3.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.H6239P	c.A18716C	p.H6239P			18980	orf1ab	ORF1ab	MISSENSE	16	16			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	13	3.0,0.0,0.0	A	C	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H6547Y	c.C19639T	p.H6547Y			19903	orf1ab	ORF1ab	MISSENSE	34	34			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	27	7.0,0.0,0.0	C	T	AY.47					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H6686H	c.T20058C	p.H6686H			20322	orf1ab	ORF1ab	SILENT	6	6			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	5	1.0,0.0,0.0	T	C	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H6686Y	c.C20056T	p.H6686Y			20320	orf1ab	ORF1ab	MISSENSE	31	16			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	9	22.0,0.0,0.0	C	T	AY.40, AY.46.4, AY.45, AY.81, AY.51					False	True, False, False, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.H712Q	c.C2136A	p.H712Q			2401	orf1ab	ORF1ab	MISSENSE	7145	25			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	332	6813.0,0.0,0.0	C	A	AY.38, AY.67, AY.9, AY.27					False	False, True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.H93Y	c.C277T	p.H93Y			25669	ORF3a	ORF3a	MISSENSE	39	5						34	5.0,0.0,0.0	C	T	AY.45, AY.47					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I1091V	c.A3271G	p.I1091V			3536	orf1ab	ORF1ab	MISSENSE	9	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	8.0,0.0,0.0	A	G	AY.99.2, AY.99					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I10T	c.T29C	p.I10T			27922	ORF8	ORF8	MISSENSE	3	3						1	2.0,0.0,0.0	T	C	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I1159V	c.A3475G	p.I1159V			3740	orf1ab	ORF1ab	MISSENSE	120	120			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	107	13.0,0.0,0.0	A	G	AY.15					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I118V	c.A352G	p.I118V			26874	M	M	MISSENSE	8	8						7	1.0,0.0,0.0	A	G	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I130I	c.C390T	p.I130I			28663	N	N	SILENT	9	9						8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I1551V	c.A4651G	p.I1551V			4916	orf1ab	ORF1ab	MISSENSE	24	24			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	21	3.0,0.0,0.0	A	G	AY.33					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I1577V	c.A4729G	p.I1577V			4994	orf1ab	ORF1ab	MISSENSE	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	A	G	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I157I	c.C471T	p.I157I			28744	N	N	SILENT	48	48						12	36.0,0.0,0.0	C	T	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I161I	c.C483T	p.I161I			27005	M	M	SILENT	186	152						125	61.0,0.0,0.0	C	T	AY.103, AY.64, AY.65, AY.55, AY.87, AY.24					False	False, True, True, False, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I1785T	c.T5354C	p.I1785T			5619	orf1ab	ORF1ab	MISSENSE	12	12			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	9	3.0,0.0,0.0	T	C	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I2230T	c.T6689C	p.I2230T			6954	orf1ab	ORF1ab	MISSENSE	130	130			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	3	127.0,0.0,0.0	T	C	AY.10					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I2490I	c.C7470T	p.I2490I			7735	orf1ab	ORF1ab	SILENT	164	120			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	77	87.0,0.0,0.0	C	T	AY.15, AY.13, AY.75.1, AY.77					False	False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I2501I	c.C7503T	p.I2501I			7768	orf1ab	ORF1ab	SILENT	15	15			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	15.0,0.0,0.0	C	T	AY.98.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I2541V	c.A7621G	p.I2541V			7886	orf1ab	ORF1ab	MISSENSE	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	6.0,0.0,0.0	A	G	AY.63					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I2790T	c.T8369C	p.I2790T			8634	orf1ab	ORF1ab	MISSENSE	2	2			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	0	2.0,0.0,0.0	T	C	AY.60					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I2806I	c.C8418T	p.I2806I			8683	orf1ab	ORF1ab	SILENT	5	5			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	4	1.0,0.0,0.0	C	T	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I2895I	c.C8685T	p.I2895I			8950	orf1ab	ORF1ab	SILENT	23	3			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	16	7.0,0.0,0.0	C	T	AY.28, AY.107					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I3108V	c.A9322G	p.I3108V			9587	orf1ab	ORF1ab	MISSENSE	20	20			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	18	2.0,0.0,0.0	A	G	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I312I	c.C936T	p.I312I			22498	S	S	SILENT	14	7						0	14.0,0.0,0.0	C	T	AY.34, AY.34					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I3140M	c.A9420G	p.I3140M			9685	orf1ab	ORF1ab	MISSENSE	5	5			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	4	1.0,0.0,0.0	A	G	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I3145I	c.C9435T	p.I3145I			9700	orf1ab	ORF1ab	SILENT	11	5			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	7	4.0,0.0,0.0	C	T	AY.32, AY.63					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I3257I	c.C9771T	p.I3257I			10036	orf1ab	ORF1ab	SILENT	164	120			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	77	87.0,0.0,0.0	C	T	AY.15, AY.13, AY.75.1, AY.77					False	False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I32I	c.C96T	p.I32I			27297	ORF6	ORF6	SILENT	2	2						0	2.0,0.0,0.0	C	T	AY.84					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I337F	c.A1009T	p.I337F			29282	N	N	MISSENSE	1	1						0	1.0,0.0,0.0	A	T	AY.111					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I3731V	c.A11191G	p.I3731V			11456	orf1ab	ORF1ab	MISSENSE	88	1			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	15	73.0,0.0,0.0	A	G	AY.3.1, AY.3, AY.92					False	True, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I3738I	c.C11214T	p.I3738I			11479	orf1ab	ORF1ab	SILENT	6	6			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	4	2.0,0.0,0.0	C	T	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I4062I	c.A12186T	p.I4062I			12451	orf1ab	ORF1ab	SILENT	15	15			nsp8	produced by both pp1a and pp1ab	YP_009725304.1	2	13.0,0.0,0.0	A	T	AY.98.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I410I	c.C1230T	p.I410I			22792	S	S	SILENT	439	25						1	438.0,0.0,0.0	C	T	AY.9.2, AY.9.1, AY.9.2.1, AY.9					False	True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I431M	c.A1293G	p.I431M			1558	orf1ab	ORF1ab	MISSENSE	16	16			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	16.0,0.0,0.0	A	G	AY.40					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I453T	c.T1358C	p.I453T			1623	orf1ab	ORF1ab	MISSENSE	4577	7			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	2808	1769.0,0.0,0.0	T	C	AY.34, AY.45, AY.35, AY.74					False	False, False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I4699I	c.T14097C	p.I4699I			14361	orf1ab	ORF1ab	SILENT	52	52			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	43	9.0,0.0,0.0	T	C	AY.26					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I473I	c.C1419T	p.I473I			1684	orf1ab	ORF1ab	SILENT	58	24			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	22	36.0,0.0,0.0	C	T	AY.39, AY.47					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I47V	c.A139G	p.I47V			28032	ORF8	ORF8	MISSENSE	3	3						0	3.0,0.0,0.0	A	G	AY.81					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I4858V	c.A14572G	p.I4858V			14836	orf1ab	ORF1ab	MISSENSE	27	27			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	27.0,0.0,0.0	A	G	AY.109					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I5107T	c.T15320C	p.I5107T			15584	orf1ab	ORF1ab	MISSENSE	17	17			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	15	2.0,0.0,0.0	T	C	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I5658V	c.A16972G	p.I5658V			17236	orf1ab	ORF1ab	MISSENSE	172	152			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	17	155.0,0.0,0.0	A	G	AY.103, AY.41, AY.92					False	True, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I5804I	c.C17412T	p.I5804I			17676	orf1ab	ORF1ab	SILENT	8	8			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	7	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I5869M	c.A17607G	p.I5869M			17871	orf1ab	ORF1ab	MISSENSE	6	6			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	4	2.0,0.0,0.0	A	G	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I5916I	c.T17748C	p.I5916I			18012	orf1ab	ORF1ab	SILENT	7	7			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	6	1.0,0.0,0.0	T	C	AY.100					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I6012V	c.A18034G	p.I6012V			18298	orf1ab	ORF1ab	MISSENSE	95	95			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	77	18.0,0.0,0.0	A	G	AY.86					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I616I	c.C1848T	p.I616I			2113	orf1ab	ORF1ab	SILENT	6	6			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	5	1.0,0.0,0.0	C	T	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I6399V	c.A19195G	p.I6399V			19459	orf1ab	ORF1ab	MISSENSE	2	2			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	2.0,0.0,0.0	A	G	AY.60					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I6674I	c.T20022A	p.I6674I			20286	orf1ab	ORF1ab	SILENT	6	6			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	5	1.0,0.0,0.0	T	A	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I6687I	c.C20061T	p.I6687I			20325	orf1ab	ORF1ab	SILENT	30	30			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	27	3.0,0.0,0.0	C	T	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I671T	c.T2012C	p.I671T			2277	orf1ab	ORF1ab	MISSENSE	78	78			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	58	20.0,0.0,0.0	T	C	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I7035I	c.T21105C	p.I7035I			21369	orf1ab	ORF1ab	SILENT	11	11			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	9	2.0,0.0,0.0	T	C	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I740I	c.C2220T	p.I740I			2485	orf1ab	ORF1ab	SILENT	48	48			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	13	35.0,0.0,0.0	C	T	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I7I	c.C21T	p.I7I			25413	ORF3a	ORF3a	SILENT	4639	9						57	4582.0,0.0,0.0	C	T	AY.106, AY.38, AY.23, AY.45, AY.88, AY.35, AY.72, AY.59, AY.55, AY.24, AY.74					False	False, False, False, True, False, False, False, False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I82T	c.T245C	p.I82T			26763	M	M	MISSENSE	43	25						0	12.0,31.0,0.0	GCTAT	TCTAC,GCTAC	AY.38, AY.60, AY.9	homoplasy	Shen et al. (2021)		This mutation presents mainly within the B.1 (44.0%) and B.1.525 (38.1%) lineages.  Currently, 99.7% of the B.1.525 lineage isolates carry the M:I82T mutation. While this mutation is scattered across multiple  phylogenetic clades, most cases cluster in two recent clades, suggesting a likely selective advantage in certain haplotype backgrounds.	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I82T	c.T245C	p.I82T			26767	M	M	MISSENSE	18866	1,924						1	18864.0,0.0,0.0	T	C	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.25	homoplasy	Shen et al. (2021)		This mutation presents mainly within the B.1 (44.0%) and B.1.525 (38.1%) lineages.  Currently, 99.7% of the B.1.525 lineage isolates carry the M:I82T mutation. While this mutation is scattered across multiple  phylogenetic clades, most cases cluster in two recent clades, suggesting a likely selective advantage in certain haplotype backgrounds.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I850L	c.A2548C	p.I850L			24110	S	S	MISSENSE	28	28						23	5.0,0.0,0.0	A	C	AY.46					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I870V	c.A2608G	p.I870V			24170	S	S	MISSENSE	25	25						14	11.0,0.0,0.0	A	G	AY.38	immunosuppression variant emergence	Choi et al. (2020)		Appeared (day 75) and persisted in chronic (152 day) SARS-CoV-2 infection of immunocompromised patient with severe antiphospholipid syndrome Appeared at same time as T478K,S494P but listed separately due to distance and different domains affected in the Spike (i.e. putatively an independent mutation from a functional standpoint since the former are from S1, the latter from S2).	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.I882I	c.C2646T	p.I882I			24208	S	S	SILENT	152	152						1	151.0,0.0,0.0	C	T	AY.103					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I88I	c.C264T	p.I88I			27657	ORF7a	ORF7a	SILENT	1	1						0	1.0,0.0,0.0	C	T	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.I895F	c.A2683T	p.I895F			2948	orf1ab	ORF1ab	MISSENSE	10	10			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	9	1.0,0.0,0.0	A	T	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K1045N	c.G3135T	p.K1045N			24697	S	S	MISSENSE	5	5						4	1.0,0.0,0.0	G	T	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K1073N	c.G3219C	p.K1073N			24781	S	S	MISSENSE	8	8						7	1.0,0.0,0.0	G	C	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K1212K	c.G3636A	p.K1212K			3901	orf1ab	ORF1ab	SILENT	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	1.0,0.0,0.0	G	A	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K1348N	c.G4044T	p.K1348N			4309	orf1ab	ORF1ab	MISSENSE	22	22			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	19	3.0,0.0,0.0	G	T	AY.108					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K1405K	c.A4215G	p.K1405K			4480	orf1ab	ORF1ab	SILENT	48	48			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	41	7.0,0.0,0.0	A	G	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K141K	c.G423A	p.K141K			688	orf1ab	ORF1ab	SILENT	7	7			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	6	1.0,0.0,0.0	G	A	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K141_F143del	c.421_429delAAGTCATTT	p.K141_F143del			685	orf1ab	ORF1ab		56	48			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	3	53.0,0.0,0.0	AAAGTCATTT	A	AY.110, AY.72, AY.70					False	True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K147I	c.A440T	p.K147I			22002	S	S	MISSENSE	5	5						4	1.0,0.0,0.0	A	T	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K1512K	c.A4536G	p.K1512K			4801	orf1ab	ORF1ab	SILENT	4	4			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	3	1.0,0.0,0.0	A	G	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K16T	c.A47C	p.K16T			25439	ORF3a	ORF3a	MISSENSE	28	28						23	5.0,0.0,0.0	A	C	AY.46					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K1791N	c.A5373T	p.K1791N			5638	orf1ab	ORF1ab	MISSENSE	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	5.0,1.0,0.0	A	G,T	AY.99.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K1895N	c.G5685T	p.K1895N			5950	orf1ab	ORF1ab	MISSENSE	25	25			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	17	8.0,0.0,0.0	G	T	AY.9.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K2497N	c.G7491T	p.K2497N			7756	orf1ab	ORF1ab	MISSENSE	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	6	1.0,0.0,0.0	G	T	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K261N	c.G783T	p.K261N			1048	orf1ab	ORF1ab	MISSENSE	2065	1,924			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1591	474.0,0.0,0.0	G	T	B.1.617.2, AY.12, AY.88, AY.43, AY.92					False	False, True, False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K2735R	c.A8204G	p.K2735R			8469	orf1ab	ORF1ab	MISSENSE	4	4			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	2.0,0.0,0.0	A	G	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K2901K	c.A8703G	p.K2901K			8968	orf1ab	ORF1ab	SILENT	20	20			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	18	2.0,0.0,0.0	A	G	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K2E	c.A4G	p.K2E			27397	ORF7a	ORF7a	MISSENSE	48	48						12	36.0,0.0,0.0	A	G	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K3353R	c.A10058G	p.K3353R			10323	orf1ab	ORF1ab	MISSENSE	71	65			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	55	16.0,0.0,0.0	A	G	AY.102, AY.70					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K342K	c.A1026G	p.K342K			29299	N	N	SILENT	27	27						23	4.0,0.0,0.0	A	G	AY.19					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K356N	c.G1068T	p.K356N			22630	S	S	MISSENSE	1	1						0	1.0,0.0,0.0	G	T	AY.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K373N	c.G1119T	p.K373N			29392	N	N	MISSENSE	4622	9						50	4572.0,0.0,0.0	G	T	AY.106, AY.38, AY.45, AY.88, AY.35, AY.72, AY.59, AY.55, AY.24, AY.74					False	False, False, False, False, False, False, False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K3839K	c.A11517G	p.K3839K			11782	orf1ab	ORF1ab	SILENT	6	6			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	4	2.0,0.0,0.0	A	G	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K38R	c.A113G	p.K38R			28386	N	N	MISSENSE	11	11						9	2.0,0.0,0.0	A	G	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K4003K	c.G12009A	p.K4003K			12274	orf1ab	ORF1ab	SILENT	41	41			nsp8	produced by both pp1a and pp1ab	YP_009725304.1	14	27.0,0.0,0.0	G	A	AY.13					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	ACE2 receptor binding affinity	Barton et al. (2021)		The K417N mutation decreased the affinity ~4 fold, mainly by decreasing the k(on) but also by increasing the k(off) as measured by surface plasmon resonance.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	ACE2 receptor binding affinity	Collier et al. (2021)		This combination showed ~3x increase binding to ACE2 vs wild type, about half that of the B.1.1.7 lineage, suggesting that the K417N mutation is slightly detrimental to ACE2 binding, probably as a result of disrupting the salt bridge formed with ACE2 residue D30	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	ACE2 receptor binding affinity	Gong et al. (2021)	'D614G'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.5x decrease in binding (KD) relative to D614G.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	ACE2 receptor binding affinity	Laffeber et al. (2021)		RBD containing the N501Y mutation results in 9-fold stronger binding to the hACE2 receptor than  wild type RBD. The E484K mutation does not significantly influence the affinity for the receptor,  while K417N attenuates affinity. As a result, RBD from B.1.351 containing all three mutations binds  3-fold stronger to hACE2 than wild type RBD but 3-fold weaker than N501Y.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	ACE2 receptor binding affinity	Liu et al. (2021)		Studying the key covariants in lineage of concern 501Y.V2,  observed about 2-fold increase in ACE2 binding vs wildtype, but greatly decreased mAb binding, suggesting evolutionary optimum tension between  immune evasion and ACE2 binding affinity as the N501Y variant alone has 10x increase in affinity but no effect on tested mAb binding.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	ACE2 receptor binding affinity	Ramanathan et al. (2021)		Using Mircoscale Thermopheresis, the B.1.351 variant harboring three mutations, binds ACE2 at nearly  five-fold greater affinity than the original SARS-COV-2 RBD (Kd 87.6, vs 402.5 nM).	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	ACE2 receptor binding affinity	Tian et al. (2021)		Reported 3-fold decrease in affinity compared to wild-type RBD on the cell surface (Kd 	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	ACE2 receptor binding affinity	Tian et al. (2021)		Reported slight increase in affinity compared to wild-type RBD on the cell surface (Kd 	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	ACE2 receptor binding affinity	Vogel et al. (2021)		The affinity of ACE2 for this mutation combination was twice as high as for wild type. Having in mind that the affinity of SARS-CoV-2 for ACE2 is only 4-fold higher compared to SARS-CoV-1, this factor of 2 is expected to be biologically significant.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	antibody epitope effects	Sun et al. (2021)		>20% (ELISA significance threshold) drop in antibody binding (ELISA) by this variant against IgG1 monoclonal antibody ab1.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	antibody epitope effects	Wang et al. (2021)		5 antibodies tested were less potent against K417N by ten-fold or more (class 1 mAbs)	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	antibody epitope effects	Wang et al. (2021)		Pseudotyped virus model ablates binding by RBD-directed mAbs CB6 and 910-30 (targeting the inner side of the RBD). Pseudotyped virus model impairs binding by RBD-directed mAbs 4-20 and REGN10933.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	convalescent plasma binding	Gong et al. (2021)	'D614G'	2.16x increase in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	convalescent plasma escape	Cele et al. (2021)		The 501Y.V2 to first wave IC50 ratio ranged from 6 to 200-fold. Averaging across all 7 participant convalescent sera highlighted the dramatic decrease in sensitivity to neutralization of authentic 501Y.V2 variants. PG: I'm purposefully ignoring D614G and A701V as contributors	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	convalescent plasma escape	Chen et al. (2021)		In 19 convalescent human sera ~1mo post infection, Two-tailed Wilcoxon matched-pairs signed-rank test shows mild resistence P	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	convalescent plasma escape	Wibmer et al. (2021)		"27% of 44 early pandemic exposure convalescent plasma/sera lose all activity against a RBD triple mutant pseudovirus (RBD mutatants of the 501Y.V2 ""South African"" lineage), while only 23% retained high titres "	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	convalescent plasma escape	Wibmer et al. (2021)		"Nearly half (21 of 44, 48%) of early pandemic exposure convalescent plasma/sera failed to neutralize the 501Y.V2 (""South African"") lineage pseudovirus construct Only 3 of 44 convascent sera (those with the highest titer, which correlated direectly with initial infection severity) had high neutralization against this 501Y.V2  PG: note that lineage variant R246I was excluded from the text in reference to these sera assays, not sure if that was an oversight."	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	gene expression increase	Starr et al. (2020)		Experimentally, Spike gene expression increased 0.1 fold	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	monoclonal antibody serial passage escape	Starr et al. (2021)		Escape mutation against monoclonal antibody LY-CoV016	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	monoclonal antibody serial passage escape	Wang et al. (2021)		In vitro selection against class 1 (Spike 'up' conformation) monoclonal antibody C682, and to a lesser extent C614 and C660	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	pharmaceutical effectiveness	Engelhart et al. (2021)		COR-101 lost ~6x binding against this isolated mutation. Estesevimab lost ~100x binding against this isolated mutation.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	pharmaceutical effectiveness	Engelhart et al. (2021)		Tixagevimab, Regdanvimab and COR-101 display reduced binding affinity to virus pseudotyped as RBD from B.1.351.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	pharmaceutical effectiveness	Liu et al. (2021)		This mutated version of RBD completely abolishes the binding to a therapeutic antibody, Bamlanivimab, in vitro.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	trafficking	Kuzmina et al. (2021)	'D614G'	~2x more infectivity than D614G alone in HEK293T-ACE2 cells 48h post-transduction.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	trafficking	Tada et al. (2021)		Lentiviral pseudotyped with this individual mutation from B.1.351 was tested on ACE2.293T cells. Luciferase activity was measured two days postinfection,  showing mild decrease in infection rate amongst the cells, suggesting that this  mutation does not contributing to cell entry fitness.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	vaccine neutralization efficacy	Kuzmina et al. (2021)	'D614G'	This variant showed only minor in Pfizer sera (one or two dose) neutralization efficiency vs D614G (using lentivirus pseudotype).	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	vaccinee plasma binding	Gong et al. (2021)	'D614G'	1.76x increase in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.75x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K417N	c.G1251T	p.K417N			22813	S	S	MISSENSE	3	2						0	3.0,0.0,0.0	G	T	AY.1, AY.2	virion structure	Spratt et al. (2021)		Estimated free energy change (ddG) for this variant is -0.86 kcal/mol (i.e. destabilizing relative to wild type) 	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K42E	c.A124G	p.K42E			27325	ORF6	ORF6	MISSENSE	5	5						4	1.0,0.0,0.0	A	G	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K4451N	c.G13353T	p.K4451N			13617	orf1ab	ORF1ab	MISSENSE	4	4			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	2	2.0,0.0,0.0	G	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K4483E	c.A13447G	p.K4483E			13711	orf1ab	ORF1ab	MISSENSE	2	2			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	1	1.0,0.0,0.0	A	G	AY.39.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K4483R	c.A13448G	p.K4483R			13712	orf1ab	ORF1ab	MISSENSE	3	3			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	3.0,0.0,0.0	A	G	AY.41					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K458N	c.A1374C	p.K458N			1639	orf1ab	ORF1ab	MISSENSE	3	3			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	2.0,0.0,0.0	A	C	AY.46.1	convalescent plasma escape	Li et al. (2020)		Resistant to a pool of 10 convalescent sera (but less than 4x, a typical threshold for definition of escape)	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K48N	c.A144T	p.K48N			27345	ORF6	ORF6	MISSENSE	52	52						6	46.0,0.0,0.0	A	T	AY.26					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K500R	c.A1499G	p.K500R			1764	orf1ab	ORF1ab	MISSENSE	8	8			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	7	1.0,0.0,0.0	A	G	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K5784R	c.A17351G	p.K5784R			17615	orf1ab	ORF1ab	MISSENSE	12	12			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	9	3.0,0.0,0.0	A	G	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K6236N	c.G18708T	p.K6236N			18972	orf1ab	ORF1ab	MISSENSE	25	25			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	18	7.0,0.0,0.0	G	T	AY.38					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K6274K	c.G18822A	p.K6274K			19086	orf1ab	ORF1ab	SILENT	17	17			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	8	9.0,0.0,0.0	G	A	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K634N	c.G1902T	p.K634N			2167	orf1ab	ORF1ab	MISSENSE	3	3			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	3.0,0.0,0.0	G	T	AY.28					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K634Q	c.A1900C	p.K634Q			2165	orf1ab	ORF1ab	MISSENSE	2	2			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	2.0,0.0,0.0	A	C	AY.60					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K6437K	c.A19311G	p.K6437K			19575	orf1ab	ORF1ab	SILENT	1	1			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	1.0,0.0,0.0	A	G	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K6561N	c.G19683T	p.K6561N			19947	orf1ab	ORF1ab	MISSENSE	9	9			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	8	1.0,0.0,0.0	G	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K6610K	c.A19830G	p.K6610K			20094	orf1ab	ORF1ab	SILENT	4544	9			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	4044	500.0,0.0,0.0	A	G	AY.106, AY.74					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K669N	c.G2007C	p.K669N			2272	orf1ab	ORF1ab	MISSENSE	2	2			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	1.0,0.0,0.0	G	C	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K669N	c.G2007T	p.K669N			2272	orf1ab	ORF1ab	MISSENSE	3	3			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	3.0,0.0,0.0	G	T	AY.41					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K6711R	c.A20132G	p.K6711R			20396	orf1ab	ORF1ab	MISSENSE	1963	1,924			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	1727	236.0,0.0,0.0	A	G	B.1.617.2, AY.48, AY.35, AY.51					False	False, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K680N	c.G2040T	p.K680N			2305	orf1ab	ORF1ab	MISSENSE	4570	5			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	2870	1700.0,0.0,0.0	G	T	AY.45, AY.35, AY.74					False	False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K6822N	c.G20466T	p.K6822N			20730	orf1ab	ORF1ab	MISSENSE	5	5			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	3	2.0,0.0,0.0	G	T	AY.46.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K6958R	c.A20873G	p.K6958R			21137	orf1ab	ORF1ab	MISSENSE	28	28			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	23	5.0,0.0,0.0	A	G	AY.46					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K7047K	c.A21141G	p.K7047K			21405	orf1ab	ORF1ab	SILENT	34	34			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	24	10.0,0.0,0.0	A	G	AY.47					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.K77T	c.A230C	p.K77T			21792	S	S	MISSENSE	1884	1,924						1656	228.0,0.0,0.0	A	C	B.1.617.2, AY.48, AY.35, AY.51					False	False, True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K854K	c.G2562A	p.K854K			24124	S	S	SILENT	5	5						0	5.0,0.0,0.0	G	A	AY.32					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.K97E	c.A289G	p.K97E			21851	S	S	MISSENSE	76	78						60	16.0,0.0,0.0	A	G	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L101I	c.C301A	p.L101I			25693	ORF3a	ORF3a	MISSENSE	8	8						6	2.0,0.0,0.0	C	A	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L101P	c.T302C	p.L101P			25694	ORF3a	ORF3a	MISSENSE	9	9						8	1.0,0.0,0.0	T	C	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L1063F	c.G3189T	p.L1063F			24751	S	S	MISSENSE	16	16						14	2.0,0.0,0.0	G	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L106L	c.C318T	p.L106L			25710	ORF3a	ORF3a	SILENT	76	6						68	8.0,0.0,0.0	C	T	AY.4.2, AY.3					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L108F	c.C322T	p.L108F			25714	ORF3a	ORF3a	MISSENSE	18	10						15	3.0,0.0,0.0	C	T	AY.65, AY.46.6					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L1144L	c.C3430T	p.L1144L			3695	orf1ab	ORF1ab	SILENT	8	8			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	7	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L116F	c.C346T	p.L116F			27739	ORF7a	ORF7a	MISSENSE	2253	1,924						1669	584.0,0.0,0.0	C	T	B.1.617.2, AY.19, AY.16, AY.40, AY.15, AY.14, AY.13, AY.17, AY.75.1, AY.18, AY.45, AY.81, AY.54, AY.53, AY.77, AY.68, AY.51					False	False, False, True, True, True, True, True, True, False, True, False, True, True, True, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L1218L	c.C3652T	p.L1218L			25214	S	S	SILENT	12	12						10	2.0,0.0,0.0	C	T	AY.42					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L1243L	c.G3729A	p.L1243L			3994	orf1ab	ORF1ab	SILENT	4629	9			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	45	4584.0,0.0,0.0	G	A	AY.106, AY.38, AY.45, AY.88, AY.35, AY.72, AY.59, AY.55, AY.24, AY.74					False	False, False, False, False, False, False, False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L1265F	c.C3793T	p.L1265F			25355	S	S	MISSENSE	7	7						2	5.0,0.0,0.0	C	T	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L129L	c.C385T	p.L129L			26907	M	M	SILENT	17	17						15	2.0,0.0,0.0	C	T	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L138L	c.C414A	p.L138L			26936	M	M	SILENT	17	17						15	2.0,0.0,0.0	C	A	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L139F	c.G417T	p.L139F			28690	N	N	MISSENSE	16	16						0	16.0,0.0,0.0	G	T	AY.40					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L147F	c.C439T	p.L147F			25831	ORF3a	ORF3a	MISSENSE	5	5						4	1.0,0.0,0.0	C	T	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L1507L	c.T4521C	p.L1507L			4786	orf1ab	ORF1ab	SILENT	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	1.0,0.0,0.0	T	C	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L1523L	c.C4567T	p.L1523L			4832	orf1ab	ORF1ab	SILENT	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	C	T	AY.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L159I	c.C475A	p.L159I			28748	N	N	MISSENSE	25	25						14	11.0,0.0,0.0	C	A	AY.38					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L15F	c.G45T	p.L15F			25437	ORF3a	ORF3a	MISSENSE	70	70						62	8.0,0.0,0.0	G	T	AY.3					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L164L	c.G492T	p.L164L			27014	M	M	SILENT	7	7						0	7.0,0.0,0.0	G	T	AY.34					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L1963L	c.T5887C	p.L1963L			6152	orf1ab	ORF1ab	SILENT	410	394			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	11	399.0,0.0,0.0	T	C	AY.9.2.1, AY.9					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L2146P	c.T6437C	p.L2146P			6702	orf1ab	ORF1ab	MISSENSE	10	10			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	9	1.0,0.0,0.0	T	C	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L215L	c.G645A	p.L215L			910	orf1ab	ORF1ab	SILENT	20	20			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	18	2.0,0.0,0.0	G	A	AY.107					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L216F	c.C646T	p.L216F			22208	S	S	MISSENSE	40	20						36	4.0,0.0,0.0	C	T	AY.64, AY.64					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L219L	c.C655T	p.L219L			920	orf1ab	ORF1ab	SILENT	3	3			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	2.0,0.0,0.0	C	T	AY.99					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L2226L	c.C6676T	p.L2226L			6941	orf1ab	ORF1ab	SILENT	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	4.0,0.0,0.0	C	T	AY.17					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L222L	c.C664T	p.L222L			28937	N	N	SILENT	2	2						1	1.0,0.0,0.0	C	T	AY.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L230F	c.C688T	p.L230F			28961	N	N	MISSENSE	7	7						2	5.0,0.0,0.0	C	T	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L2329V	c.T6985G	p.L2329V			7250	orf1ab	ORF1ab	MISSENSE	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	T	G	AY.4.3					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L2333F	c.C6997T	p.L2333F			7262	orf1ab	ORF1ab	MISSENSE	549	550			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	547.0,0.0,0.0	C	T	AY.93					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L27L	c.C81T	p.L27L			346	orf1ab	ORF1ab	SILENT	27	20			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	23	4.0,0.0,0.0	C	T	AY.64, AY.24, AY.62					False	False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L291L	c.A873T	p.L291L			29146	N	N	SILENT	28	25						16	12.0,0.0,0.0	A	T	AY.38, AY.59					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L291L	c.C871T	p.L291L			29144	N	N	SILENT	16	16						14	2.0,0.0,0.0	C	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L29F	c.C85T	p.L29F			26607	M	M	MISSENSE	572	2						508	64.0,0.0,0.0	C	T	AY.1, AY.64, AY.93					False	False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3116F	c.C9346T	p.L3116F			9611	orf1ab	ORF1ab	MISSENSE	4	4			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	2	2.0,0.0,0.0	C	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3180L	c.C9538T	p.L3180L			9803	orf1ab	ORF1ab	SILENT	12	9			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	9	3.0,0.0,0.0	C	T	AY.106, AY.46.1					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3198L	c.C9592T	p.L3198L			9857	orf1ab	ORF1ab	SILENT	12	6			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	4	8.0,0.0,0.0	C	T	AY.57, AY.63					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3338L	c.C10014T	p.L3338L			10279	orf1ab	ORF1ab	SILENT	15	15			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	0	15.0,0.0,0.0	C	T	AY.82					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3378L	c.A10134G	p.L3378L			10399	orf1ab	ORF1ab	SILENT	95	95			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	77	18.0,0.0,0.0	A	G	AY.86					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3535L	c.G10605T	p.L3535L			10870	orf1ab	ORF1ab	SILENT	12	12			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	7	5.0,0.0,0.0	G	T	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3549L	c.T10645C	p.L3549L			10910	orf1ab	ORF1ab	SILENT	5	5			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	4	1.0,0.0,0.0	T	C	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3585L	c.C10755T	p.L3585L			11020	orf1ab	ORF1ab	SILENT	3	3			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	1	2.0,0.0,0.0	C	T	AY.12					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3602F	c.GTTC10806_10809CTTT	p.L3602F			11071	orf1ab	ORF1ab		3	3			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	1	2.0,0.0,0.0	GTTC	CTTT	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3606F	c.G10818T	p.L3606F			11083	orf1ab	ORF1ab	MISSENSE	700	20	mask	highly_homoplasic	nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	263	437.0,0.0,0.0	G	T	AY.107, AY.65, AY.23, AY.61, AY.9.2.1, AY.39.1, AY.9, AY.24, AY.99					False	False, False, False, False, True, False, False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3636L	c.C10908T	p.L3636L			11173	orf1ab	ORF1ab	SILENT	8	8			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	7	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3935L	c.C11803T	p.L3935L			12068	orf1ab	ORF1ab	SILENT	7	7			nsp7	produced by both pp1a and pp1ab	YP_009725303.1	6	1.0,0.0,0.0	C	T	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L3935L	c.G11805T	p.L3935L			12070	orf1ab	ORF1ab	SILENT	238	238			nsp7	produced by both pp1a and pp1ab	YP_009725303.1	176	62.0,0.0,0.0	G	T	AY.61					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L4059L	c.T12175C	p.L4059L			12440	orf1ab	ORF1ab	SILENT	6	6			nsp8	produced by both pp1a and pp1ab	YP_009725304.1	5	1.0,0.0,0.0	T	C	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L4184L	c.C12550T	p.L4184L			12815	orf1ab	ORF1ab	SILENT	1	1			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab	YP_009725305.1	0	1.0,0.0,0.0	C	T	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L4252L	c.C12754T	p.L4252L			13019	orf1ab	ORF1ab	SILENT	14565	1,924			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab	YP_009725305.1	1738	12827.0,0.0,0.0	C	T	B.1.617.2, AY.28, AY.106, AY.26, AY.2, AY.38, AY.10, AY.75.1, AY.64, AY.65, AY.45, AY.60, AY.88, AY.57, AY.35, AY.72, AY.59, AY.9.2, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.73, AY.61, AY.9.2.1, AY.67, AY.37, AY.63, AY.9, AY.24, AY.68, AY.70, AY.62, AY.74, AY.27					False	False, True, False, True, True, True, True, False, True, True, False, True, False, True, False, True, True, True, False, True, True, False, True, True, True, True, True, True, True, True, True, False, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37139	1,924						4	37130.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	ACE2 receptor binding affinity	Gong et al. (2021)	'D614G'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 2.66x increase in binding (KD) relative to D614G.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	T	G	AY.35, AY.70	ACE2 receptor binding affinity	Gong et al. (2021)	'E484Q', 'D614G'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant combination (representing lineage B.1.617) showed a 1.85x increase  in binding (KD) relative to D614G. [exact variant list not provided in manuscript, is inferred fro common knowledge]	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	ACE2 receptor binding affinity	Motozono et al. (2021)		~1.7-fold increase in binding affinity vs wild type.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	T cell evasion	Motozono et al. (2021)		L452R derivative virus did not induce IFN-gamma expression even at the highest concentration tested (10 nM) in two different A*24:02 convalescent sera  donor plasma (linear epitope NYNYLYRLF 448,456).	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	antibody epitope effects	Li et al. (2020)		Resistent to some neutralizing antibodies: mAbs X593 and P2B-2F6	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	antibody epitope effects	Liu et al. (2021)		Mutant screen in neutralization assay with a broad range of monoclonal antibodies shows resistence to more than one antibody.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	antibody epitope effects	McCallum et al. (2021)		10 of 14 RBD-specific mAbs that showed at least 10-fold reduced neutralization of B.1.427/B.1.429 variant pseudotype (S13I, W152C, and L452R) were also found to poorly bind to just a L452R RBD mutant, demonstrating a role for this mutation as an escape mechanism for certain RBD-targeting mAbs.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	antibody epitope effects	Sun et al. (2021)		~20% (ELISA significance threshold) drop in antibody binding (ELISA) by this variant against monoclonal antibody VH ab6.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37139	1,924						4	37130.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	convalescent plasma binding	Gong et al. (2021)	'D614G'	2.15x increase in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	T	G	AY.35, AY.70	convalescent plasma binding	Gong et al. (2021)	'E484Q', 'D614G'	This variant combination (representing lineage B.1.617) showed a 1.22x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 8 months post-symptom-onset. [exact variant list not provided in manuscript, is inferred fro common knowledge]	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	convalescent plasma escape	Alenquer et al. (2021)		Observed ~2x decrease on average in 16 health workers' convalescent sera.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	convalescent plasma escape	Liu et al. (2021)		Ablation of neutralization capability of 3 of 4 convalescent sera tested, the other is significantly hindered.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	T	G	AY.35, AY.70	convalescent plasma escape	Tada et al. (2021)	'E484Q', 'D614G'	Pseudotyped viruses for B.1.617 was 2.3-fold resistant to neutralization by convalescent sera compared to wild type - a finding that was similar to that of the 3-fold resistance of the South Africa B.1.351 variant using the same assay. The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617. [details on the convalescent patient sera collection are not abundantly clear in the preprint]	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37139	1,924						4	37130.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	convalescent plasma escape	Wilhelm et al. (2021)	'D614G'	Relative to B.1, Epsilon (B.1.417/429) shows 1.74x-2.35x decrease in neutralization efficiency by convalescent plasma [no cohort details provided]	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	gene expression increase	Starr et al. (2020)		Experimentally, Spike gene expression increased 0.32 fold	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	monoclonal antibody serial passage escape	Greaney et al. (2020)		Ranked effective mutant against this position in the RBD for highly neutralizing COV2-2096	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	monoclonal antibody serial passage escape	Starr et al. (2021)		Escape mutation against monoclonal antibody LY-CoV555 (antibody that forms the basis for Eli Lilly's bamlanivimab)	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	monoclonal antibody serial passage escape	Wang et al. (2021)		Class 2/3 antibody C628 and class 2 antibody C643 selected for the emergence of the L452R mutation in vitro.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	pharmaceutical effectiveness	Engelhart et al. (2021)		Bamlanivimab (LY-CoV555) lost ~5x binding against this isolated mutation. Cligavimab lost ~4x binding against this isolated mutation. Regdanvimab lost ~4x binding against this isolated mutation.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	pharmaceutical effectiveness	McCallum et al. (2021)		Bamlanivimab (LY-CoV555) entirely lost its neutralizing activity due to the central location of L452R in the epitopes recognized by this mAb. Regdanvimab (CT-P59), and to a smaller extent etesevimab, showed a reduction in neutralization potency.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	T	G	AY.35, AY.70	symptom prevalence	Yadav et al. (2021)	'E484Q', 'P681R'	Gross examination of 3+3 hamster lung specimens showed pronounced congestion and hemorrhages on days 5 and 7 post-infection in the case of the B.1.617.1 as compared with the B.1. The lung lesions with  the B.1 variant were minimal to mild whereas with B.1.617.1 they were moderate. For B.1 pneumonic changes were minimal to mild (inflammatory cell infiltration, focal consolidation and mild congestion). The pronounced changes (moderate to severe) with mononuclear infiltration in the alveolar interstitial space, interstitial septal thickening, consolidation and pneumocyte hyperplasia were observed with B.1.617.1 variant consistently.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	trafficking	Deng et al. (2021)		We observed increased entry by pseudoviruses carrying the L452R mutation compared to D614G alone,  with a 6.7 to 22.5-fold increase in 293T cells and a 5.8 to 14.7-fold increase in human airway organoids.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	trafficking	Ferriera et al (2021)		This variant alone shows a ~5x decrease in cell entry efficiency (RLU measurement in 293T cells) compared to D614G. [listed as L454R in Figure, but L452R in text, also text  suggests not statistucally significant, but error bars say otherwise in Figure 4]	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	trafficking	Motozono et al. (2021)		Increased stability of RBD expression in yeast, suggesting increased Spike protein stability.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37139	1,924						4	37130.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	transmissibility	Tada et al. (2021)	'D614G'	Increased infectivity of the B.1.617 spike was attributed to L452R, which itself caused a 3.5-fold increase in infectivity relative to D614G wild type.  [In combination with E484Q caused a lower 3-fold increase]	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	T	G	AY.35, AY.70	transmissibility	Tada et al. (2021)	'E484Q', 'D614G'	The combination caused a 3-fold increase in infectivity relative to D614G wild type. [compare to 3.5x for L452R alone]	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	T	G	AY.35, AY.70	transmissibility	Tada et al. (2021)	'E484Q', 'P681R', 'D614G'	Normalized for particle number, on ACE2.293T cells showed that the B.1.617 spike protein was >2-fold increase in infectivity relative to D614G wild type.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	vaccine neutralization efficacy	Ferreira et al. (2021)		Nine stored sera from Pfizer BNT162b2 vaccinees were tested against a range of spike mutation bearing PV. L452R conferred about a two-fold reduction in neutralisation by vaccine sera, but was not statistically significant with this sample size.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	T	G	AY.35, AY.70	vaccine neutralization efficacy	Ferreira et al. (2021)	'E484Q'	Nine stored sera from Pfizer BNT162b2 vaccinees were tested against a range of spike mutation bearing PV. E484Q had a ~5x drop in neutralization (vs ~10x for E484K). When E484Q and L452R were combined, the fold change was significant, but similar to that of L452R alone (~2x), suggesting no evidence for an additive effect [perhaps even E484Q effect dilution]. 	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	T	G	AY.35, AY.70	vaccine neutralization efficacy	Gong et al. (2021)	'E484Q', 'D614G'	1.4x reduction in neutralization (ID50) in sera 3 weeks after one dose of Pfizer/BioNTech BNT162b2 (up to 5 naive and post infection vaccinees)	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	vaccine neutralization efficacy	Jacobson et al. (2021)		The presence of this variant in 189 post-mRNA-vaccination COVID-19 cases was proportionally in line with lineage prevalence in Northen California during the study period, suggesting no effect of these variants on immune escape.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	T	G	AY.35, AY.70	vaccine neutralization efficacy	Tada et al. (2021)	'E484Q', 'D614G'	Pseudotyped viruses for B.1.617 was 4-fold resistant to neutralization by 6 BNT162b2 vaccine sera 28 days post-booster compared to wild type - a finding that was similar to that of the 3.4-fold resistance of the South Africa B.1.351 variant using the same assay. Neutralization by 3 Moderna vaccine sera 28 days post-booster was 5-fold resistant (vs. 2.2-fold for B.1.351). The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37139	1,924						4	37130.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	vaccine neutralization efficacy	Wilhelm et al. (2021)	'D614G'	Relative to B.1, Epsilon (B.1.417/429) shows 1.74x-2.35x decrease in neutralization efficiency by 18 vaccinee sera (BNT162b2 and mRNA1273).	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37139	1,924						4	37130.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	vaccinee plasma binding	Gong et al. (2021)	'D614G'	1.05x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects. 1.16x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	T	G	AY.35, AY.70	vaccinee plasma binding	Gong et al. (2021)	'E484Q', 'D614G'	This variant combination (representing lineage B.1.617) showed a 1.30x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.   1.18x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees. [exact variant list not provided in manuscript, is inferred fro common knowledge]	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	T	G	AY.35, AY.70	viral load	Yadav et al. (2021)	'E484Q', 'P681R'	In 9 infected hamsters each for B.1 and B.1.617.1, no significant change in viral load or subgenomic RNA levels were detected. 	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452R	c.T1355G	p.L452R			22917	S	S	MISSENSE	37140	1,924						4	37131.0,0.0,0.0	T	G	B.1.617.2, AY.109, AY.109, AY.19, AY.19, AY.28, AY.111, AY.111, AY.104, AY.103, AY.103, AY.16, AY.16, AY.100, AY.100, AY.106, AY.40, AY.40, AY.12, AY.12, AY.15, AY.15, AY.14, AY.14, AY.26, AY.29, AY.29, AY.107, AY.107, AY.110, AY.110, AY.1, AY.34, AY.2, AY.13, AY.13, AY.17, AY.17, AY.38, AY.46.4, AY.4.5, AY.4.5, AY.44, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.46.2, AY.41, AY.18, AY.18, AY.102, AY.102, AY.64, AY.4.2, AY.48, AY.48, AY.65, AY.4, AY.4, AY.23, AY.23, AY.45, AY.6, AY.6, AY.36, AY.36, AY.91, AY.91, AY.60, AY.3, AY.3, AY.86, AY.86, AY.88, AY.5, AY.5, AY.57, AY.20, AY.32, AY.39, AY.39, AY.35, AY.46, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.108, AY.81, AY.81, AY.54, AY.61, AY.85, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.4.3, AY.53, AY.53, AY.63, AY.99.2, AY.99.2, AY.93, AY.93, AY.82, AY.77, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.99, AY.70, AY.51, AY.51, AY.62, AY.7.1, AY.7.1, AY.74, AY.27, AY.25, AY.25	virion structure	Spratt et al. (2021)		Estimated free energy change (ddG) for this variant is -0.67 kcal/mol (i.e. destabilizing relative to wild type) 	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L452W	c.CT1354_1355TG	p.L452W			22916	S	S		2	1						0	2.0,0.0,0.0	CT	TG	AY.3.1, AY.3.1	monoclonal antibody serial passage escape	Greaney et al. (2020)		Ranked effective mutant against this position in the RBD for highly neutralizing COV2-2096	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L454L	c.C1362T	p.L454L			1627	orf1ab	ORF1ab	SILENT	3	3			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	2.0,0.0,0.0	C	T	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L4597L	c.G13791T	p.L4597L			14055	orf1ab	ORF1ab	SILENT	58	48			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	48	10.0,0.0,0.0	G	T	AY.110, AY.65					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L4700L	c.C14098T	p.L4700L			14362	orf1ab	ORF1ab	SILENT	4	4			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	3	1.0,0.0,0.0	C	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L4779L	c.C14335T	p.L4779L			14599	orf1ab	ORF1ab	SILENT	19	12			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	12	7.0,0.0,0.0	C	T	AY.14, AY.29					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L4829L	c.A14487G	p.L4829L			14751	orf1ab	ORF1ab	SILENT	7	7			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	6	1.0,0.0,0.0	A	G	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L4890L	c.C14668T	p.L4890L			14932	orf1ab	ORF1ab	SILENT	20	20			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	18	2.0,0.0,0.0	C	T	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L5167L	c.C15499T	p.L5167L			15763	orf1ab	ORF1ab	SILENT	34	34			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	27	7.0,0.0,0.0	C	T	AY.47					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L5230I	c.C15688A	p.L5230I			15952	orf1ab	ORF1ab	MISSENSE	119	114			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	59	59.0,0.0,0.0	C	A	AY.43, AY.9.1					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L52F	c.C154T	p.L52F			25546	ORF3a	ORF3a	MISSENSE	2	2						1	1.0,0.0,0.0	C	T	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L533F	c.C1597T	p.L533F			1862	orf1ab	ORF1ab	MISSENSE	238	238			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	209	29.0,0.0,0.0	C	T	AY.61					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L5389L	c.A16167G	p.L5389L			16431	orf1ab	ORF1ab	SILENT	9	9			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	8	1.0,0.0,0.0	A	G	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L53F	c.C157T	p.L53F			25549	ORF3a	ORF3a	MISSENSE	5	3						2	3.0,0.0,0.0	C	T	AY.12, AY.1					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L5416L	c.A16248G	p.L5416L			16512	orf1ab	ORF1ab	SILENT	7	7			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	6	1.0,0.0,0.0	A	G	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L54F	c.G162T	p.L54F			21724	S	S	MISSENSE	1	1						0	1.0,0.0,0.0	G	T	AY.4.3					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L54L	c.T160C	p.L54L			21722	S	S	SILENT	17	17						15	2.0,0.0,0.0	T	C	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L5551L	c.C16651T	p.L5551L			16915	orf1ab	ORF1ab	SILENT	52	27			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	44	8.0,0.0,0.0	C	T	AY.19, AY.64, AY.35					False	False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L5649F	c.G16947T	p.L5649F			17211	orf1ab	ORF1ab	MISSENSE	5	5			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	3	2.0,0.0,0.0	G	T	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L5649V	c.T16945G	p.L5649V			17209	orf1ab	ORF1ab	MISSENSE	9	9			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	8	1.0,0.0,0.0	T	G	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L5F	c.C13T	p.L5F			21575	S	S	MISSENSE	15	10	mask	highly_homoplasic				13	2.0,0.0,0.0	C	T	AY.65, AY.35	ACE2 receptor binding affinity	Gong et al. (2021)	'D614G'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.1x decrease in binding (KD) relative to D614G.	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L5F	c.C13T	p.L5F			21575	S	S	MISSENSE	15	10	mask	highly_homoplasic				13	2.0,0.0,0.0	C	T	AY.65, AY.35	convalescent plasma binding	Gong et al. (2021)	'D614G'	No change in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L5F	c.C13T	p.L5F			21575	S	S	MISSENSE	15	10	mask	highly_homoplasic				13	2.0,0.0,0.0	C	T	AY.65, AY.35	vaccinee plasma binding	Gong et al. (2021)	'D614G'	1.23x increase in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.1x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6032L	c.A18096G	p.L6032L			18360	orf1ab	ORF1ab	SILENT	152	152			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	122	30.0,0.0,0.0	A	G	AY.103					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L60F	c.G180T	p.L60F			28073	ORF8	ORF8	MISSENSE	410	410						246	164.0,0.0,0.0	G	T	AY.44					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6102F	c.C18304T	p.L6102F			18568	orf1ab	ORF1ab	MISSENSE	4	4			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	3	1.0,0.0,0.0	C	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6102L	c.C18306T	p.L6102L			18570	orf1ab	ORF1ab	SILENT	1	1			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	1.0,0.0,0.0	C	T	AY.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L611L	c.T1833C	p.L611L			23395	S	S	SILENT	78	78						66	12.0,0.0,0.0	T	C	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L613I	c.C1837A	p.L613I			2102	orf1ab	ORF1ab	MISSENSE	28	28			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	25	3.0,0.0,0.0	C	A	AY.46					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6331L	c.C18991T	p.L6331L			19255	orf1ab	ORF1ab	SILENT	6	6			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	5	1.0,0.0,0.0	C	T	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6418F	c.G19254T	p.L6418F			19518	orf1ab	ORF1ab	MISSENSE	13	65			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	11	2.0,0.0,0.0	G	T	AY.102					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6420L	c.C19260T	p.L6420L			19524	orf1ab	ORF1ab	SILENT	29	10			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	10	19.0,0.0,0.0	C	T	AY.65, AY.98.1, AY.68					False	False, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6433L	c.G19299A	p.L6433L			19563	orf1ab	ORF1ab	SILENT	3	7			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	3.0,0.0,0.0	G	A	AY.34					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L65L	c.C195T	p.L65L			25587	ORF3a	ORF3a	SILENT	3	3						2	1.0,0.0,0.0	C	T	AY.41					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6614F	c.C19840T	p.L6614F			20104	orf1ab	ORF1ab	MISSENSE	70	70			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	57	13.0,0.0,0.0	C	T	AY.3					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6666L	c.A19998G	p.L6666L			20262	orf1ab	ORF1ab	SILENT	2255	1,924			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	1667	588.0,0.0,0.0	A	G	B.1.617.2, AY.19, AY.16, AY.40, AY.15, AY.14, AY.13, AY.17, AY.75.1, AY.18, AY.45, AY.81, AY.54, AY.53, AY.77, AY.68, AY.51					False	False, False, True, True, True, True, True, True, False, True, False, True, True, True, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6700L	c.A20100G	p.L6700L			20364	orf1ab	ORF1ab	SILENT	3	3			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	2	1.0,0.0,0.0	A	G	AY.99					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6848L	c.C20542T	p.L6848L			20806	orf1ab	ORF1ab	SILENT	6	6			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	5	1.0,0.0,0.0	C	T	AY.99.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6848L	c.G20544A	p.L6848L			20808	orf1ab	ORF1ab	SILENT	10	11			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	9	1.0,0.0,0.0	G	A	AY.5					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6883L	c.T20647C	p.L6883L			20911	orf1ab	ORF1ab	SILENT	2	2			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	0	2.0,0.0,0.0	T	C	AY.37					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L6981I	c.C20941A	p.L6981I			21205	orf1ab	ORF1ab	MISSENSE	12	12			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	4	8.0,0.0,0.0	C	A	AY.42					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L7050I	c.C21148A	p.L7050I			21412	orf1ab	ORF1ab	MISSENSE	1923	1,924			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	1704	219.0,0.0,0.0	C	A	B.1.617.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L71L	c.C211T	p.L71L			25603	ORF3a	ORF3a	SILENT	14	15						12	2.0,0.0,0.0	C	T	AY.98.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L73L	c.C219T	p.L73L			25611	ORF3a	ORF3a	SILENT	5	5						4	1.0,0.0,0.0	C	T	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L778L	c.T2332C	p.L778L			2597	orf1ab	ORF1ab	SILENT	10	10			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	8	2.0,0.0,0.0	T	C	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L84L	c.C250T	p.L84L			21812	S	S	SILENT	17	17						15	2.0,0.0,0.0	C	T	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L853F	c.C2557T	p.L853F			2822	orf1ab	ORF1ab	MISSENSE	48	48			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	39	9.0,0.0,0.0	C	T	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L85F	c.G255T	p.L85F			25647	ORF3a	ORF3a	MISSENSE	1	1						0	1.0,0.0,0.0	G	T	AY.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L893L	c.G2679A	p.L893L			2944	orf1ab	ORF1ab	SILENT	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	G	A	AY.7.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L93L	c.C279G	p.L93L			26801	M	M	SILENT	11	11						9	2.0,0.0,0.0	C	G	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.L93L	c.C279T	p.L93L			26801	M	M	SILENT	1	1						0	1.0,0.0,0.0	C	T	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.L94P	c.T281C	p.L94P			25673	ORF3a	ORF3a	MISSENSE	3	3						1	2.0,0.0,0.0	T	C	AY.46.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M1229I	c.G3687T	p.M1229I			25249	S	S	MISSENSE	9	9						8	1.0,0.0,0.0	G	T	AY.106	trafficking	Tada et al. (2021)		Lentiviral pseudotyped with this mutation from Mink Cluster 5 lineage, was tested on ACE2.293T cells. Luciferase activity was measured two days postinfection,  showing slight decrease in infection rate amongst the cells, suggesting that this  variant does not contributing to human cell entry fitness.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M153I	c.G459T	p.M153I			22021	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	G	T	AY.108					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M21I	c.G63T	p.M21I			29620	ORF10	ORF10	MISSENSE	70	70						62	8.0,0.0,0.0	G	T	AY.3					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M2410V	c.A7228G	p.M2410V			7493	orf1ab	ORF1ab	MISSENSE	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	A	G	AY.3.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.M260K	c.T779A	p.M260K			26171	ORF3a	ORF3a	MISSENSE	3	3						2	1.0,0.0,0.0	T	A	AY.53					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M2796I	c.G8388T	p.M2796I			8653	orf1ab	ORF1ab	MISSENSE	2	2			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	1	1.0,0.0,0.0	G	T	AY.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M2796V	c.A8386G	p.M2796V			8651	orf1ab	ORF1ab	MISSENSE	130	130			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	1	129.0,0.0,0.0	A	G	AY.10					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.M297V	c.A889G	p.M297V			1154	orf1ab	ORF1ab	MISSENSE	30	30			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	15	15.0,0.0,0.0	A	G	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M3087I	c.G9261T	p.M3087I			9526	orf1ab	ORF1ab	MISSENSE	135	130			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	5	130.0,0.0,0.0	G	T	AY.10, AY.35					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M3684V	c.A11050G	p.M3684V			11315	orf1ab	ORF1ab	MISSENSE	5	5			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	4	1.0,0.0,0.0	A	G	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M3712I	c.G11136T	p.M3712I			11401	orf1ab	ORF1ab	MISSENSE	79	79			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	53	26.0,0.0,0.0	G	T	AY.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M4516I	c.G13548T	p.M4516I			13812	orf1ab	ORF1ab	MISSENSE	5	5			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	4	1.0,0.0,0.0	G	T	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M4588I	c.G13764T	p.M4588I			14028	orf1ab	ORF1ab	MISSENSE	51	41			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	14	37.0,0.0,0.0	G	T	AY.13, AY.65					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.M5210V	c.A15628G	p.M5210V			15892	orf1ab	ORF1ab	MISSENSE	16	16			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	16.0,0.0,0.0	A	G	AY.40					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.M5598I	c.G16794T	p.M5598I			17058	orf1ab	ORF1ab	MISSENSE	3	3			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	1	2.0,0.0,0.0	G	T	AY.46.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M585V	c.A1753G	p.M585V			2018	orf1ab	ORF1ab	MISSENSE	120	120			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	107	13.0,0.0,0.0	A	G	AY.15					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M5997I	c.G17991T	p.M5997I			18255	orf1ab	ORF1ab	MISSENSE	7	7			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	7.0,0.0,0.0	G	T	AY.34					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.M6815I	c.G20445T	p.M6815I			20709	orf1ab	ORF1ab	MISSENSE	8	8			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	4	4.0,0.0,0.0	G	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.M6818I	c.G20454T	p.M6818I			20718	orf1ab	ORF1ab	MISSENSE	12	12			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	0	12.0,0.0,0.0	G	T	AY.14					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.M789I	c.G2367A	p.M789I			2632	orf1ab	ORF1ab	MISSENSE	1	1			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	1.0,0.0,0.0	G	A	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N1074S	c.A3221G	p.N1074S			24783	S	S	MISSENSE	52	52						24	28.0,0.0,0.0	A	G	AY.26					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N1080S	c.A3239G	p.N1080S			3504	orf1ab	ORF1ab	MISSENSE	6	6	caution	single_src,highly_ambiguous	nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	1.0,0.0,0.0	A	G	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N1081N	c.T3243C	p.N1081N			3508	orf1ab	ORF1ab	SILENT	10	10			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	5.0,0.0,0.0	T	C	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N113N	c.T339C	p.N113N			26861	M	M	SILENT	3	3						2	1.0,0.0,0.0	T	C	AY.46.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N1178N	c.C3534T	p.N1178N			25096	S	S	SILENT	41	41						34	7.0,0.0,0.0	C	T	AY.13					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N117N	c.C351T	p.N117N			26873	M	M	SILENT	1	1						0	1.0,0.0,0.0	C	T	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N1181N	c.T3543C	p.N1181N			3808	orf1ab	ORF1ab	SILENT	17	17			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	15	2.0,0.0,0.0	T	C	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N121N	c.C363T	p.N121N			26885	M	M	SILENT	15	11						12	3.0,0.0,0.0	C	T	AY.23, AY.68					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N137K	c.C411A	p.N137K			25803	ORF3a	ORF3a	MISSENSE	34	34						27	7.0,0.0,0.0	C	A	AY.47					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N137N	c.C411T	p.N137N			25803	ORF3a	ORF3a	SILENT	4	4						3	1.0,0.0,0.0	C	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N148T	c.A443C	p.N148T			22005	S	S	MISSENSE	19	20						15	4.0,0.0,0.0	A	C	AY.64, AY.55					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N1576N	c.C4728T	p.N1576N			4993	orf1ab	ORF1ab	SILENT	10	10			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	8	2.0,0.0,0.0	C	T	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N1578N	c.C4734T	p.N1578N			4999	orf1ab	ORF1ab	SILENT	30	30			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	26	4.0,0.0,0.0	C	T	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N160N	c.C480T	p.N160N			745	orf1ab	ORF1ab	SILENT	24	2			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	2	22.0,0.0,0.0	C	T	AY.104, AY.108					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N1623N	c.T4869C	p.N1623N			5134	orf1ab	ORF1ab	SILENT	25	20			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	9	16.0,0.0,0.0	T	C	AY.64, AY.55					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N1709N	c.C5127T	p.N1709N			5392	orf1ab	ORF1ab	SILENT	27	27			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	22.0,0.0,0.0	C	T	AY.109					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N1749N	c.C5247T	p.N1749N			5512	orf1ab	ORF1ab	SILENT	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	2.0,0.0,0.0	C	T	AY.60					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N189N	c.C567T	p.N189N			832	orf1ab	ORF1ab	SILENT	1	1			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	1.0,0.0,0.0	C	T	AY.87					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N207N	c.C621T	p.N207N			27143	M	M	SILENT	31	6						23	8.0,0.0,0.0	C	T	AY.17, AY.46					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N2147N	c.C6441T	p.N2147N			6706	orf1ab	ORF1ab	SILENT	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	C	T	AY.4.3					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N2678N	c.C8034T	p.N2678N			8299	orf1ab	ORF1ab	SILENT	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	C	T	AY.4.3					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N278N	c.T834C	p.N278N			1099	orf1ab	ORF1ab	SILENT	5	5			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	4	1.0,0.0,0.0	T	C	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N278S	c.A833G	p.N278S			1098	orf1ab	ORF1ab	MISSENSE	52	52			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	43	9.0,0.0,0.0	A	G	AY.26					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N2847S	c.A8540G	p.N2847S			8805	orf1ab	ORF1ab	MISSENSE	2	2			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	1	1.0,0.0,0.0	A	G	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N2894N	c.C8682T	p.N2894N			8947	orf1ab	ORF1ab	SILENT	1	1			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	0	1.0,0.0,0.0	C	T	AY.4.3					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N3007N	c.C9021T	p.N3007N			9286	orf1ab	ORF1ab	SILENT	5	5			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	2	3.0,0.0,0.0	C	T	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N3029N	c.T9087C	p.N3029N			9352	orf1ab	ORF1ab	SILENT	9	9			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	8	1.0,0.0,0.0	T	C	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N3314N	c.C9942T	p.N3314N			10207	orf1ab	ORF1ab	SILENT	8	8			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	7	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N3443N	c.C10329T	p.N3443N			10594	orf1ab	ORF1ab	SILENT	30	30			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	25	5.0,0.0,0.0	C	T	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N348S	c.A1043G	p.N348S			1308	orf1ab	ORF1ab	MISSENSE	11	11			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	9	2.0,0.0,0.0	A	G	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N3494N	c.C10482T	p.N3494N			10747	orf1ab	ORF1ab	SILENT	409	410			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	351	58.0,0.0,0.0	C	T	AY.44					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N3774S	c.A11321G	p.N3774S			11586	orf1ab	ORF1ab	MISSENSE	4	4			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	3	1.0,0.0,0.0	A	G	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N3928N	c.C11784T	p.N3928N			12049	orf1ab	ORF1ab	SILENT	34	34			nsp7	produced by both pp1a and pp1ab	YP_009725303.1	3	31.0,0.0,0.0	C	T	AY.47					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N3937N	c.C11811T	p.N3937N			12076	orf1ab	ORF1ab	SILENT	8	3			nsp7	produced by both pp1a and pp1ab	YP_009725303.1	3	5.0,0.0,0.0	C	T	AY.12, AY.9.1					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N4992N	c.C14976T	p.N4992N			15240	orf1ab	ORF1ab	SILENT	16	7			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	1	15.0,0.0,0.0	C	T	AY.100, AY.99.2, AY.99					False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N52N	c.C156T	p.N52N			27549	ORF7a	ORF7a	SILENT	27	27						0	27.0,0.0,0.0	C	T	AY.109					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N5375N	c.T16125C	p.N5375N			16389	orf1ab	ORF1ab	SILENT	394	394			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	279	115.0,0.0,0.0	T	C	AY.9.2.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N5419N	c.T16257C	p.N5419N			16521	orf1ab	ORF1ab	SILENT	20	20			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	18	2.0,0.0,0.0	T	C	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N5426S	c.A16277G	p.N5426S			16541	orf1ab	ORF1ab	MISSENSE	8	8			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	7	1.0,0.0,0.0	A	G	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N5592N	c.T16776C	p.N5592N			17040	orf1ab	ORF1ab	SILENT	85	6			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	57	28.0,0.0,0.0	T	C	AY.4.2, AY.4					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N594D	c.A1780G	p.N594D			2045	orf1ab	ORF1ab	MISSENSE	24	24			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	20	4.0,0.0,0.0	A	G	AY.39					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N615N	c.C1845T	p.N615N			2110	orf1ab	ORF1ab	SILENT	6	6			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	4	2.0,0.0,0.0	C	T	AY.4.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N6729N	c.C20187T	p.N6729N			20451	orf1ab	ORF1ab	SILENT	16	16			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	14	2.0,0.0,0.0	C	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N6862S	c.A20585G	p.N6862S			20849	orf1ab	ORF1ab	MISSENSE	34	34			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	27	7.0,0.0,0.0	A	G	AY.47					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N6862T	c.AT20585_20586CC	p.N6862T			20849	orf1ab	ORF1ab		20	20			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	12	1.0,7.0,0.0	AT	CC,AC	AY.107					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N6941N	c.T20823C	p.N6941N			21087	orf1ab	ORF1ab	SILENT	25	25			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	22	3.0,0.0,0.0	T	C	AY.9.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N801N	c.T2403C	p.N801N			23965	S	S	SILENT	160	160						136	24.0,0.0,0.0	T	C	AY.36					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N811N	c.T2433C	p.N811N			2698	orf1ab	ORF1ab	SILENT	6	6			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	5.0,0.0,0.0	T	C	AY.70					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.N856N	c.C2568T	p.N856N			24130	S	S	SILENT	27	1						23	4.0,0.0,0.0	C	T	AY.3.1, AY.64, AY.24					False	True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.N99N	c.C297T	p.N99N			21859	S	S	SILENT	2	1						0	2.0,0.0,0.0	C	T	AY.67, AY.4.3					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1010L	c.C3029T	p.P1010L			3294	orf1ab	ORF1ab	MISSENSE	4	4			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	3	1.0,0.0,0.0	C	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P104L	c.C311T	p.P104L			25703	ORF3a	ORF3a	MISSENSE	3	3						2	1.0,0.0,0.0	C	T	AY.46.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P104S	c.C310T	p.P104S			25702	ORF3a	ORF3a	MISSENSE	158	152						121	37.0,0.0,0.0	C	T	AY.103, AY.24					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1054L	c.C3161T	p.P1054L			3426	orf1ab	ORF1ab	MISSENSE	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	C	T	AY.87					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P10P	c.G30A	p.P10P			29587	ORF10	ORF10	SILENT	7	7						6	1.0,0.0,0.0	G	A	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P114P	c.A342T	p.P114P			26864	M	M	SILENT	52	52						40	12.0,0.0,0.0	A	T	AY.26					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1158L	c.C3473T	p.P1158L			3738	orf1ab	ORF1ab	MISSENSE	27	27			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	22	5.0,0.0,0.0	C	T	AY.19					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1158S	c.C3472T	p.P1158S			3737	orf1ab	ORF1ab	MISSENSE	410	410			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	320	90.0,0.0,0.0	C	T	AY.44					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P115S	c.C343T	p.P115S			608	orf1ab	ORF1ab	MISSENSE	5	5			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	4	1.0,0.0,0.0	C	T	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1162L	c.C3485T	p.P1162L			25047	S	S	MISSENSE	6	6						5	1.0,0.0,0.0	C	T	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P123P	c.A369G	p.P123P			26891	M	M	SILENT	4	4						3	1.0,0.0,0.0	A	G	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1263R	c.C3788G	p.P1263R			25350	S	S	MISSENSE	79	79						53	26.0,0.0,0.0	C	G	AY.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1284P	c.A3852G	p.P1284P			4117	orf1ab	ORF1ab	SILENT	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	A	G	AY.4.3					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P132P	c.G396T	p.P132P			26918	M	M	SILENT	9	9						8	1.0,0.0,0.0	G	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P138P	c.A414G	p.P138P			25806	ORF3a	ORF3a	SILENT	43	43						2	41.0,0.0,0.0	A	G	AY.54					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P13L	c.C38T	p.P13L			28311	N	N	MISSENSE	11	11						9	2.0,0.0,0.0	C	T	AY.23	T cell evasion	de Silva et al. (2021)		Variant causes complete loss of T cell line responsiveness to B*27:05-restricted CD8+ N epitope QRNAPRITF 1-17(2,13).	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P13L	c.C38T	p.P13L			28311	N	N	MISSENSE	11	11						9	2.0,0.0,0.0	C	T	AY.23	homoplasy	Borges et al. (2021)		In experimental models of SARS-CoV-2 mutational evolution (without immune pressure), this mutation appears convergent. 	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P13P	c.C39T	p.P13P			28312	N	N	SILENT	16	11						11	5.0,0.0,0.0	C	T	AY.23, AY.32					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P13T	c.C37A	p.P13T			28310	N	N	MISSENSE	27	27						23	4.0,0.0,0.0	C	A	AY.19	T cell evasion	de Silva et al. (2021)		Variant causes complete loss of T cell line responsiveness to B*27:05-restricted CD8+ N epitope QRNAPRITF 1-17(2,13).	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P151S	c.C451T	p.P151S			28724	N	N	MISSENSE	8	8						0	8.0,0.0,0.0	C	T	AY.88					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P159S	c.C475T	p.P159S			25867	ORF3a	ORF3a	MISSENSE	6	6						5	1.0,0.0,0.0	C	T	AY.99.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1640L	c.C4919T	p.P1640L			5184	orf1ab	ORF1ab	MISSENSE	15003	1,924			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1273	13730.0,0.0,0.0	C	T	B.1.617.2, AY.19, AY.28, AY.16, AY.106, AY.40, AY.15, AY.14, AY.26, AY.2, AY.13, AY.17, AY.38, AY.10, AY.75.1, AY.18, AY.64, AY.48, AY.65, AY.45, AY.60, AY.88, AY.57, AY.35, AY.72, AY.59, AY.9.2, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.73, AY.81, AY.54, AY.61, AY.9.2.1, AY.67, AY.37, AY.53, AY.63, AY.77, AY.9, AY.24, AY.68, AY.70, AY.51, AY.62, AY.74, AY.27					False	False, False, True, True, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1692L	c.C5075T	p.P1692L			5340	orf1ab	ORF1ab	MISSENSE	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	1.0,0.0,0.0	C	T	AY.104					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1692S	c.C5074T	p.P1692S			5339	orf1ab	ORF1ab	MISSENSE	3	3			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	2.0,0.0,0.0	C	T	AY.53					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1810S	c.C5428T	p.P1810S			5693	orf1ab	ORF1ab	MISSENSE	34	34			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	27	7.0,0.0,0.0	C	T	AY.47					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1919P	c.A5757G	p.P1919P			6022	orf1ab	ORF1ab	SILENT	152	152			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	134	18.0,0.0,0.0	A	G	AY.103					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1921Q	c.C5762A	p.P1921Q			6027	orf1ab	ORF1ab	MISSENSE	42	35			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	38.0,0.0,0.0	C	A	AY.48, AY.35, AY.51					False	True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1921S	c.C5761T	p.P1921S			6026	orf1ab	ORF1ab	MISSENSE	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	2.0,0.0,0.0	C	T	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P193L	c.C578T	p.P193L			843	orf1ab	ORF1ab	MISSENSE	5	5			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	4	1.0,0.0,0.0	C	T	AY.55					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P1977P	c.C5931A	p.P1977P			6196	orf1ab	ORF1ab	SILENT	70	70			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	62	8.0,0.0,0.0	C	A	AY.3					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P2046L	c.C6137T	p.P2046L			6402	orf1ab	ORF1ab	MISSENSE	12899	1,924			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	728	12171.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.111, AY.104, AY.103, AY.100, AY.106, AY.12, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.46.4, AY.4.5, AY.44, AY.33, AY.46.2, AY.41, AY.102, AY.4.2, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.5, AY.20, AY.32, AY.39, AY.46, AY.43, AY.9.1, AY.46.1, AY.92, AY.42, AY.98.1, AY.87, AY.108, AY.85, AY.39.1, AY.46.6, AY.4.3, AY.99.2, AY.93, AY.82, AY.84, AY.99, AY.7.1, AY.25					False	False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P2287S	c.C6859T	p.P2287S			7124	orf1ab	ORF1ab	MISSENSE	12982	1,924			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	726	12256.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.111, AY.104, AY.103, AY.100, AY.106, AY.12, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.46.4, AY.4.5, AY.44, AY.33, AY.46.2, AY.41, AY.102, AY.4.2, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.5, AY.20, AY.32, AY.39, AY.46, AY.43, AY.9.1, AY.46.1, AY.92, AY.42, AY.98.1, AY.87, AY.108, AY.85, AY.39.1, AY.46.6, AY.4.3, AY.99.2, AY.93, AY.82, AY.84, AY.99, AY.7.1, AY.25					False	False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P2376P	c.G7128T	p.P2376P			7393	orf1ab	ORF1ab	SILENT	28	30			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	23.0,0.0,0.0	G	T	AY.75					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P2483P	c.T7449C	p.P2483P			7714	orf1ab	ORF1ab	SILENT	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	6	1.0,0.0,0.0	T	C	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P251L	c.C752T	p.P251L			22314	S	S	MISSENSE	17	2						1	16.0,0.0,0.0	C	T	AY.75.1, AY.98.1	monoclonal antibody serial passage escape	McCallum et al. (2021)		Escape mutation against Spike N terminal domain antigenic supersite i mAb S2X28	False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P2685T	c.C8053A	p.P2685T			8318	orf1ab	ORF1ab	MISSENSE	7	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	2.0,0.0,0.0	C	A	AY.57, AY.4.3					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P26S	c.C76T	p.P26S			21638	S	S	MISSENSE	6	5						4	2.0,0.0,0.0	C	T	AY.9.1, AY.4.3	ACE2 receptor binding affinity	Gong et al. (2021)	'D614G'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.58x increase in binding (KD) relative to D614G.	False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P26S	c.C76T	p.P26S			21638	S	S	MISSENSE	6	5						4	2.0,0.0,0.0	C	T	AY.9.1, AY.4.3	convalescent plasma binding	Gong et al. (2021)	'D614G'	1.08x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P26S	c.C76T	p.P26S			21638	S	S	MISSENSE	6	5						4	2.0,0.0,0.0	C	T	AY.9.1, AY.4.3	vaccinee plasma binding	Gong et al. (2021)	'D614G'	1.23x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.37x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P279S	c.C835T	p.P279S			29108	N	N	MISSENSE	8	2						4	4.0,0.0,0.0	C	T	AY.6, AY.63					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P302P	c.G906A	p.P302P			29179	N	N	SILENT	5	5						4	1.0,0.0,0.0	G	A	AY.55					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P309L	c.C926T	p.P309L			1190	orf1ab	ORF1ab	MISSENSE	120	120			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	8.0,112.0,0.0	CC	TT,CT	AY.15					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P309L	c.C926T	p.P309L			1191	orf1ab	ORF1ab	MISSENSE	2176	1,924			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1476	700.0,0.0,0.0	C	T	B.1.617.2, AY.19, AY.16, AY.40, AY.14, AY.13, AY.17, AY.75.1, AY.18, AY.48, AY.45, AY.35, AY.81, AY.54, AY.53, AY.77, AY.68, AY.51					False	False, False, True, True, True, True, True, False, True, True, False, False, True, True, True, True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P30S	c.C88T	p.P30S			27981	ORF8	ORF8	MISSENSE	6	6						5	1.0,0.0,0.0	C	T	AY.99.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P3134S	c.C9400T	p.P3134S			9665	orf1ab	ORF1ab	MISSENSE	16	16			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	14	2.0,0.0,0.0	C	T	AY.40					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P3371S	c.C10111T	p.P3371S			10376	orf1ab	ORF1ab	MISSENSE	6	6			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	4	2.0,0.0,0.0	C	T	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P3395L	c.C10184T	p.P3395L			10449	orf1ab	ORF1ab	MISSENSE	25	25			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	22	3.0,0.0,0.0	C	T	AY.9.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P3395P	c.C10185T	p.P3395P			10450	orf1ab	ORF1ab	SILENT	5	5			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	4	1.0,0.0,0.0	C	T	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P3447L	c.C10340T	p.P3447L			10605	orf1ab	ORF1ab	MISSENSE	6	6			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	5	1.0,0.0,0.0	C	T	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P361P	c.C1083T	p.P361P			1348	orf1ab	ORF1ab	SILENT	1	1			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	1.0,0.0,0.0	C	T	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P364L	c.C1091T	p.P364L			29364	N	N	MISSENSE	11	15						2	9.0,0.0,0.0	C	T	AY.98.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P36P	c.G108C	p.P36P			28001	ORF8	ORF8	SILENT	6	6						5	1.0,0.0,0.0	G	C	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P36S	c.C106T	p.P36S			27999	ORF8	ORF8	MISSENSE	160	152						127	33.0,0.0,0.0	C	T	AY.103, AY.88					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P380L	c.C1139T	p.P380L			1404	orf1ab	ORF1ab	MISSENSE	11	11			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	2	9.0,0.0,0.0	C	T	AY.23					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P380S	c.C1138T	p.P380S			1403	orf1ab	ORF1ab	MISSENSE	6	6			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	6.0,0.0,0.0	C	T	AY.57					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P383P	c.G1149A	p.P383P			29422	N	N	SILENT	78	78						65	13.0,0.0,0.0	G	A	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P383P	c.G1149T	p.P383P			29422	N	N	SILENT	7140	25						30	7110.0,0.0,0.0	G	T	AY.38, AY.67, AY.9, AY.27					False	False, True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P383S	c.C1147T	p.P383S			29420	N	N	MISSENSE	238	238						140	98.0,0.0,0.0	C	T	AY.61					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P38P	c.T114C	p.P38P			28007	ORF8	ORF8	SILENT	7	7						0	7.0,0.0,0.0	T	C	AY.100					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P4261P	c.T12783C	p.P4261P			13048	orf1ab	ORF1ab	SILENT	2	2			nsp10	nsp10_CysHis, formerly known as growth-factor-like protein (GFL), produced by both pp1a and pp1ab	YP_009725306.1	0	2.0,0.0,0.0	T	C	AY.104					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P42S	c.C124T	p.P42S			25516	ORF3a	ORF3a	MISSENSE	3	3						0	3.0,0.0,0.0	C	T	AY.12					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P4337S	c.C13009T	p.P4337S			13274	orf1ab	ORF1ab	MISSENSE	2	2			nsp10	nsp10_CysHis, formerly known as growth-factor-like protein (GFL), produced by both pp1a and pp1ab	YP_009725306.1	0	2.0,0.0,0.0	C	T	AY.37					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P4339S	c.C13015T	p.P4339S			13280	orf1ab	ORF1ab	MISSENSE	238	238			nsp10	nsp10_CysHis, formerly known as growth-factor-like protein (GFL), produced by both pp1a and pp1ab	YP_009725306.1	177	61.0,0.0,0.0	C	T	AY.61					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P4486L	c.C13457T	p.P4486L			13721	orf1ab	ORF1ab	MISSENSE	16	16			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	14	2.0,0.0,0.0	C	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P45L	c.C134T	p.P45L			27527	ORF7a	ORF7a	MISSENSE	2062	1,924						1681	381.0,0.0,0.0	C	T	B.1.617.2, AY.12, AY.88, AY.43, AY.92					False	False, True, False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P4619L	c.C13856T	p.P4619L			14120	orf1ab	ORF1ab	MISSENSE	7	7			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	3	4.0,0.0,0.0	C	T	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P4619S	c.C13855T	p.P4619S			14119	orf1ab	ORF1ab	MISSENSE	3	3			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	3.0,0.0,0.0	C	T	AY.41					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P4715L	c.C14144T	p.P4715L			14408	orf1ab	ORF1ab	MISSENSE	26011	1,924			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	1	26010.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P4715R	c.C14144G	p.P4715R			14408	orf1ab	ORF1ab	MISSENSE	1	1			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	1.0,0.0,0.0	C	G	AY.3.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P4897P	c.A14691G	p.P4897P			14955	orf1ab	ORF1ab	SILENT	5	5			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	4	1.0,0.0,0.0	A	G	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P48S	c.C142T	p.P48S			27535	ORF7a	ORF7a	MISSENSE	6	6						2	4.0,0.0,0.0	C	T	AY.99.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P5401L	c.C16202T	p.P5401L			16466	orf1ab	ORF1ab	MISSENSE	25977	1,924			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	204	25773.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P5578P	c.A16734G	p.P5578P			16998	orf1ab	ORF1ab	SILENT	8	8			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	7	1.0,0.0,0.0	A	G	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P5624L	c.C16871T	p.P5624L			17135	orf1ab	ORF1ab	MISSENSE	5	5			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	4	1.0,0.0,0.0	C	T	AY.46.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P5828P	c.T17484A	p.P5828P			17748	orf1ab	ORF1ab	SILENT	1	1			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	0	1.0,0.0,0.0	T	A	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P5971L	c.C17912T	p.P5971L			18176	orf1ab	ORF1ab	MISSENSE	305	27			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	29	276.0,0.0,0.0	C	T	AY.19, AY.16, AY.15, AY.14, AY.13, AY.17, AY.75.1, AY.18, AY.54, AY.53, AY.77, AY.68					False	False, True, True, True, True, True, False, True, True, True, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P600P	c.A1800G	p.P600P			23362	S	S	SILENT	2	2						1	1.0,0.0,0.0	A	G	AY.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P6065S	c.C18193T	p.P6065S			18457	orf1ab	ORF1ab	MISSENSE	24	24			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	21	3.0,0.0,0.0	C	T	AY.39					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P6065T	c.C18193A	p.P6065T			18457	orf1ab	ORF1ab	MISSENSE	16	16			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	14	2.0,0.0,0.0	C	A	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P6164P	c.G18492T	p.P6164P			18756	orf1ab	ORF1ab	SILENT	28	25			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	16	12.0,0.0,0.0	G	T	AY.38, AY.59					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P6519P	c.A19557G	p.P6519P			19821	orf1ab	ORF1ab	SILENT	1	1			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	0	1.0,0.0,0.0	A	G	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P6657L	c.C19970T	p.P6657L			20234	orf1ab	ORF1ab	MISSENSE	8874	8			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	6273	2601.0,0.0,0.0	C	T	AY.46.6, AY.25					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P6657P	c.C19971T	p.P6657P			20235	orf1ab	ORF1ab	SILENT	15	15			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	11	4.0,0.0,0.0	C	T	AY.98.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P6657S	c.C19969T	p.P6657S			20233	orf1ab	ORF1ab	MISSENSE	3	3			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	1	2.0,0.0,0.0	C	T	AY.41					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P665P	c.C1995T	p.P665P			23557	S	S	SILENT	31	7						27	4.0,0.0,0.0	C	T	AY.29, AY.33					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P681R	c.C2042G	p.P681R			23601	S	S	MISSENSE	8	8						0	3.0,5.0,0.0	CTCC	TTCG,CTCG	AY.88	trafficking	Maaroufi (2021)		This mutation in the first base of the furin clevage site maintains the RXXR recognition motif, and is presumed to enhance cleavage based on the removal of a proline-directed phosphotase recognition site at S680. In a homologuous site in Infectious  Bronchitis Virus (IBV, Gammacoronaviruses), abolition of S680 phosphorylation improves furin cleavage  (and presumably cell entry). [Inference from similar positively charged substitution P681H actually described in the work]	False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P681R	c.C2042G	p.P681R			23601	S	S	MISSENSE	8	8						0	3.0,5.0,0.0	CTCC	TTCG,CTCG	AY.88	trafficking	Tada et al. (2021)	'D614G'	Quantification of the band intensities showed that the P681R mutation, which lies near the proteolytic processing site,  caused a small increase in proteolytic processing as measured by a 2-fold decrease in the ratio of S/S2.	False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P681R	c.C2042G	p.P681R			23601	S	S	MISSENSE	8	8						0	3.0,5.0,0.0	CTCC	TTCG,CTCG	AY.88	virion structure	Tada et al. (2021)		The Ratio of S2 (processed Spike) to full length Spike is higher for this mutation,  due to a drop in the full length Spike measured, suggesting that this mutation compensates for decreased Spike production by improved proteolytic processing. [PG: Inferred by conservative AA substitution of described P681H]	False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P681R	c.C2042G	p.P681R			23604	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	C	G	AY.35, AY.70	symptom prevalence	Yadav et al. (2021)	'L452R', 'E484Q'	Gross examination of 3+3 hamster lung specimens showed pronounced congestion and hemorrhages on days 5 and 7 post-infection in the case of the B.1.617.1 as compared with the B.1. The lung lesions with  the B.1 variant were minimal to mild whereas with B.1.617.1 they were moderate. For B.1 pneumonic changes were minimal to mild (inflammatory cell infiltration, focal consolidation and mild congestion). The pronounced changes (moderate to severe) with mononuclear infiltration in the alveolar interstitial space, interstitial septal thickening, consolidation and pneumocyte hyperplasia were observed with B.1.617.1 variant consistently.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P681R	c.C2042G	p.P681R			23604	S	S	MISSENSE	26002	1,924						1	25979.0,10.0,0.0	C	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25	trafficking	Maaroufi (2021)		This mutation in the first base of the furin clevage site maintains the RXXR recognition motif, and is presumed to enhance cleavage based on the removal of a proline-directed phosphotase recognition site at S680. In a homologuous site in Infectious  Bronchitis Virus (IBV, Gammacoronaviruses), abolition of S680 phosphorylation improves furin cleavage  (and presumably cell entry). [Inference from similar positively charged substitution P681H actually described in the work]	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P681R	c.C2042G	p.P681R			23604	S	S	MISSENSE	26001	1,924						1	25978.0,10.0,0.0	C	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25	trafficking	Tada et al. (2021)	'D614G'	Quantification of the band intensities showed that the P681R mutation, which lies near the proteolytic processing site,  caused a small increase in proteolytic processing as measured by a 2-fold decrease in the ratio of S/S2.	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P681R	c.C2042G	p.P681R			23604	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	C	G	AY.35, AY.70	transmissibility	Tada et al. (2021)	'L452R', 'E484Q', 'D614G'	Normalized for particle number, on ACE2.293T cells showed that the B.1.617 spike protein was >2-fold increase in infectivity relative to D614G wild type.	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P681R	c.C2042G	p.P681R			23604	S	S	MISSENSE	11	5						0	11.0,0.0,0.0	C	G	AY.35, AY.70	viral load	Yadav et al. (2021)	'L452R', 'E484Q'	In 9 infected hamsters each for B.1 and B.1.617.1, no significant change in viral load or subgenomic RNA levels were detected. 	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P681R	c.C2042G	p.P681R			23604	S	S	MISSENSE	26002	1,924						1	25979.0,10.0,0.0	C	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25	virion structure	Tada et al. (2021)		The Ratio of S2 (processed Spike) to full length Spike is higher for this mutation,  due to a drop in the full length Spike measured, suggesting that this mutation compensates for decreased Spike production by improved proteolytic processing. [PG: Inferred by conservative AA substitution of described P681H]	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P6L	c.C17T	p.P6L			28290	N	N	MISSENSE	5	6						4	1.0,0.0,0.0	C	T	AY.4.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P7013L	c.C21038T	p.P7013L			21302	orf1ab	ORF1ab	MISSENSE	3	3	caution	neighbour_linked	2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	1	2.0,0.0,0.0	C	T	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P715P	c.C2145T	p.P715P			23707	S	S	SILENT	9	9						8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P748P	c.C2244T	p.P748P			2509	orf1ab	ORF1ab	SILENT	4578	9			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	46	4532.0,0.0,0.0	C	T	AY.106, AY.2, AY.38, AY.45, AY.88, AY.35, AY.72, AY.59, AY.55, AY.37, AY.24, AY.74					False	False, True, False, False, False, False, True, False, False, True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P765P	c.A2295G	p.P765P			2560	orf1ab	ORF1ab	SILENT	209	95			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	168	41.0,0.0,0.0	A	G	AY.86, AY.43					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P782L	c.C2345T	p.P782L			2610	orf1ab	ORF1ab	MISSENSE	3	3			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	2	1.0,0.0,0.0	C	T	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P809S	c.C2425T	p.P809S			23987	S	S	MISSENSE	16	6						14	2.0,0.0,0.0	C	T	AY.4.2, AY.65					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P84L	c.C251T	p.P84L			27644	ORF7a	ORF7a	MISSENSE	2	2						1	1.0,0.0,0.0	C	T	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P885L	c.C2654T	p.P885L			2919	orf1ab	ORF1ab	MISSENSE	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	2.0,0.0,0.0	C	T	AY.60					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.P93S	c.C277T	p.P93S			28170	ORF8	ORF8	MISSENSE	7	7						6	1.0,0.0,0.0	C	T	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.P971L	c.C2912T	p.P971L			3177	orf1ab	ORF1ab	MISSENSE	11	3			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	9	2.0,0.0,0.0	C	T	AY.41, AY.46.6					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q1021_I1023delinsL	c.3062_3067delAGACTA	p.Q1021_I1023delinsL			3326	orf1ab	ORF1ab		1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	CAGACTA	C	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q1519H	c.A4557C	p.Q1519H			4822	orf1ab	ORF1ab	MISSENSE	36	41			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	31	5.0,0.0,0.0	A	C	AY.13					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q1758Q	c.G5274A	p.Q1758Q			5539	orf1ab	ORF1ab	SILENT	4631	9			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	52	4579.0,0.0,0.0	G	A	AY.106, AY.38, AY.45, AY.88, AY.35, AY.72, AY.59, AY.55, AY.24, AY.74					False	False, False, False, False, False, True, False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q18X	c.C52T	p.Q18X			27945	ORF8	ORF8	NONSENSE	50	52						45	5.0,0.0,0.0	C	T	AY.26					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q2058Q	c.G6174A	p.Q2058Q			6439	orf1ab	ORF1ab	SILENT	8	8			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	7	1.0,0.0,0.0	G	A	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q2840R	c.A8519G	p.Q2840R			8784	orf1ab	ORF1ab	MISSENSE	16	16			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	14	2.0,0.0,0.0	A	G	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q28Q	c.G84A	p.Q28Q			28357	N	N	SILENT	3	3						1	2.0,0.0,0.0	G	A	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q3777H	c.G11331T	p.Q3777H			11596	orf1ab	ORF1ab	MISSENSE	11	11			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	9	2.0,0.0,0.0	G	T	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q3777R	c.A11330G	p.Q3777R			11595	orf1ab	ORF1ab	MISSENSE	27	27			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	0	27.0,0.0,0.0	A	G	AY.109					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q389Q	c.G1167A	p.Q389Q			29440	N	N	SILENT	1	1						0	1.0,0.0,0.0	G	A	AY.62					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q3966H	c.G11898T	p.Q3966H			12163	orf1ab	ORF1ab	MISSENSE	95	95			nsp8	produced by both pp1a and pp1ab	YP_009725304.1	80	15.0,0.0,0.0	G	T	AY.86					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q4151H	c.G12453T	p.Q4151H			12718	orf1ab	ORF1ab	MISSENSE	1	1			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab	YP_009725305.1	0	1.0,0.0,0.0	G	T	AY.7.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q4916Q	c.A14748G	p.Q4916Q			15012	orf1ab	ORF1ab	SILENT	20	20			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	20.0,0.0,0.0	A	G	AY.107					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q57R	c.A170G	p.Q57R			25562	ORF3a	ORF3a	MISSENSE	10	6						2	8.0,0.0,0.0	A	G	AY.17, AY.68					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q5842H	c.G17526T	p.Q5842H			17790	orf1ab	ORF1ab	MISSENSE	12	12			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	7	5.0,0.0,0.0	G	T	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q5947Q	c.G17841A	p.Q5947Q			18105	orf1ab	ORF1ab	SILENT	7	7			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	6	1.0,0.0,0.0	G	A	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q6033Q	c.G18099A	p.Q6033Q			18363	orf1ab	ORF1ab	SILENT	41	41			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	35	6.0,0.0,0.0	G	A	AY.13					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q62X	c.C184T	p.Q62X			27577	ORF7a	ORF7a	NONSENSE	19	7						14	5.0,0.0,0.0	C	T	AY.100, AY.34, AY.32					False	False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q6696Q	c.G20088A	p.Q6696Q			20352	orf1ab	ORF1ab	SILENT	6	6			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	3	3.0,0.0,0.0	G	A	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q676P	c.A2027C	p.Q676P			2292	orf1ab	ORF1ab	MISSENSE	3	3			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	3.0,0.0,0.0	A	C	AY.53					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q7036H	c.G21108T	p.Q7036H			21372	orf1ab	ORF1ab	MISSENSE	51	25			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	16	35.0,0.0,0.0	G	T	AY.38, AY.39, AY.39.1					False	False, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q70L	c.A209T	p.Q70L			25601	ORF3a	ORF3a	MISSENSE	6	6						5	1.0,0.0,0.0	A	T	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q72H	c.G216T	p.Q72H			28109	ORF8	ORF8	MISSENSE	13	7						11	2.0,0.0,0.0	G	T	AY.100, AY.57					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q72X	c.C214T	p.Q72X			28107	ORF8	ORF8	NONSENSE	160	160						136	24.0,0.0,0.0	C	T	AY.36					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q762Q	c.A2286G	p.Q762Q			23848	S	S	SILENT	6	6						0	6.0,0.0,0.0	A	G	AY.63					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q7K	c.C19A	p.Q7K			28292	N	N	MISSENSE	10	11						9	1.0,0.0,0.0	C	A	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q91H	c.G273T	p.Q91H			28166	ORF8	ORF8	MISSENSE	2	2						1	1.0,0.0,0.0	G	T	AY.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Q9L	c.A26T	p.Q9L			28299	N	N	MISSENSE	114	114						58	56.0,0.0,0.0	A	T	AY.43					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.QD613HG	c.GGA1839_1841TGG	p.QD613HG			23401	S	S		1	1						0	1.0,0.0,0.0	GGA	TGG	AY.67					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R101L	c.G302T	p.R101L			28195	ORF8	ORF8	MISSENSE	10	10						5	5.0,0.0,0.0	G	T	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R101R	c.T303C	p.R101R			28196	ORF8	ORF8	SILENT	20	20						18	2.0,0.0,0.0	T	C	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R115C	c.C343T	p.R115C			28236	ORF8	ORF8	MISSENSE	1	1						0	1.0,0.0,0.0	C	T	AY.91					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R124C	c.C370T	p.R124C			635	orf1ab	ORF1ab	MISSENSE	6	6	mask	highly_ambiguous,homoplasic,narrow_src	leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	3	3.0,0.0,0.0	C	T	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R149R	c.C447T	p.R149R			28720	N	N	SILENT	10	10						8	2.0,0.0,0.0	C	T	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R150R	c.T450C	p.R150R			26972	M	M	SILENT	155	160						137	18.0,0.0,0.0	T	C	AY.36					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R1530S	c.A4590C	p.R1530S			4855	orf1ab	ORF1ab	MISSENSE	27	27			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	23	4.0,0.0,0.0	A	C	AY.19					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R158G	c.467_472delAGTTCA	p.E156_R158delinsG	E156_R158delinsG	'E156del', '157del'	22028	S	S		25280	1,924						8	25272.0,0.0,0.0	GAGTTCA	G	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.7.1, AY.74, AY.27, AY.25	monoclonal antibody serial passage escape	McCallum et al. (2021)		Escape mutation against Spike N terminal domain antigenic supersite i mAb S2X28	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R191H	c.G572A	p.R191H			28845	N	N	MISSENSE	6	6						5	1.0,0.0,0.0	G	A	AY.4.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R203M	c.G608T	p.R203M			28881	N	N	MISSENSE	25971	1,924	caution	neighbour_linked				1	25970.0,0.0,0.0	G	T	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25	RNA binding	Syed et al. (2021)		Northern blot analysis of novel mutant virus-like-particles (VLPs) shows most increase in RNA content of any N mutation tested, suggesting that this mutation improves virus particle production (requisite RNA packaging signal binding site in nsp15/16 boundary is included in the VLP).	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R24C	c.C70T	p.R24C			335	orf1ab	ORF1ab	MISSENSE	10	3			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	5	5.0,0.0,0.0	C	T	AY.28, AY.100					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R24H	c.G71A	p.R24H			29628	ORF10	ORF10	MISSENSE	9	9						8	1.0,0.0,0.0	G	A	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R24R	c.C72T	p.R24R			337	orf1ab	ORF1ab	SILENT	6	6			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	5	1.0,0.0,0.0	C	T	AY.4.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R259R	c.G777A	p.R259R			29050	N	N	SILENT	88	1						15	73.0,0.0,0.0	G	A	AY.3.1, AY.3, AY.92					False	True, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R2638R	c.G7914T	p.R2638R			8179	orf1ab	ORF1ab	SILENT	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	2.0,0.0,0.0	G	T	AY.60					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R287R	c.A859C	p.R287R			1124	orf1ab	ORF1ab	SILENT	22	22			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	18	4.0,0.0,0.0	A	C	AY.108					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R2985R	c.G8955A	p.R2985R			9220	orf1ab	ORF1ab	SILENT	3	3			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	0	3.0,0.0,0.0	G	A	AY.41					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R3164H	c.G9491A	p.R3164H			9756	orf1ab	ORF1ab	MISSENSE	7	7			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	6	1.0,0.0,0.0	G	A	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R385K	c.G1154A	p.R385K			29427	N	N	MISSENSE	26	16	caution	ambiguous,neighbour_linked,single_src				5	21.0,0.0,0.0	G	A	AY.40, AY.45, AY.81, AY.51					False	True, False, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R41R	c.G123A	p.R41R			28396	N	N	SILENT	31	7						27	4.0,0.0,0.0	G	A	AY.29, AY.33					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R4575R	c.C13725T	p.R4575R			13989	orf1ab	ORF1ab	SILENT	5	5			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	4	1.0,0.0,0.0	C	T	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R4589Q	c.G13766A	p.R4589Q			14030	orf1ab	ORF1ab	MISSENSE	440	25			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	15	425.0,0.0,0.0	G	A	AY.9.2, AY.9.1, AY.9.2.1, AY.9					False	True, False, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R4641R	c.G13923A	p.R4641R			14187	orf1ab	ORF1ab	SILENT	43	43			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	2	41.0,0.0,0.0	G	A	AY.54					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R4677H	c.G14030A	p.R4677H			14294	orf1ab	ORF1ab	MISSENSE	52	52			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	46	6.0,0.0,0.0	G	A	AY.26					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R5250R	c.G15750A	p.R5250R			16014	orf1ab	ORF1ab	SILENT	3	3			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	2	1.0,0.0,0.0	G	A	AY.46.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R550H	c.G1649A	p.R550H			1914	orf1ab	ORF1ab	MISSENSE	6	6			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	5	1.0,0.0,0.0	G	A	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R5536R	c.A16608G	p.R5536R			16872	orf1ab	ORF1ab	SILENT	164	120			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	15	149.0,0.0,0.0	A	G	AY.15, AY.13, AY.75.1, AY.77					False	True, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R5661R	c.T16983C	p.R5661R			17247	orf1ab	ORF1ab	SILENT	3	3			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	1	2.0,0.0,0.0	T	C	AY.53					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R5714R	c.A17142G	p.R5714R			17406	orf1ab	ORF1ab	SILENT	41	41			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	29	12.0,0.0,0.0	A	G	AY.13					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R5716C	c.C17146T	p.R5716C			17410	orf1ab	ORF1ab	MISSENSE	9	9			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R5831K	c.G17492A	p.R5831K			17756	orf1ab	ORF1ab	MISSENSE	1	1			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	0	1.0,0.0,0.0	G	A	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R6137R	c.A18411G	p.R6137R			18675	orf1ab	ORF1ab	SILENT	1	1			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	1.0,0.0,0.0	A	G	AY.7.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R6709R	c.T20127G	p.R6709R			20391	orf1ab	ORF1ab	SILENT	3	3			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	0	3.0,0.0,0.0	T	G	AY.59					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R683L	c.G2048T	p.R683L			23610	S	S	MISSENSE	5	5						2	3.0,0.0,0.0	G	T	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R68R	c.A204C	p.R68R			28477	N	N	SILENT	2	2						0	2.0,0.0,0.0	A	C	AY.84					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R7014C	c.C21040T	p.R7014C			21304	orf1ab	ORF1ab	MISSENSE	5	5	caution	neighbour_linked	2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	0	5.0,0.0,0.0	C	T	AY.32					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.R7014R	c.C21042T	p.R7014R			21306	orf1ab	ORF1ab	SILENT	48	48			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	14	34.0,0.0,0.0	C	T	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R78C	c.C232T	p.R78C			27625	ORF7a	ORF7a	MISSENSE	12	12						9	3.0,0.0,0.0	C	T	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.R89I	c.G266T	p.R89I			27659	ORF7a	ORF7a	MISSENSE	5	5						4	1.0,0.0,0.0	G	T	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.RM209II	c.GAATG626_630TAATT	p.RM209II			28899	N	N		6	6						1	5.0,0.0,0.0	GAATG	TAATT	AY.70					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S100C	c.A298T	p.S100C			563	orf1ab	ORF1ab	MISSENSE	1	1			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	0	1.0,0.0,0.0	A	T	AY.4.3					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S1102G	c.A3304G	p.S1102G			3569	orf1ab	ORF1ab	MISSENSE	10	10			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	9	1.0,0.0,0.0	A	G	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S1195R	c.T3585G	p.S1195R			3850	orf1ab	ORF1ab	MISSENSE	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	1.0,0.0,0.0	T	G	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S1239S	c.T3717C	p.S1239S			25279	S	S	SILENT	12	12						10	2.0,0.0,0.0	T	C	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S135S	c.C405T	p.S135S			25797	ORF3a	ORF3a	SILENT	78	78						66	12.0,0.0,0.0	C	T	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S136N	c.G407A	p.S136N			26929	M	M	MISSENSE	1	1						0	1.0,0.0,0.0	G	A	AY.91					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S1517S	c.T4551C	p.S1517S			4816	orf1ab	ORF1ab	SILENT	15	15			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	13.0,0.0,0.0	T	C	AY.98.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S155_R158delinsIG	c.GTGAGTTCA464_472TTG	p.S155_R158delinsIG			22026	S	S		1	1						0	1.0,0.0,0.0	GTGAGTTCA	TTG	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S15G	c.A43G	p.S15G			29600	ORF10	ORF10	MISSENSE	10	10						8	2.0,0.0,0.0	A	G	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S1612L	c.C4835T	p.S1612L			5100	orf1ab	ORF1ab	MISSENSE	409	410			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	277	132.0,0.0,0.0	C	T	AY.44					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S166L	c.C497T	p.S166L			25889	ORF3a	ORF3a	MISSENSE	11	11						9	2.0,0.0,0.0	C	T	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S171L	c.C512T	p.S171L			25904	ORF3a	ORF3a	MISSENSE	9	9						8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S193G	c.A577G	p.S193G			28850	N	N	MISSENSE	2	2						1	1.0,0.0,0.0	A	G	AY.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S194L	c.C581T	p.S194L			28854	N	N	MISSENSE	6	6						4	2.0,0.0,0.0	C	T	AY.70	homoplasy	Barona-Gomez et al. (2021)		Mutation with a population frequency of 30% in a Mexican dataset, primarily of lineage 20B, but also present in a substantial number of 20A lineage sequences, suggesting convergent evolution.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S194L	c.C581T	p.S194L			28854	N	N	MISSENSE	6	6						4	2.0,0.0,0.0	C	T	AY.70	outcome hazard ratio	Joshi et al. (2021)		In March 2021 this variant had an allele frequency of 47.62 and 7.25% in deceased patients, compared to 35.16 and 3.20% of the same variant in recovered patients, from the Gujarat and global datasets.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S194L	c.C581T	p.S194L			28854	N	N	MISSENSE	6	6						4	2.0,0.0,0.0	C	T	AY.70	symptom prevalence	Barona-Gomez et al. (2021)		Mutation in the Nucleocapsid region showing a significant higher (ANOVA: F 	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S197N	c.G590A	p.S197N			27112	M	M	MISSENSE	28	30						5	23.0,0.0,0.0	G	A	AY.75					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2015S	c.C6045T	p.S2015S			6310	orf1ab	ORF1ab	SILENT	8	8	caution	neighbour_linked	nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	8.0,0.0,0.0	C	T	AY.46.6					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S201N	c.G602A	p.S201N			28875	N	N	MISSENSE	6	6						5	1.0,0.0,0.0	G	A	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2024A	c.T6070G	p.S2024A			6335	orf1ab	ORF1ab	MISSENSE	16	16			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	14	2.0,0.0,0.0	T	G	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S205T	c.G614C	p.S205T			26006	ORF3a	ORF3a	MISSENSE	5	5						4	1.0,0.0,0.0	G	C	AY.46.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2132G	c.A6394G	p.S2132G			6659	orf1ab	ORF1ab	MISSENSE	10	10			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	5.0,0.0,0.0	A	G	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S214I	c.G641T	p.S214I			27163	M	M	MISSENSE	23	24						20	3.0,0.0,0.0	G	T	AY.33					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S216Y	c.C647A	p.S216Y			912	orf1ab	ORF1ab	MISSENSE	48	48			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	47.0,0.0,0.0	C	A	AY.110					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2188F	c.C6563T	p.S2188F			6828	orf1ab	ORF1ab	MISSENSE	22	22			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	21.0,0.0,0.0	C	T	AY.108					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S21P	c.T61C	p.S21P			28334	N	N	MISSENSE	25	25						18	7.0,0.0,0.0	T	C	AY.38					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S220R	c.A658C	p.S220R			26050	ORF3a	ORF3a	MISSENSE	9	9						8	1.0,0.0,0.0	A	C	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2214S	c.A6642G	p.S2214S			6907	orf1ab	ORF1ab	SILENT	238	238			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	140	98.0,0.0,0.0	A	G	AY.61					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S221L	c.C662T	p.S221L			22224	S	S	MISSENSE	102	43						70	32.0,0.0,0.0	C	T	AY.54, AY.54, AY.46.6, AY.46.6					False	False, False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S221S	c.G663T	p.S221S			22225	S	S	SILENT	18	9						16	2.0,0.0,0.0	G	T	AY.106, AY.106					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2261F	c.C6782T	p.S2261F			7047	orf1ab	ORF1ab	MISSENSE	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	6	1.0,0.0,0.0	C	T	AY.100					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2285F	c.C6854T	p.S2285F			7119	orf1ab	ORF1ab	MISSENSE	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	3.0,0.0,0.0	C	T	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2433S	c.C7299T	p.S2433S			7564	orf1ab	ORF1ab	SILENT	16	16			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	12	4.0,0.0,0.0	C	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2488F	c.C7463T	p.S2488F			7728	orf1ab	ORF1ab	MISSENSE	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	1.0,0.0,0.0	C	T	AY.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2500F	c.C7499T	p.S2500F			7764	orf1ab	ORF1ab	MISSENSE	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	3	4.0,0.0,0.0	C	T	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S253S	c.C759T	p.S253S			26151	ORF3a	ORF3a	SILENT	12	7						5	7.0,0.0,0.0	C	T	AY.29, AY.9.1					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S255F	c.C764T	p.S255F			22326	S	S	MISSENSE	9	9						4	5.0,0.0,0.0	C	T	AY.106	monoclonal antibody serial passage escape	McCallum et al. (2021)		Escape mutation against Spike N terminal domain antigenic supersite i mAb S2L28	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S255P	c.T763C	p.S255P			22325	S	S	MISSENSE	1	1						0	1.0,0.0,0.0	T	C	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2599S	c.A7797G	p.S2599S			8062	orf1ab	ORF1ab	SILENT	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	1.0,0.0,0.0	A	G	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S26L	c.C77T	p.S26L			25466	ORF3a	ORF3a	MISSENSE	11	11						0	1.0,10.0,0.0	CTTC	TTTT,CTTT	AY.5					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S26L	c.C77T	p.S26L			25468	ORF3a	ORF3a	MISSENSE	3	3						0	1.0,2.0,0.0	TC	CT,TT	AY.59					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S26L	c.C77T	p.S26L			25469	ORF3a	ORF3a	MISSENSE	25996	1,924						1	25971.0,24.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S279F	c.C836T	p.S279F			1101	orf1ab	ORF1ab	MISSENSE	549	550			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	548.0,0.0,0.0	C	T	AY.93					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2900L	c.C8699T	p.S2900L			8964	orf1ab	ORF1ab	MISSENSE	6	6			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	3	3.0,0.0,0.0	C	T	AY.63					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2900P	c.T8698C	p.S2900P			8963	orf1ab	ORF1ab	MISSENSE	4	4			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	3	1.0,0.0,0.0	T	C	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2960F	c.C8879T	p.S2960F			9144	orf1ab	ORF1ab	MISSENSE	15	15			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	0	15.0,0.0,0.0	C	T	AY.82					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S2972F	c.C8915T	p.S2972F			9180	orf1ab	ORF1ab	MISSENSE	20	20			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	18	2.0,0.0,0.0	C	T	AY.107					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S308S	c.A924C	p.S308S			1189	orf1ab	ORF1ab	SILENT	410	394			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	14	396.0,0.0,0.0	A	C	AY.9.2.1, AY.9					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S310S	c.C930T	p.S310S			29203	N	N	SILENT	70	70						57	13.0,0.0,0.0	C	T	AY.3					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S3149F	c.C9446T	p.S3149F			9711	orf1ab	ORF1ab	MISSENSE	9	9			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S3158S	c.T9474C	p.S3158S			9739	orf1ab	ORF1ab	SILENT	6	6			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	5	1.0,0.0,0.0	T	C	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S318L	c.C953T	p.S318L			1218	orf1ab	ORF1ab	MISSENSE	164	120			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	85	79.0,0.0,0.0	C	T	AY.15, AY.13, AY.75.1, AY.77					False	False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S327L	c.C980T	p.S327L			29253	N	N	MISSENSE	20	9						10	10.0,0.0,0.0	C	T	AY.106, AY.5					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S327S	c.G981T	p.S327S			29254	N	N	SILENT	148	3						106	42.0,0.0,0.0	G	T	AY.12, AY.13, AY.64, AY.20, AY.24					False	False, False, False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S375S	c.C1125T	p.S375S			22687	S	S	SILENT	5	5						4	1.0,0.0,0.0	C	T	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S37P	c.T109C	p.S37P			28382	N	N	MISSENSE	7	7						3	4.0,0.0,0.0	T	C	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S3834S	c.C11502T	p.S3834S			11767	orf1ab	ORF1ab	SILENT	7	7			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	5	2.0,0.0,0.0	C	T	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S3884L	c.C11651T	p.S3884L			11916	orf1ab	ORF1ab	MISSENSE	7	7			nsp7	produced by both pp1a and pp1ab	YP_009725303.1	5	2.0,0.0,0.0	C	T	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S3920S	c.C11760T	p.S3920S			12025	orf1ab	ORF1ab	SILENT	5	5			nsp7	produced by both pp1a and pp1ab	YP_009725303.1	4	1.0,0.0,0.0	C	T	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S4027S	c.T12081C	p.S4027S			12346	orf1ab	ORF1ab	SILENT	8	8			nsp8	produced by both pp1a and pp1ab	YP_009725304.1	7	1.0,0.0,0.0	T	C	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S412R	c.A1234C	p.S412R			29507	N	N	MISSENSE	7140	25						348	6792.0,0.0,0.0	A	C	AY.38, AY.67, AY.9, AY.27					False	False, True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S412S	c.C1236T	p.S412S			29509	N	N	SILENT	88	1						15	73.0,0.0,0.0	C	T	AY.3.1, AY.3, AY.92					False	True, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S443Y	c.C1328A	p.S443Y			1593	orf1ab	ORF1ab	MISSENSE	9	9			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	8	1.0,0.0,0.0	C	A	AY.106	monoclonal antibody serial passage escape	Greaney et al. (2020)		Mostand highly effective escape variant in the RBD for highly neutralizing COV2-2499 monoclonal antibody	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S4647S	c.A13941G	p.S4647S			14205	orf1ab	ORF1ab	SILENT	6	6			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	5	1.0,0.0,0.0	A	G	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S4776P	c.T14326C	p.S4776P			14590	orf1ab	ORF1ab	MISSENSE	3	3			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	2	1.0,0.0,0.0	T	C	AY.53					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S4912N	c.G14735A	p.S4912N			14999	orf1ab	ORF1ab	MISSENSE	17	17			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	15	2.0,0.0,0.0	G	A	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S494P	c.T1480C	p.S494P			23042	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	ACE2 receptor binding affinity	Chakraborty (2021)		Using molecular dynamic simulation, the mildly (~1kcal/mol) enhanced binding energy of this variant is primarily  contributed by Tyr505 (4.98 kcal/mol) which is now involved in a strong hydrogen bonding network with Arg393.  Another important energetic contribution comes from the altered orientation of Tyr41 which is now involved with  two hydrogen-bonding interactions with Asp355 and Thr500. 	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S494P	c.T1480C	p.S494P			23042	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	ACE2 receptor binding affinity	Zahradnik et al. (2021)		Minor variant selected in late rounds of an in vitro evolution experiment for ACE2 binding. Shown to increase the thermostability but decrease the association rate constant of the RBD to ACE2	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S494P	c.T1480C	p.S494P			23042	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	antibody epitope effects	Liu et al. (2020)		Mutant screen in neutralization assay with a broad range of monoclonal antibodies shows resistence to mAb SARS2-01.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S494P	c.T1480C	p.S494P			23042	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	antibody epitope effects	Rappazzo et al. (2021)		Greater than 10-fold rediuction of binding effeiency vs wild type for mAb LY-CoV555.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S494P	c.T1480C	p.S494P			23042	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	convalescent plasma escape	Alenquer et al. (2021)		S494P frequently engages in interactions with antibodies but not with ACE2. It reduces antibody  neutralization of all 16 convalescent sera tested, averaging WT ratio of 0.41+-0.08 (less dramatic than E484K).  This amino acid emerges as an additional hotspot for immune evasion and a target for therapies, vaccines and diagnostics. It has emerged independently in multiple lineages.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S494P	c.T1480C	p.S494P			23042	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	convalescent plasma escape	Greaney et al. (2021)		In 2 of 11 subjects' convalescent sera in an early+late mutational landscape analysis of the RBD,  S484P shows a slightly resistent profile across both timepoints (i.e. resistant to immune cell somatic mutation evolution)	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S494P	c.T1480C	p.S494P			23042	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	convalescent plasma escape	Liu et al. (2021)		Mixed bag of positive and negative changes in neutralization capability of all 4 convalescent sera tested.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S494P	c.T1480C	p.S494P			23042	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	immunosuppression variant emergence	Choi et al. (2020)		Combination of RBD mutations appeared (day 75) and persisted in chronic (152 day) SARS-CoV-2 infection of immunocompromised patient with severe antiphospholipid syndrome complicated by diffuse alveolar hemorrhage, who was receiving anticoagulation therapy, glucocorticoids, cyclophosphamide, and intermittent rituximab and eculizumab. 	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S494P	c.T1480C	p.S494P			23042	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	monoclonal antibody serial passage escape	Starr et al. (2021)		Escape mutation against monoclonal antibody LY-CoV555 (antibody that forms the basis for Eli Lilly's bamlanivimab)	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S494P	c.T1480C	p.S494P			23042	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	pharmaceutical effectiveness	Engelhart et al. (2021)		Bamlanivimab (LY-CoV555) lost ~8x binding against this isolated mutation. Regdanvimab lost ~32x binding against this isolated mutation.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S5039I	c.G15116T	p.S5039I			15380	orf1ab	ORF1ab	MISSENSE	122	27			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	7	115.0,0.0,0.0	G	T	AY.19, AY.86					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S5187F	c.C15560T	p.S5187F			15824	orf1ab	ORF1ab	MISSENSE	9	9			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	7	2.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S5206S	c.T15618G	p.S5206S			15882	orf1ab	ORF1ab	SILENT	1	1			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	1.0,0.0,0.0	T	G	AY.7.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S528L	c.C1583T	p.S528L			1848	orf1ab	ORF1ab	MISSENSE	1	1			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	1.0,0.0,0.0	C	T	AY.87					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S538A	c.T1612G	p.S538A			1877	orf1ab	ORF1ab	MISSENSE	12	12			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	12.0,0.0,0.0	T	G	AY.14					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S549S	c.C1647T	p.S549S			1912	orf1ab	ORF1ab	SILENT	1949	1,924			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1723	226.0,0.0,0.0	C	T	B.1.617.2, AY.19					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S58S	c.C174T	p.S58S			25566	ORF3a	ORF3a	SILENT	7	1						5	2.0,0.0,0.0	C	T	AY.91, AY.24					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S60I	c.G179T	p.S60I			27572	ORF7a	ORF7a	MISSENSE	8	8						7	1.0,0.0,0.0	G	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S6299F	c.C18896T	p.S6299F			19160	orf1ab	ORF1ab	MISSENSE	219	120			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	16	203.0,0.0,0.0	C	T	AY.15, AY.14, AY.13, AY.75.1, AY.54, AY.77					False	True, True, False, False, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S6739L	c.C20216T	p.S6739L			20480	orf1ab	ORF1ab	MISSENSE	7	5			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	5	2.0,0.0,0.0	C	T	AY.45, AY.39.1					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S67F	c.C200T	p.S67F			28093	ORF8	ORF8	MISSENSE	1	1						0	1.0,0.0,0.0	C	T	AY.62					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S6831I	c.G20492T	p.S6831I			20756	orf1ab	ORF1ab	MISSENSE	6	6			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	5	1.0,0.0,0.0	G	T	AY.99.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S6999S	c.A20997G	p.S6999S			21261	orf1ab	ORF1ab	SILENT	2	2			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	0	2.0,0.0,0.0	A	G	AY.39.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S7039S	c.C21117T	p.S7039S			21381	orf1ab	ORF1ab	SILENT	2	2			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	1	1.0,0.0,0.0	C	T	AY.75.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S71F	c.C212T	p.S71F			21774	S	S	MISSENSE	35	35						31	4.0,0.0,0.0	C	T	AY.48					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S723S	c.C2169T	p.S723S			2434	orf1ab	ORF1ab	SILENT	12	12			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	9	3.0,0.0,0.0	C	T	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S74S	c.C222T	p.S74S			25614	ORF3a	ORF3a	SILENT	6	6						0	6.0,0.0,0.0	C	T	AY.4.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S83A	c.T247G	p.S83A			27640	ORF7a	ORF7a	MISSENSE	23	35						0	23.0,0.0,0.0	T	G	AY.48					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.S939F	c.C2816T	p.S939F			24378	S	S	MISSENSE	6	6						5	1.0,0.0,0.0	C	T	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S944L	c.C2831T	p.S944L			3096	orf1ab	ORF1ab	MISSENSE	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	1.0,0.0,0.0	C	T	AY.39.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S94S	c.C282T	p.S94S			26804	M	M	SILENT	3	3						2	1.0,0.0,0.0	C	T	AY.59					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S984I	c.G2951T	p.S984I			3216	orf1ab	ORF1ab	MISSENSE	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	1.0,0.0,0.0	G	T	AY.39.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.S98F	c.C293T	p.S98F			21855	S	S	MISSENSE	4	6						3	1.0,0.0,0.0	C	T	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.ST477IK	c.GCAC1430_1433TCAA	p.ST477IK			22992	S	S		3	3						0	3.0,0.0,0.0	GCAC	TCAA	AY.41					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.SV81LA	c.CAGT242_245TAGC	p.SV81LA			27635	ORF7a	ORF7a		1	1						0	1.0,0.0,0.0	CAGT	TAGC	AY.87					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1000I	c.C2999T	p.T1000I			3264	orf1ab	ORF1ab	MISSENSE	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	3	4.0,0.0,0.0	C	T	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1022I	c.C3065T	p.T1022I			3330	orf1ab	ORF1ab	MISSENSE	8	8			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	7	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1076T	c.A3228G	p.T1076T			24790	S	S	SILENT	5	5						3	2.0,0.0,0.0	A	G	AY.46.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1168I	c.C3503T	p.T1168I			3768	orf1ab	ORF1ab	MISSENSE	36	27			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	30	6.0,0.0,0.0	C	T	AY.109, AY.106					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T11A	c.A31G	p.T11A			26275	E	E	MISSENSE	5	5						2	3.0,0.0,0.0	A	G	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T120I	c.C359T	p.T120I			27752	ORF7a	ORF7a	MISSENSE	25978	1,924						2	25976.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.87, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1238T	c.C3714T	p.T1238T			25276	S	S	SILENT	17	17						0	17.0,0.0,0.0	C	T	AY.18					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1242T	c.T3726C	p.T1242T			3991	orf1ab	ORF1ab	SILENT	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	6	1.0,0.0,0.0	T	C	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T12I	c.C35T	p.T12I			300	orf1ab	ORF1ab	MISSENSE	8	8			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	7	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T130T	c.C390T	p.T130T			26912	M	M	SILENT	159	160						114	45.0,0.0,0.0	C	T	AY.36					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1344T	c.A4032G	p.T1344T			4297	orf1ab	ORF1ab	SILENT	9	9			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	8	1.0,0.0,0.0	A	G	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1429I	c.C4286T	p.T1429I			4551	orf1ab	ORF1ab	MISSENSE	20	20			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	18	2.0,0.0,0.0	C	T	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1496I	c.C4487T	p.T1496I			4752	orf1ab	ORF1ab	MISSENSE	11	11			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	9.0,0.0,0.0	C	T	AY.23					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1521I	c.C4562T	p.T1521I			4827	orf1ab	ORF1ab	MISSENSE	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	1.0,0.0,0.0	C	T	AY.46.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1542T	c.C4626T	p.T1542T			4891	orf1ab	ORF1ab	SILENT	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	6.0,0.0,0.0	C	T	AY.70					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1581M	c.C4742T	p.T1581M			5007	orf1ab	ORF1ab	MISSENSE	12	12			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	10	2.0,0.0,0.0	C	T	AY.42					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1581T	c.G4743T	p.T1581T			5008	orf1ab	ORF1ab	SILENT	30	30			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	27	3.0,0.0,0.0	G	T	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1617I	c.C4850T	p.T1617I			5115	orf1ab	ORF1ab	MISSENSE	17	17			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	10	7.0,0.0,0.0	C	T	AY.18					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T163I	c.C488T	p.T163I			753	orf1ab	ORF1ab	MISSENSE	9	9			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1682I	c.C5045T	p.T1682I			5310	orf1ab	ORF1ab	MISSENSE	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	1.0,0.0,0.0	C	T	AY.99.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T175I	c.C524T	p.T175I			25916	ORF3a	ORF3a	MISSENSE	3	3						1	2.0,0.0,0.0	C	T	AY.53					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1773T	c.A5319G	p.T1773T			5584	orf1ab	ORF1ab	SILENT	14636	1,924			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1740	12873.0,0.0,0.0	A	G	B.1.617.2, AY.28, AY.106, AY.26, AY.2, AY.38, AY.10, AY.75.1, AY.64, AY.65, AY.45, AY.60, AY.88, AY.35, AY.72, AY.59, AY.9.2, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.73, AY.61, AY.9.2.1, AY.67, AY.37, AY.63, AY.9, AY.24, AY.68, AY.70, AY.62, AY.74, AY.27					False	False, True, False, True, True, True, True, False, True, True, False, True, False, False, True, True, True, False, True, True, False, True, True, True, True, True, True, True, True, True, False, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1773T	c.A5319T	p.T1773T			5584	orf1ab	ORF1ab	SILENT	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	6.0,0.0,0.0	A	T	AY.57					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1788T	c.G5364T	p.T1788T			5629	orf1ab	ORF1ab	SILENT	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	1.0,0.0,0.0	G	T	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1840I	c.C5519T	p.T1840I			5784	orf1ab	ORF1ab	MISSENSE	96	20			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	82	14.0,0.0,0.0	C	T	AY.64, AY.3, AY.24					False	False, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1844I	c.C5531T	p.T1844I			5796	orf1ab	ORF1ab	MISSENSE	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	2.0,0.0,0.0	C	T	AY.37					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T1874I	c.C5621T	p.T1874I			5886	orf1ab	ORF1ab	MISSENSE	43	43			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	16	27.0,0.0,0.0	C	T	AY.54					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2007I	c.C6020T	p.T2007I			6285	orf1ab	ORF1ab	MISSENSE	24	24			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	19	5.0,0.0,0.0	C	T	AY.39					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2068I	c.C6203T	p.T2068I			6468	orf1ab	ORF1ab	MISSENSE	21	9			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	17	4.0,0.0,0.0	C	T	AY.106, AY.14					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2106I	c.C6317T	p.T2106I			6582	orf1ab	ORF1ab	MISSENSE	76	78			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	64	12.0,0.0,0.0	C	T	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T217I	c.C650T	p.T217I			26042	ORF3a	ORF3a	MISSENSE	24	24						15	9.0,0.0,0.0	C	T	AY.39					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2197I	c.C6590T	p.T2197I			6855	orf1ab	ORF1ab	MISSENSE	77	78			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	65	12.0,0.0,0.0	C	T	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T223I	c.C668T	p.T223I			26060	ORF3a	ORF3a	MISSENSE	187	27						106	81.0,0.0,0.0	C	T	AY.19, AY.36					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2283I	c.C6848T	p.T2283I			7113	orf1ab	ORF1ab	MISSENSE	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	1.0,0.0,0.0	C	T	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2300I	c.C6899T	p.T2300I			7164	orf1ab	ORF1ab	MISSENSE	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	3.0,0.0,0.0	C	T	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2495I	c.C7484T	p.T2495I			7749	orf1ab	ORF1ab	MISSENSE	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	1.0,0.0,0.0	C	T	AY.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T250I	c.C749T	p.T250I			22311	S	S	MISSENSE	58	24						12	46.0,0.0,0.0	C	T	AY.33, AY.33, AY.32, AY.32					False	True, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T250S	c.A748T	p.T250S			22310	S	S	MISSENSE	24	25						21	3.0,0.0,0.0	A	T	AY.38					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2615T	c.T7845C	p.T2615T			8110	orf1ab	ORF1ab	SILENT	9	9			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	8	1.0,0.0,0.0	T	C	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2648I	c.C7943T	p.T2648I			8208	orf1ab	ORF1ab	MISSENSE	4	4			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	3	1.0,0.0,0.0	C	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2648T	c.T7944C	p.T2648T			8209	orf1ab	ORF1ab	SILENT	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	2.0,0.0,0.0	T	C	AY.100					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T270I	c.C809T	p.T270I			26201	ORF3a	ORF3a	MISSENSE	41	41						14	27.0,0.0,0.0	C	T	AY.13					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2876T	c.A8628G	p.T2876T			8893	orf1ab	ORF1ab	SILENT	1	1			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	0	1.0,0.0,0.0	A	G	AY.3.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T28I	c.C83T	p.T28I			27476	ORF7a	ORF7a	MISSENSE	6	6						2	4.0,0.0,0.0	C	T	AY.99.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2936I	c.C8807T	p.T2936I			9072	orf1ab	ORF1ab	MISSENSE	9	9			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T2967T	c.C8901T	p.T2967T			9166	orf1ab	ORF1ab	SILENT	10	10			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	9	1.0,0.0,0.0	C	T	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T299I	c.C896T	p.T299I			22458	S	S	MISSENSE	24	24						12	12.0,0.0,0.0	C	T	AY.33					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T29A	c.A85G	p.T29A			21647	S	S	MISSENSE	24	24						4	20.0,0.0,0.0	A	G	AY.33					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T3058I	c.C9173T	p.T3058I			9438	orf1ab	ORF1ab	MISSENSE	3	3			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	2	1.0,0.0,0.0	C	T	AY.46.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T30T	c.A90G	p.T30T			26612	M	M	SILENT	48	48						14	34.0,0.0,0.0	A	G	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T3182T	c.C9546T	p.T3182T			9811	orf1ab	ORF1ab	SILENT	9	9			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	3	6.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T323K	c.C968A	p.T323K			22530	S	S	MISSENSE	8	8						7	1.0,0.0,0.0	C	A	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T3255I	c.C9764T	p.T3255I			10029	orf1ab	ORF1ab	MISSENSE	12982	1,924			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	727	12255.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.19, AY.111, AY.104, AY.103, AY.100, AY.106, AY.12, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.46.4, AY.4.5, AY.44, AY.33, AY.46.2, AY.41, AY.102, AY.4.2, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.5, AY.20, AY.32, AY.39, AY.46, AY.43, AY.9.1, AY.46.1, AY.92, AY.42, AY.98.1, AY.87, AY.108, AY.85, AY.39.1, AY.46.6, AY.4.3, AY.99.2, AY.93, AY.82, AY.84, AY.99, AY.7.1, AY.25					False	False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T3258T	c.C9774T	p.T3258T			10039	orf1ab	ORF1ab	SILENT	17	17			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	15	2.0,0.0,0.0	C	T	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T3287T	c.A9861T	p.T3287T			10126	orf1ab	ORF1ab	SILENT	15	15			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	11	4.0,0.0,0.0	A	T	AY.98.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T3356I	c.C10067T	p.T3356I			10332	orf1ab	ORF1ab	MISSENSE	8	8			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	7	1.0,0.0,0.0	C	T	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T3459T	c.G10377T	p.T3459T			10642	orf1ab	ORF1ab	SILENT	78	78			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	62	16.0,0.0,0.0	G	T	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T355N	c.C1064A	p.T355N			1329	orf1ab	ORF1ab	MISSENSE	2	2			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	1.0,0.0,0.0	C	A	AY.75.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T362I	c.C1085T	p.T362I			29358	N	N	MISSENSE	23	20						0	23.0,0.0,0.0	C	T	AY.107, AY.81	T cell evasion	de Silva et al. (2021)		"Variant causes complete loss of T cell line responsiveness to A*03:01/A*11:01-restricted CD8+ N epitope  KTFPPTEPK 361-369(2,8,10,20), which otherwise is ""consistently dominant and of high magnitude""."	False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T362K	c.C1085A	p.T362K			29358	N	N	MISSENSE	11	11						9	2.0,0.0,0.0	C	A	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T3646A	c.A10936G	p.T3646A			11201	orf1ab	ORF1ab	MISSENSE	12982	1,924			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	729	12253.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.111, AY.104, AY.103, AY.100, AY.106, AY.12, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.46.4, AY.4.5, AY.44, AY.33, AY.46.2, AY.41, AY.102, AY.4.2, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.5, AY.20, AY.32, AY.39, AY.46, AY.43, AY.9.1, AY.46.1, AY.92, AY.42, AY.98.1, AY.87, AY.108, AY.85, AY.39.1, AY.46.6, AY.4.3, AY.99.2, AY.93, AY.82, AY.84, AY.99, AY.7.1, AY.25					False	False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T366I	c.C1097T	p.T366I			29370	N	N	MISSENSE	8	8						6	2.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T3750I	c.C11249T	p.T3750I			11514	orf1ab	ORF1ab	MISSENSE	14643	1,924			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	1738	12904.0,1.0,0.0	C	T	B.1.617.2, AY.28, AY.106, AY.26, AY.2, AY.38, AY.10, AY.75.1, AY.64, AY.65, AY.45, AY.60, AY.88, AY.57, AY.35, AY.72, AY.59, AY.9.2, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.73, AY.61, AY.9.2.1, AY.67, AY.37, AY.63, AY.9, AY.24, AY.68, AY.70, AY.62, AY.74, AY.27					False	False, True, False, True, True, True, True, False, True, True, False, True, False, True, False, True, True, True, False, True, True, False, True, True, True, True, True, True, True, True, True, False, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T379I	c.C1136T	p.T379I			29409	N	N	MISSENSE	238	238						140	98.0,0.0,0.0	C	T	AY.61	homoplasy	Borges et al. (2021)		In experimental models of SARS-CoV-2 mutational evolution (without immune pressure), this mutation appears convergent. 	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T391I	c.C1172T	p.T391I			29445	N	N	MISSENSE	122	27						7	115.0,0.0,0.0	C	T	AY.19, AY.86					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T4083T	c.G12249T	p.T4083T			12514	orf1ab	ORF1ab	SILENT	5	5			nsp8	produced by both pp1a and pp1ab	YP_009725304.1	4	1.0,0.0,0.0	G	T	AY.46.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T4087I	c.C12260T	p.T4087I			12525	orf1ab	ORF1ab	MISSENSE	6	6			nsp8	produced by both pp1a and pp1ab	YP_009725304.1	1	5.0,0.0,0.0	C	T	AY.99.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T4129I	c.C12386T	p.T4129I			12651	orf1ab	ORF1ab	MISSENSE	4	4			nsp8	produced by both pp1a and pp1ab	YP_009725304.1	2	2.0,0.0,0.0	C	T	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T4159I	c.C12476T	p.T4159I			12741	orf1ab	ORF1ab	MISSENSE	7	7			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab	YP_009725305.1	5	2.0,0.0,0.0	C	T	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T4164I	c.C12491T	p.T4164I			12756	orf1ab	ORF1ab	MISSENSE	130	130			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab	YP_009725305.1	0	130.0,0.0,0.0	C	T	AY.10					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T4354I	c.C13061T	p.T4354I			13326	orf1ab	ORF1ab	MISSENSE	48	48			nsp10	nsp10_CysHis, formerly known as growth-factor-like protein (GFL), produced by both pp1a and pp1ab	YP_009725306.1	13	35.0,0.0,0.0	C	T	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T4533A	c.A13597G	p.T4533A			13861	orf1ab	ORF1ab	MISSENSE	1	1			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	1.0,0.0,0.0	A	G	AY.73					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T4638T	c.C13914T	p.T4638T			14178	orf1ab	ORF1ab	SILENT	2	2			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	1	1.0,0.0,0.0	C	T	AY.104					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T478K	c.C1433A	p.T478K			22992	S	S	MISSENSE	90	20						0	12.0,78.0,0.0	GCAC	TCAA,GCAA	AY.107, AY.110, AY.108	immunosuppression variant emergence	Choi et al. (2020)		Combination of RBD mutations appeared (day 75) and persisted in chronic (152 day) SARS-CoV-2 infection of immunocompromised patient with severe antiphospholipid syndrome complicated by diffuse alveolar hemorrhage, who was receiving anticoagulation therapy, glucocorticoids, cyclophosphamide, and intermittent rituximab and eculizumab. 	False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T478K	c.C1433A	p.T478K			22995	S	S	MISSENSE	25917	1,924						2	25907.0,0.0,0.0	C	A	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.18, AY.102, AY.64, AY.4.2, AY.48, AY.65, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25	immunosuppression variant emergence	Choi et al. (2020)		Combination of RBD mutations appeared (day 75) and persisted in chronic (152 day) SARS-CoV-2 infection of immunocompromised patient with severe antiphospholipid syndrome complicated by diffuse alveolar hemorrhage, who was receiving anticoagulation therapy, glucocorticoids, cyclophosphamide, and intermittent rituximab and eculizumab. 	False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T5035I	c.C15104T	p.T5035I			15368	orf1ab	ORF1ab	MISSENSE	164	120			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	84	80.0,0.0,0.0	C	T	AY.15, AY.13, AY.75.1, AY.77					False	False, False, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T5036M	c.C15107T	p.T5036M			15371	orf1ab	ORF1ab	MISSENSE	9	9			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T5036T	c.G15108T	p.T5036T			15372	orf1ab	ORF1ab	SILENT	8	8			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	7	1.0,0.0,0.0	G	T	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T5131I	c.C15392T	p.T5131I			15656	orf1ab	ORF1ab	MISSENSE	3	3			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	3.0,0.0,0.0	C	T	AY.81					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T5195I	c.C15584T	p.T5195I			15848	orf1ab	ORF1ab	MISSENSE	160	160			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	113	47.0,0.0,0.0	C	T	AY.36					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T5198I	c.C15593T	p.T5198I			15857	orf1ab	ORF1ab	MISSENSE	6	6			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	5	1.0,0.0,0.0	C	T	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T5262I	c.C15785T	p.T5262I			16049	orf1ab	ORF1ab	MISSENSE	27	27			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	6	21.0,0.0,0.0	C	T	AY.109					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T568I	c.C1703T	p.T568I			1968	orf1ab	ORF1ab	MISSENSE	2	2			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	2.0,0.0,0.0	C	T	AY.60					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T5691I	c.C17072T	p.T5691I			17336	orf1ab	ORF1ab	MISSENSE	1	1			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	0	1.0,0.0,0.0	C	T	AY.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T572I	c.C1715T	p.T572I			23277	S	S	MISSENSE	37	2						24	13.0,0.0,0.0	C	T	AY.104, AY.16, AY.32					False	True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T5825A	c.A17473G	p.T5825A			17737	orf1ab	ORF1ab	MISSENSE	10	10			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	9	1.0,0.0,0.0	A	G	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T587T	c.A1761G	p.T587T			2026	orf1ab	ORF1ab	SILENT	30	30			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	26	4.0,0.0,0.0	A	G	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T588A	c.A1762G	p.T588A			23324	S	S	MISSENSE	25	25						18	7.0,0.0,0.0	A	G	AY.38					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T5941I	c.C17822T	p.T5941I			18086	orf1ab	ORF1ab	MISSENSE	440	25			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	16	424.0,0.0,0.0	C	T	AY.9.2, AY.9.1, AY.9.2.1, AY.9					False	True, False, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T5956I	c.C17867T	p.T5956I			18131	orf1ab	ORF1ab	MISSENSE	3	3			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	2	1.0,0.0,0.0	C	T	AY.53					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6022A	c.A18064G	p.T6022A			18328	orf1ab	ORF1ab	MISSENSE	11	11			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	9	2.0,0.0,0.0	A	G	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6028T	c.C18084T	p.T6028T			18348	orf1ab	ORF1ab	SILENT	28	25			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	17	11.0,0.0,0.0	C	T	AY.9.2, AY.53					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6131T	c.C18393T	p.T6131T			18657	orf1ab	ORF1ab	SILENT	152	152			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	120	32.0,0.0,0.0	C	T	AY.103					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6175I	c.C18524T	p.T6175I			18788	orf1ab	ORF1ab	MISSENSE	12	12			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	9	3.0,0.0,0.0	C	T	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T619A	c.A1855G	p.T619A			2120	orf1ab	ORF1ab	MISSENSE	7	7			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	6	1.0,0.0,0.0	A	G	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T61I	c.C182T	p.T61I			27575	ORF7a	ORF7a	MISSENSE	8	8						7	1.0,0.0,0.0	C	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6297I	c.C18890T	p.T6297I			19154	orf1ab	ORF1ab	MISSENSE	48	48			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	13	35.0,0.0,0.0	C	T	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6499T	c.A19497G	p.T6499T			19761	orf1ab	ORF1ab	SILENT	7	7			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	6	1.0,0.0,0.0	A	G	AY.100					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6500I	c.C19499T	p.T6500I			19763	orf1ab	ORF1ab	MISSENSE	30	30			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	26	4.0,0.0,0.0	C	T	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6550T	c.T19650C	p.T6550T			19914	orf1ab	ORF1ab	SILENT	2	2			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	1	1.0,0.0,0.0	T	C	AY.84					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6566T	c.G19698T	p.T6566T			19962	orf1ab	ORF1ab	SILENT	6	6			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	5	1.0,0.0,0.0	G	T	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6777I	c.C20330T	p.T6777I			20594	orf1ab	ORF1ab	MISSENSE	5	5			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	4	1.0,0.0,0.0	C	T	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6792T	c.A20376G	p.T6792T			20640	orf1ab	ORF1ab	SILENT	20	20			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	18	2.0,0.0,0.0	A	G	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6889M	c.C20666T	p.T6889M			20930	orf1ab	ORF1ab	MISSENSE	10	10			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	8	2.0,0.0,0.0	C	T	AY.65					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6891T	c.G20673T	p.T6891T			20937	orf1ab	ORF1ab	SILENT	1952	1,924			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	1673	276.0,0.0,0.0	G	T	B.1.617.2, AY.12, AY.88, AY.92					False	False, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T6938I	c.C20813T	p.T6938I			21077	orf1ab	ORF1ab	MISSENSE	160	160			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	129	31.0,0.0,0.0	C	T	AY.36					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T724T	c.A2172G	p.T724T			23734	S	S	SILENT	130	130						1	129.0,0.0,0.0	A	G	AY.10					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T732T	c.C2196T	p.T732T			23758	S	S	SILENT	77	78						33	44.0,0.0,0.0	C	T	AY.20					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T778T	c.C2334T	p.T778T			23896	S	S	SILENT	6	6						2	4.0,0.0,0.0	C	T	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T791I	c.C2372T	p.T791I			23934	S	S	MISSENSE	14	3						9	5.0,0.0,0.0	C	T	AY.12, AY.23					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T882T	c.T2646G	p.T882T			2911	orf1ab	ORF1ab	SILENT	52	52			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	15	37.0,0.0,0.0	T	G	AY.26					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T89T	c.A267C	p.T89T			25659	ORF3a	ORF3a	SILENT	1	1						0	1.0,0.0,0.0	A	C	AY.111					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T95I	c.C284T	p.T95I			21846	S	S	MISSENSE	2458	1,924						1300	1158.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.111, AY.104, AY.100, AY.106, AY.29, AY.107, AY.110, AY.1, AY.34, AY.4.5, AY.33, AY.102, AY.4.2, AY.4, AY.36, AY.20, AY.39, AY.46, AY.92, AY.42, AY.108, AY.85, AY.39.1, AY.4.3	ACE2 receptor binding affinity	Gong et al. (2021)	'D614G'	Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.33x decrease in binding (KD) relative to D614G.	False	False, True, True, True, True, False, True, True, True, True, True, True, False, True, True, True, True, True, True, False, False, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T95I	c.C284T	p.T95I			21846	S	S	MISSENSE	2458	1,924						1300	1158.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.111, AY.104, AY.100, AY.106, AY.29, AY.107, AY.110, AY.1, AY.34, AY.4.5, AY.33, AY.102, AY.4.2, AY.4, AY.36, AY.20, AY.39, AY.46, AY.92, AY.42, AY.108, AY.85, AY.39.1, AY.4.3	convalescent plasma binding	Gong et al. (2021)	'D614G'	No change in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.	False	False, True, True, True, True, False, True, True, True, True, True, True, False, True, True, True, True, True, True, False, False, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T95I	c.C284T	p.T95I			21846	S	S	MISSENSE	2458	1,924						1300	1158.0,0.0,0.0	C	T	B.1.617.2, AY.109, AY.111, AY.104, AY.100, AY.106, AY.29, AY.107, AY.110, AY.1, AY.34, AY.4.5, AY.33, AY.102, AY.4.2, AY.4, AY.36, AY.20, AY.39, AY.46, AY.92, AY.42, AY.108, AY.85, AY.39.1, AY.4.3	vaccinee plasma binding	Gong et al. (2021)	'D614G'	1.16x increase in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.02x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.	False	False, True, True, True, True, False, True, True, True, True, True, True, False, True, True, True, True, True, True, False, False, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.T987I	c.C2960T	p.T987I			3225	orf1ab	ORF1ab	MISSENSE	10	11			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	9	1.0,0.0,0.0	C	T	AY.23					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.T9I	c.C26T	p.T9I			26270	E	E	MISSENSE	410	394						210	200.0,0.0,0.0	C	T	AY.9.2.1, AY.9	homoplasy	Borges et al. (2021)		In experimental models of SARS-CoV-2 mutational evolution (without immune pressure), this mutation appears convergent. 	False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.TY39IN	c.CAT116_118TAA	p.TY39IN			27509	ORF7a	ORF7a		12	12						10	2.0,0.0,0.0	CAT	TAA	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1008V	c.G3024T	p.V1008V			24586	S	S	SILENT	1	1						0	1.0,0.0,0.0	G	T	AY.4.3					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1019V	c.T3057C	p.V1019V			3322	orf1ab	ORF1ab	SILENT	20	20			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	18	2.0,0.0,0.0	T	C	AY.107					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1040A	c.T3119C	p.V1040A			24681	S	S	MISSENSE	16	16						14	2.0,0.0,0.0	T	C	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1046V	c.G3138T	p.V1046V			3403	orf1ab	ORF1ab	SILENT	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	G	T	AY.7.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1056V	c.G3168T	p.V1056V			3433	orf1ab	ORF1ab	SILENT	24	24			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	21	3.0,0.0,0.0	G	T	AY.39					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1061V	c.C3183T	p.V1061V			24745	S	S	SILENT	26	16						5	21.0,0.0,0.0	C	T	AY.40, AY.45, AY.81, AY.51					False	True, False, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1063F	c.G3187T	p.V1063F			3452	orf1ab	ORF1ab	MISSENSE	8	8			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	7	1.0,0.0,0.0	G	T	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1096I	c.G3286A	p.V1096I			24848	S	S	MISSENSE	5	5						4	1.0,0.0,0.0	G	A	AY.32					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1104L	c.G3310T	p.V1104L			24872	S	S	MISSENSE	255	160						16	239.0,0.0,0.0	G	T	AY.36, AY.20, AY.92					False	True, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1122V	c.G3366T	p.V1122V			24928	S	S	SILENT	22	9						9	13.0,0.0,0.0	G	T	AY.106, AY.5, AY.72					False	False, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1143F	c.G3427T	p.V1143F			3692	orf1ab	ORF1ab	MISSENSE	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	1.0,0.0,0.0	G	T	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1173V	c.C3519T	p.V1173V			3784	orf1ab	ORF1ab	SILENT	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	1.0,0.0,0.0	C	T	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1177L	c.G3529T	p.V1177L			25091	S	S	MISSENSE	1	1						0	1.0,0.0,0.0	G	T	AY.67					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1264L	c.G3790T	p.V1264L			25352	S	S	MISSENSE	73	52						8	65.0,0.0,0.0	G	T	AY.26, AY.65, AY.23					False	True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V127I	c.G379A	p.V127I			21941	S	S	MISSENSE	5	6						3	2.0,0.0,0.0	G	A	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1299V	c.G3897T	p.V1299V			4162	orf1ab	ORF1ab	SILENT	2	2			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	2.0,0.0,0.0	G	T	AY.60					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V143V	c.G429C	p.V143V			26951	M	M	SILENT	17	17						15	2.0,0.0,0.0	G	C	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1550F	c.G4648T	p.V1550F			4913	orf1ab	ORF1ab	MISSENSE	7100	7,103			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	6315	785.0,0.0,0.0	G	T	AY.27					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1565V	c.G4695T	p.V1565V			4960	orf1ab	ORF1ab	SILENT	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	1.0,0.0,0.0	G	T	AY.55					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1570V	c.G4710A	p.V1570V			4975	orf1ab	ORF1ab	SILENT	8	8			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	2	6.0,0.0,0.0	G	A	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1583V	c.T4749C	p.V1583V			5014	orf1ab	ORF1ab	SILENT	157	160			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	118	39.0,0.0,0.0	T	C	AY.36					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V169V	c.T507C	p.V169V			772	orf1ab	ORF1ab	SILENT	20	20			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	18	2.0,0.0,0.0	T	C	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1722V	c.A5166G	p.V1722V			5431	orf1ab	ORF1ab	SILENT	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	3	2.0,0.0,0.0	A	G	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V1750A	c.T5249C	p.V1750A			5514	orf1ab	ORF1ab	MISSENSE	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	1	6.0,0.0,0.0	T	C	AY.29					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V186V	c.C558T	p.V186V			823	orf1ab	ORF1ab	SILENT	22	22			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	2	20.0,0.0,0.0	C	T	AY.108					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V197V	c.A591G	p.V197V			25983	ORF3a	ORF3a	SILENT	27	27						23	4.0,0.0,0.0	A	G	AY.109					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V202L	c.G604T	p.V202L			25996	ORF3a	ORF3a	MISSENSE	31	7						27	4.0,0.0,0.0	G	T	AY.29, AY.33					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V2071F	c.G6211T	p.V2071F			6476	orf1ab	ORF1ab	MISSENSE	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	G	T	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V2072V	c.A6216G	p.V2072V			6481	orf1ab	ORF1ab	SILENT	5	5			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	4	1.0,0.0,0.0	A	G	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V2090I	c.G6268A	p.V2090I			6533	orf1ab	ORF1ab	MISSENSE	17	17			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	8	9.0,0.0,0.0	G	A	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V213V	c.G639T	p.V213V			22201	S	S	SILENT	50	25						34	16.0,0.0,0.0	G	T	AY.9.2, AY.9.2					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V227I	c.G679A	p.V227I			22241	S	S	MISSENSE	4	2						2	2.0,0.0,0.0	G	A	AY.39.1, AY.39.1					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V228V	c.T684A	p.V228V			26076	ORF3a	ORF3a	SILENT	30	30						16	14.0,0.0,0.0	T	A	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V2436V	c.C7308T	p.V2436V			7573	orf1ab	ORF1ab	SILENT	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	1.0,0.0,0.0	C	T	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V2613F	c.G7837T	p.V2613F			8102	orf1ab	ORF1ab	MISSENSE	6	6			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	1.0,0.0,0.0	G	T	AY.17					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V2715F	c.G8143T	p.V2715F			8408	orf1ab	ORF1ab	MISSENSE	1	1			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	1.0,0.0,0.0	G	T	AY.111					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V274V	c.A822G	p.V274V			1087	orf1ab	ORF1ab	SILENT	549	550			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	1	548.0,0.0,0.0	A	G	AY.93					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V289I	c.G865A	p.V289I			22427	S	S	MISSENSE	34	34						2	31.0,0.0,0.0	G	A	AY.47					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V28I	c.G82A	p.V28I			347	orf1ab	ORF1ab	MISSENSE	22	22			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	19	3.0,0.0,0.0	G	A	AY.108					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V2930L	c.G8788T	p.V2930L			9051	orf1ab	ORF1ab	MISSENSE	33	11			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	1	3.0,29.0,0.0	CAG	TAT,CAT	AY.5, AY.108					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V2930L	c.G8788T	p.V2930L			9053	orf1ab	ORF1ab	MISSENSE	12951	1,924			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	726	12225.0,0.0,0.0	G	T	B.1.617.2, AY.109, AY.19, AY.111, AY.104, AY.103, AY.100, AY.106, AY.12, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.46.4, AY.4.5, AY.44, AY.33, AY.46.2, AY.41, AY.102, AY.4.2, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.20, AY.32, AY.39, AY.46, AY.43, AY.9.1, AY.46.1, AY.92, AY.42, AY.98.1, AY.87, AY.85, AY.39.1, AY.46.6, AY.4.3, AY.99.2, AY.93, AY.82, AY.84, AY.99, AY.7.1, AY.25					False	False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V29L	c.G85T	p.V29L			27478	ORF7a	ORF7a	MISSENSE	5	5						2	3.0,0.0,0.0	G	T	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V306F	c.G916T	p.V306F			1181	orf1ab	ORF1ab	MISSENSE	9	9			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	8	1.0,0.0,0.0	G	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V308L	c.G922T	p.V308L			22484	S	S	MISSENSE	20	20						18	2.0,0.0,0.0	G	T	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V3331V	c.A9993G	p.V3331V			10258	orf1ab	ORF1ab	SILENT	6	6			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	4	2.0,0.0,0.0	A	G	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V3420V	c.C10260T	p.V3420V			10525	orf1ab	ORF1ab	SILENT	12	12			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	10	2.0,0.0,0.0	C	T	AY.42					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V35V	c.G105T	p.V35V			370	orf1ab	ORF1ab	SILENT	22	22			leader protein	nsp1, produced by both pp1a and pp1ab	YP_009725297.1	2	20.0,0.0,0.0	G	T	AY.108					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V3660L	c.G10978T	p.V3660L			11243	orf1ab	ORF1ab	MISSENSE	5	5			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	4	1.0,0.0,0.0	G	T	AY.46.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V367L	c.G1099C	p.V367L			22661	S	S	MISSENSE	2	2	mask	ambiguous,homoplasic,single_src				0	2.0,0.0,0.0	G	C	AY.37	gene expression increase	Starr et al. (2020)		Experimentally, Spike gene expression increased 0.15 fold	False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V3689V	c.A11067G	p.V3689V			11332	orf1ab	ORF1ab	SILENT	11978	1,924			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	726	11249.0,0.0,0.0	A	G	B.1.617.2, AY.109, AY.19, AY.111, AY.104, AY.103, AY.100, AY.106, AY.12, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.46.4, AY.4.5, AY.44, AY.33, AY.46.2, AY.41, AY.102, AY.4.2, AY.4, AY.23, AY.45, AY.6, AY.36, AY.91, AY.3, AY.86, AY.88, AY.5, AY.20, AY.32, AY.39, AY.46, AY.43, AY.9.1, AY.46.1, AY.92, AY.42, AY.98.1, AY.87, AY.108, AY.85, AY.39.1, AY.46.6, AY.4.3, AY.99.2, AY.93, AY.82, AY.84, AY.99, AY.7.1, AY.25					False	False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True, True, True, False, True, True, True, True, True, True, False, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V3690V	c.G11070T	p.V3690V			11335	orf1ab	ORF1ab	SILENT	6	6			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	5	1.0,0.0,0.0	G	T	AY.57					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V3700V	c.G11100T	p.V3700V			11365	orf1ab	ORF1ab	SILENT	1	1			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	0	1.0,0.0,0.0	G	T	AY.7.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V3714V	c.C11142T	p.V3714V			11407	orf1ab	ORF1ab	SILENT	24	24			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	21	3.0,0.0,0.0	C	T	AY.33					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V3718A	c.T11153C	p.V3718A			11418	orf1ab	ORF1ab	MISSENSE	14966	1,924			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	1473	13493.0,0.0,0.0	T	C	B.1.617.2, AY.19, AY.28, AY.16, AY.106, AY.40, AY.15, AY.14, AY.26, AY.2, AY.13, AY.17, AY.38, AY.10, AY.75.1, AY.18, AY.64, AY.65, AY.45, AY.60, AY.88, AY.57, AY.35, AY.72, AY.59, AY.9.2, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.73, AY.81, AY.54, AY.61, AY.9.2.1, AY.67, AY.37, AY.53, AY.63, AY.77, AY.9, AY.24, AY.68, AY.70, AY.51, AY.62, AY.74, AY.27					False	False, False, True, True, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, False, True, True, True, False, True, True, False, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, False, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V382V	c.G1146T	p.V382V			22708	S	S	SILENT	6	6						5	1.0,0.0,0.0	G	T	AY.70					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V392V	c.G1176T	p.V392V			29449	N	N	SILENT	16	16						14	2.0,0.0,0.0	G	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V395V	c.C1185T	p.V395V			22747	S	S	SILENT	4	2						0	4.0,0.0,0.0	C	T	AY.84, AY.84					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V407V	c.C1221T	p.V407V			22783	S	S	SILENT	30	15						0	30.0,0.0,0.0	C	T	AY.82, AY.82					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V4102L	c.G12304T	p.V4102L			12569	orf1ab	ORF1ab	MISSENSE	25	20			nsp8	produced by both pp1a and pp1ab	YP_009725304.1	9	16.0,0.0,0.0	G	T	AY.64, AY.55					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V4250L	c.G12748T	p.V4250L			13013	orf1ab	ORF1ab	MISSENSE	1	1			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab	YP_009725305.1	0	1.0,0.0,0.0	G	T	AY.67					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V4406V	c.A13218G	p.V4406V			13482	orf1ab	ORF1ab	SILENT	2	2			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	2.0,0.0,0.0	A	G	AY.39.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V4594V	c.T13782A	p.V4594V			14046	orf1ab	ORF1ab	SILENT	6	6			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	3	3.0,0.0,0.0	T	A	AY.63					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V464I	c.G1390A	p.V464I			1655	orf1ab	ORF1ab	MISSENSE	17	17			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	8	9.0,0.0,0.0	G	A	AY.92					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V4802V	c.C14406T	p.V4802V			14670	orf1ab	ORF1ab	SILENT	16	16			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	14	2.0,0.0,0.0	C	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V4816V	c.G14448T	p.V4816V			14712	orf1ab	ORF1ab	SILENT	15	16			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	10	5.0,0.0,0.0	G	T	AY.40					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V483A	c.T1448C	p.V483A			23010	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	antibody epitope effects	Gaebler et al. (2021)		Ablates binding by class 3 mAbs such as C135 that do not directly interfere with ACE2 binding, but clonal somatic mutations of memory B cells at 6.2 months (evolving humoral immune response) show pronounced increase in binding to the variant.	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V483A	c.T1448C	p.V483A			23010	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	antibody epitope effects	Li et al. (2020)		Resistent to some neutralizing antibodies: mAbs X593 and P2B-2F6	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V483A	c.T1448C	p.V483A			23010	S	S	MISSENSE	22	22						18	4.0,0.0,0.0	T	C	AY.108	gene expression increase	Starr et al. (2020)		Experimentally, Spike gene expression increased 0.09 fold	False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V4887V	c.C14661T	p.V4887V			14925	orf1ab	ORF1ab	SILENT	28	28			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	23	5.0,0.0,0.0	C	T	AY.46					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V488V	c.G1464A	p.V488V			1729	orf1ab	ORF1ab	SILENT	440	25			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	17	423.0,0.0,0.0	G	A	AY.9.2, AY.9.1, AY.9.2.1, AY.9					False	True, False, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V491V	c.G1473T	p.V491V			1738	orf1ab	ORF1ab	SILENT	3	3			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	3.0,0.0,0.0	G	T	AY.53					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V4952V	c.C14856T	p.V4952V			15120	orf1ab	ORF1ab	SILENT	24	24			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	19	5.0,0.0,0.0	C	T	AY.33					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V503I	c.G1507A	p.V503I			23069	S	S	MISSENSE	3	3						2	1.0,0.0,0.0	G	A	AY.53					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5096A	c.T15287C	p.V5096A			15551	orf1ab	ORF1ab	MISSENSE	5	5			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	4	1.0,0.0,0.0	T	C	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V50I	c.G148A	p.V50I			25540	ORF3a	ORF3a	MISSENSE	6	6						3	3.0,0.0,0.0	G	A	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5168V	c.G15504T	p.V5168V			15768	orf1ab	ORF1ab	SILENT	20	20			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	15	5.0,0.0,0.0	G	T	AY.107					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5358V	c.C16074T	p.V5358V			16338	orf1ab	ORF1ab	SILENT	7138	25			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	356	6782.0,0.0,0.0	C	T	AY.38, AY.67, AY.9, AY.27					False	False, True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5493F	c.G16477T	p.V5493F			16741	orf1ab	ORF1ab	MISSENSE	5	5			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	4	1.0,0.0,0.0	G	T	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5493G	c.T16478G	p.V5493G			16742	orf1ab	ORF1ab	MISSENSE	12	12			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	4	8.0,0.0,0.0	T	G	AY.42					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5550V	c.G16650T	p.V5550V			16914	orf1ab	ORF1ab	SILENT	1	1			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	0	1.0,0.0,0.0	G	T	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5672L	c.G17014T	p.V5672L			17278	orf1ab	ORF1ab	MISSENSE	1	1			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	0	1.0,0.0,0.0	G	T	AY.85					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5680V	c.C17040T	p.V5680V			17304	orf1ab	ORF1ab	SILENT	6	6			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	3	3.0,0.0,0.0	C	T	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5721V	c.G17163T	p.V5721V			17427	orf1ab	ORF1ab	SILENT	22	22			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	18	4.0,0.0,0.0	G	T	AY.108					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V576V	c.C1728T	p.V576V			23290	S	S	SILENT	16	16						14	2.0,0.0,0.0	C	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5819V	c.G17457T	p.V5819V			17721	orf1ab	ORF1ab	SILENT	3	3			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	2	1.0,0.0,0.0	G	T	AY.46.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5845V	c.A17535G	p.V5845V			17799	orf1ab	ORF1ab	SILENT	11	1			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	5	6.0,0.0,0.0	A	G	AY.46.2, AY.65					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V58V	c.T174C	p.V58V			26418	E	E	SILENT	30	30						26	4.0,0.0,0.0	T	C	AY.16					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5939L	c.G17815T	p.V5939L			18079	orf1ab	ORF1ab	MISSENSE	160	160			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	0	160.0,0.0,0.0	G	T	AY.36					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5954V	c.T17862C	p.V5954V			18126	orf1ab	ORF1ab	SILENT	5	5			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	4	1.0,0.0,0.0	T	C	AY.46.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V5_F6del	c.13_18delGTTTTC	p.V5_F6del			27905	ORF8	ORF8		4	17						0	4.0,0.0,0.0	TGTTTTC	T	AY.18					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V6043I	c.G18127A	p.V6043I			18391	orf1ab	ORF1ab	MISSENSE	5	5			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	4	1.0,0.0,0.0	G	A	AY.9.1					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V6061I	c.G18181A	p.V6061I			18445	orf1ab	ORF1ab	MISSENSE	8	8	caution	single_src,highly_ambiguous	3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	7	1.0,0.0,0.0	G	A	AY.88					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V6161V	c.C18483T	p.V6161V			18747	orf1ab	ORF1ab	SILENT	47	27			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	36	11.0,0.0,0.0	C	T	AY.109, AY.64					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V622F	c.G1864T	p.V622F			23426	S	S	MISSENSE	17	17						9	8.0,0.0,0.0	G	T	AY.18					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V627F	c.G1879T	p.V627F			2144	orf1ab	ORF1ab	MISSENSE	3	3			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	2	1.0,0.0,0.0	G	T	AY.41					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V62F	c.G184T	p.V62F			26428	E	E	MISSENSE	21	20						17	4.0,0.0,0.0	G	T	AY.64, AY.85					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V6474L	c.G19420T	p.V6474L			19684	orf1ab	ORF1ab	MISSENSE	7	7			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	6	1.0,0.0,0.0	G	T	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V6573V	c.C19719T	p.V6573V			19983	orf1ab	ORF1ab	SILENT	3	3			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	0	3.0,0.0,0.0	C	T	AY.12					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V6579F	c.G19735T	p.V6579F			19999	orf1ab	ORF1ab	MISSENSE	25	25			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	12	13.0,0.0,0.0	G	T	AY.9.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V6607V	c.A19821G	p.V6607V			20085	orf1ab	ORF1ab	SILENT	1	1			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	0	1.0,0.0,0.0	A	G	AY.62					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V6638V	c.C19914T	p.V6638V			20178	orf1ab	ORF1ab	SILENT	12	12			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	9	3.0,0.0,0.0	C	T	AY.14					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V665I	c.G1993A	p.V665I			2258	orf1ab	ORF1ab	MISSENSE	12	12			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	12.0,0.0,0.0	G	A	AY.42					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V66L	c.G196T	p.V66L			26718	M	M	MISSENSE	27	27						5	22.0,0.0,0.0	G	T	AY.19					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V6772L	c.G20314T	p.V6772L			20578	orf1ab	ORF1ab	MISSENSE	27	5			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	21	6.0,0.0,0.0	G	T	AY.9.1, AY.108					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V6842V	c.C20526T	p.V6842V			20790	orf1ab	ORF1ab	SILENT	9	9			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	8	1.0,0.0,0.0	C	T	AY.106					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V6894V	c.C20682T	p.V6894V			20946	orf1ab	ORF1ab	SILENT	160	160			2'-O-ribose methyltransferase	nsp16_OMT, 2'-o-MT, produced by pp1ab only	YP_009725311.1	144	16.0,0.0,0.0	C	T	AY.36					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V71I	c.G211A	p.V71I			27604	ORF7a	ORF7a	MISSENSE	25	24						2	23.0,0.0,0.0	G	A	AY.39, AY.39.1					False	True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V751V	c.G2253T	p.V751V			2518	orf1ab	ORF1ab	SILENT	15	15			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	0	15.0,0.0,0.0	G	T	AY.98.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V82A	c.T245C	p.V82A			27638	ORF7a	ORF7a	MISSENSE	25772	1,924						6	25766.0,0.0,0.0	T	C	B.1.617.2, AY.109, AY.19, AY.28, AY.111, AY.104, AY.103, AY.16, AY.100, AY.106, AY.40, AY.12, AY.15, AY.14, AY.26, AY.29, AY.3.1, AY.107, AY.110, AY.1, AY.34, AY.2, AY.13, AY.17, AY.38, AY.46.4, AY.4.5, AY.44, AY.10, AY.75.1, AY.33, AY.46.2, AY.41, AY.18, AY.102, AY.64, AY.4.2, AY.65, AY.4, AY.23, AY.45, AY.6, AY.91, AY.60, AY.3, AY.86, AY.88, AY.5, AY.57, AY.20, AY.32, AY.39, AY.35, AY.46, AY.72, AY.59, AY.9.2, AY.43, AY.9.1, AY.75, AY.47, AY.46.1, AY.55, AY.92, AY.42, AY.73, AY.98.1, AY.108, AY.81, AY.54, AY.61, AY.85, AY.9.2.1, AY.67, AY.37, AY.39.1, AY.46.6, AY.4.3, AY.53, AY.63, AY.99.2, AY.93, AY.82, AY.77, AY.9, AY.24, AY.84, AY.68, AY.99, AY.70, AY.51, AY.62, AY.7.1, AY.74, AY.27, AY.25					False	True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.V879I	c.G2635A	p.V879I			2900	orf1ab	ORF1ab	MISSENSE	25	25			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	22	3.0,0.0,0.0	G	A	AY.9.2					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V90V	c.T270G	p.V90V			25662	ORF3a	ORF3a	SILENT	95	95						78	17.0,0.0,0.0	T	G	AY.86					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.V93F	c.G277T	p.V93F			27670	ORF7a	ORF7a	MISSENSE	23	1						19	4.0,0.0,0.0	G	T	AY.3.1, AY.39					False	True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.W131C	c.G393T	p.W131C			25785	ORF3a	ORF3a	MISSENSE	8	2						4	4.0,0.0,0.0	G	T	AY.104, AY.63					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.W45L	c.G134T	p.W45L			28027	ORF8	ORF8	MISSENSE	15	15						0	15.0,0.0,0.0	G	T	AY.82					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y111H	c.T331C	p.Y111H			28224	ORF8	ORF8	MISSENSE	550	550						441	109.0,0.0,0.0	T	C	AY.93					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y1155H	c.T3463C	p.Y1155H			25025	S	S	MISSENSE	19	20						17	2.0,0.0,0.0	T	C	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y1337Y	c.C4011T	p.Y1337Y			4276	orf1ab	ORF1ab	SILENT	30	30			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	27	3.0,0.0,0.0	C	T	AY.75					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y144H	c.T430C	p.Y144H			21992	S	S	MISSENSE	3	3						2	1.0,0.0,0.0	T	C	AY.53					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y145H	c.T433C	p.Y145H			21995	S	S	MISSENSE	6	6						0	6.0,0.0,0.0	T	C	AY.4.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y160Y	c.C480T	p.Y160Y			25872	ORF3a	ORF3a	SILENT	12	12						1	11.0,0.0,0.0	C	T	AY.42					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y1658Y	c.C4974T	p.Y1658Y			5239	orf1ab	ORF1ab	SILENT	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	0	7.0,0.0,0.0	C	T	AY.29					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y1700Y	c.C5100T	p.Y1700Y			5365	orf1ab	ORF1ab	SILENT	7	7			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	6	1.0,0.0,0.0	C	T	AY.29					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y1770Y	c.C5310T	p.Y1770Y			5575	orf1ab	ORF1ab	SILENT	16	16			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	14	2.0,0.0,0.0	C	T	AY.9					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y179Y	c.C537T	p.Y179Y			27059	M	M	SILENT	43	43						20	23.0,0.0,0.0	C	T	AY.54					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y1868Y	c.C5604T	p.Y1868Y			5869	orf1ab	ORF1ab	SILENT	152	152			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	134	18.0,0.0,0.0	C	T	AY.103					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y18Y	c.T54C	p.Y18Y			27447	ORF7a	ORF7a	SILENT	48	48						14	34.0,0.0,0.0	T	C	AY.110					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y1900Y	c.T5700C	p.Y1900Y			5965	orf1ab	ORF1ab	SILENT	550	550			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	488	62.0,0.0,0.0	T	C	AY.93					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y204Y	c.T612C	p.Y204Y			27134	M	M	SILENT	1	1						0	1.0,0.0,0.0	T	C	AY.111					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y211H	c.T631C	p.Y211H			26023	ORF3a	ORF3a	MISSENSE	22	22						17	5.0,0.0,0.0	T	C	AY.108					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y2561Y	c.C7683T	p.Y2561Y			7948	orf1ab	ORF1ab	SILENT	27	27			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab	YP_009725299.1	5	22.0,0.0,0.0	C	T	AY.109					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y2897Y	c.C8691T	p.Y2897Y			8956	orf1ab	ORF1ab	SILENT	152	152			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	121	31.0,0.0,0.0	C	T	AY.103					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y298Y	c.C894T	p.Y298Y			29167	N	N	SILENT	24	7						20	4.0,0.0,0.0	C	T	AY.34, AY.92					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y3062Y	c.C9186T	p.Y3062Y			9451	orf1ab	ORF1ab	SILENT	7	7			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	6	1.0,0.0,0.0	C	T	AY.34					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y3098Y	c.C9294T	p.Y3098Y			9559	orf1ab	ORF1ab	SILENT	31	7			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	19	12.0,0.0,0.0	C	T	AY.100, AY.108, AY.37					False	True, False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y3190Y	c.T9570C	p.Y3190Y			9835	orf1ab	ORF1ab	SILENT	2	2			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab	YP_009725300.1	1	1.0,0.0,0.0	T	C	AY.72					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y31F	c.A92T	p.Y31F			27985	ORF8	ORF8	MISSENSE	7	7						5	2.0,0.0,0.0	A	T	AY.100					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y3417Y	c.T10251C	p.Y3417Y			10516	orf1ab	ORF1ab	SILENT	1	1			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab	YP_009725301.1	0	1.0,0.0,0.0	T	C	AY.4.3					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y3765C	c.A11294G	p.Y3765C			11559	orf1ab	ORF1ab	MISSENSE	8	8			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	7	1.0,0.0,0.0	A	G	AY.46.6					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y3803Y	c.C11409T	p.Y3803Y			11674	orf1ab	ORF1ab	SILENT	6	6			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	3	3.0,0.0,0.0	C	T	AY.63					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y3813Y	c.C11439T	p.Y3813Y			11704	orf1ab	ORF1ab	SILENT	5	5			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab	YP_009725302.1	4	1.0,0.0,0.0	C	T	AY.35					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y4171Y	c.C12513T	p.Y4171Y			12778	orf1ab	ORF1ab	SILENT	20	20			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab	YP_009725305.1	18	2.0,0.0,0.0	C	T	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y4172Y	c.C12516T	p.Y4172Y			12781	orf1ab	ORF1ab	SILENT	1	1			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab	YP_009725305.1	0	1.0,0.0,0.0	C	T	AY.91					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y4227Y	c.T12681C	p.Y4227Y			12946	orf1ab	ORF1ab	SILENT	2256	1,924			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab	YP_009725305.1	1672	584.0,0.0,0.0	T	C	B.1.617.2, AY.19, AY.16, AY.40, AY.15, AY.14, AY.13, AY.17, AY.75.1, AY.18, AY.45, AY.81, AY.54, AY.53, AY.77, AY.68, AY.51					False	False, False, True, True, True, True, True, True, False, True, False, True, True, True, True, False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y4479Y	c.T13437C	p.Y4479Y			13701	orf1ab	ORF1ab	SILENT	2	2			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	2.0,0.0,0.0	T	C	AY.60					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y4812Y	c.T14436C	p.Y4812Y			14700	orf1ab	ORF1ab	SILENT	28	28			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	25	3.0,0.0,0.0	T	C	AY.46					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y49H	c.T145C	p.Y49H			27346	ORF6	ORF6	MISSENSE	1	1						0	1.0,0.0,0.0	T	C	AY.77					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y508Y	c.C1524T	p.Y508Y			23086	S	S	SILENT	19	20						17	2.0,0.0,0.0	C	T	AY.64					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y5111C	c.A15332G	p.Y5111C			15596	orf1ab	ORF1ab	MISSENSE	6	6			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	3	3.0,0.0,0.0	A	G	AY.24					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y5138Y	c.C15414T	p.Y5138Y			15678	orf1ab	ORF1ab	SILENT	1	1			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	0	1.0,0.0,0.0	C	T	AY.46.2					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y5276Y	c.C15828T	p.Y5276Y			16092	orf1ab	ORF1ab	SILENT	562	152			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only	YP_009725307.1	147	415.0,0.0,0.0	C	T	AY.103, AY.9.2.1, AY.9					False	False, True, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y534Y	c.T1602C	p.Y534Y			1867	orf1ab	ORF1ab	SILENT	4	4			nsp2	produced by both pp1a and pp1ab	YP_009725298.1	3	1.0,0.0,0.0	T	C	AY.68					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y5444Y	c.C16332T	p.Y5444Y			16596	orf1ab	ORF1ab	SILENT	34	34			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only	YP_009725308.1	27	7.0,0.0,0.0	C	T	AY.47					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y6160Y	c.C18480T	p.Y6160Y			18744	orf1ab	ORF1ab	SILENT	244	130			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	178	66.0,0.0,0.0	C	T	AY.10, AY.43					False	False, False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y636Y	c.T1908C	p.Y636Y			23470	S	S	SILENT	47	30						15	32.0,0.0,0.0	T	C	AY.16, AY.18					False	False, True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y6436Y	c.C19308T	p.Y6436Y			19572	orf1ab	ORF1ab	SILENT	5	5			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only	YP_009725309.1	4	1.0,0.0,0.0	C	T	AY.45					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y6645Y	c.C19935T	p.Y6645Y			20199	orf1ab	ORF1ab	SILENT	1	1			endoRNAse	nsp15-A1 and nsp15B-NendoU, produced by pp1ab only	YP_009725310.1	0	1.0,0.0,0.0	C	T	AY.3.1					False	True	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y86Y	c.C258T	p.Y86Y			28531	N	N	SILENT	78	79						54	24.0,0.0,0.0	C	T	AY.4					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
p.Y97H	c.T289C	p.Y97H			27682	ORF7a	ORF7a	MISSENSE	2	2						1	1.0,0.0,0.0	T	C	AY.72					False	False	Delta	VOC	04-Apr-2021	11-May-2021	
